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1.1   The  importance  of  human  hair  Hair   plays   a   vital   role   in   a   person's   appearance,   self-­‐image   and  communication  with   other   people   both   in   social   and   sexual   contexts   throughout  life.    This  provides  insight  into  why  it  is  possible  for  hair  growth  disorders  to  be  at  the  root  of  serious  psychological  distress  (Girman  et  al.,  1998;  Gulec  et  al.,  2004).      The   hair   follicle,   which   produces   the   hair,   represents   an   attractive  experimental   system  because   of   its   accessibility,   dispensability,   and   self-­‐renewal  capacity.  Owing   to   its   complex,  but  highly  organised  architecture,   this  miniorgan  can  serve  as  an  excellent  model  for  investigating  aspects  of  stem  cell  biology,  cell  lineage   specification,   cell   differentiation,   patterning   processes,   and   cellȂcell  interactions  (Schlake,  2007).      Its   exceptional  ability   to  regenerate   is  of  particular  interest  to  cell  and  developmental  biologists,  with  its  fascinating  recapitulation  of  the  steps  of  embryogenesis  (Dry,  1926;  Kligman,  1959b).    Zoologists  are  interested  in  the  insulation  function  of  the  hair  follicle  that  makes  it  an  essential  mammalian  characteristic   for   warm   bloodedness   and   crucial   for   their   evolutionary   success  (Young,   1957),   while   endocrinologists   perceive   the   hair   follicle   as   a   paradoxical  tissue,  that  can  simultaneously  stimulate  hair  growth  in  one  area  of  the  body,  like  the   chin,   whilst   inhibiting   growth   in   another,   such   as   the   scalp,   causing   balding  (Randall,  1994;  Randall,  2004).      
1.2   Functions  of  Hair  The  most  important  functions  of  hair  for  most  mammals  are  insulation  for  thermoregulation  and  hair  pigmentation  for  purposes  of  camouflage   (Flux,  1970).    Hair  can  also  be  specialised  as  neuroreceptors  in  certain  mammals,  (e.g.  whiskers)  
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and  provides  a  protective  physical  coating  from  harmful  rays  like  ultraviolet  rays  and  other  factors  (Oliver  and  Jahoda,  1989).    For  human  beings,  however,  such  functions  are  almost  redundant  in  light  of  thousands   of   years   of   evolution   and   technological   advances   (like   clothing   and  hats),   despite   the   display   of   hair   erection   in   response   to   cold   and   seasonal  variations  in  the  rate  of  hair  growth  (Orentreich,  1969;  Randall  and  Ebling,  1991;  Courtois  et  al.,  1996).     Consequently  hair  plays   little  vital   temperature  protective  role   in   human   beings;   its   remaining   main   functions   are   that   of   protection   and  communication.      In   children,   the   chief   function   is   protection;   eyebrows   and   eyelashes  prevent  the  intrusion  of  foreign  bodies  into  the  eyes,  and  scalp  hair  is  a  defensive  layer   against   direct   sunlight,   cold   and   physical   damage   to   the   head   and   neck  (Goodhart,  1960;  Ebling,  1985).    The  role  scalp  hair  plays  in  social  communication  is   also   rather   fascinating,   for   abundance   of   strong   healthy   hair   indicates   good  health   to   others,   whilst   brittle   and   sparse   growth   of   hair,   which   can   develop  through   starvation   or   disease   is   an   indicator   of   poor   health   (Bradfield,   1971).    Human   hair   is   also   a   signalling   characteristic   in   sexual   communication.      The  development  of  pubic  and  axillary  hair  in  males  and  females  is  an  indicator  of  the  onset   of   puberty   (Reynolds,   1951;   Marshall   and   Tanner,   1969;   Marshall   and  Tanner,   1970).      Growth   of   hair   on   the   face   and   chest,   upper   pubic   triangle   and  limbs  are  all  an  indicative  exhibition  of  sexual  maturity  in  men.      Taking  into  account  the  noteworthy  communication  roles  hair  performs,  it  is   understandable   how   a   defect   of   its   natural   form   can   stimulate   serious  psychological   consequences,   and   have   a   negative   impact   on   the   quality   of   life  (Girman  et  al.,  1998;  Gulec  et  al.,  2004).    Examples  of  this  include  hirsutism,  which  
 -16- 
 
is   excessive   male   pattern   hair   growth   in   women   and   alopecia   areata,   an  autoimmune  disease  of  hair   loss,   affecting  both   sexes  at   all   ages   (Randall,  2001).    Androgenetic  alopecia,  common  balding  or  male  pattern  hair  loss  (Randall,  2005),  also  causes  negative  consequences,  even  amongst  sufferers  who  have  chosen  not  to  seek  medical  consultation   (Girman  et  al.,  1998),   these  are  also  severe   in  those  who  suffer  from  hair  loss  as  a  side  effect  of  chemotherapy.    Thus,  an  understanding  of  the  mechanisms  controlling  hair  growth,  leading  to  control  of  these  conditions  is  of  great  interest  worldwide.      
  
1.3   Structure  of  the  hair  and  its  follicle  Hairs   are   greatly   variable   in   colour,   length,   diameter   and   cross-­‐sectional  shape.    Following  birth,  hairs  can  be  classified  into  two  main  types,  vellus  hairs  and  terminal  hairs.    Vellus  hairs  are  defined  as  small,  fine,  unpigmented  hairs  located  in  regions        Ǯǯǡ ǤǤ   (Blume   et   al.,   1991;  Randall,   1994).      In   contrast,   terminal   hairs   are   longer,   thicker,   and   deeply  pigmented,   located   in   regions   such   as   the   scalp,   eyebrows   and   eyelashes   (Abell,  1988;  Randall,  1994).  Hairs  outside  the  skin  are  flexible  shafts  of  dead,  fully  keratinised  epithelial  cells   which   are   produced   by   follicles   and   taper   to   a   point.      Hair   follicles   are  continuous   with   the   epidermis   and   cylindrical   epithelial   layers   grow   to   various  depths   downwards   into   the   dermis   and   in   some   species   project   into   the  subcutaneous   adipose   layer.      The   follicle   enlarges   at   the   base   into   the   hair   bulb  surrounding  the  mesenchyme-­‐derived  dermal  papilla  (Auber,  1952;  Montagna  and  Van  Scott,  1958;  Oliver  and  Jahoda,  1989).    
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The   hair   and   its   follicle   both   unveil   a   complex   structure   consisting   of  various   compartments   (Figure   1.1).     The  hair   itself   consists   of   three   distinct   cell  lineages,   the   cuticle,   cortex,   and  medulla.      The   cortex   is   composed   of   bundles   of  keratin   filaments.      The  medulla,   which   is   only   present   in   terminal   hairs,   can   be  both  continuous  and  discontinuous.    Hair  fibres  with  a  continuous  medulla,  such  as  eyelashes,  are  stiff  in  character  (Forslind,  2000).  The  hair  follicle  is  made  up  of  several  layers  that  act  to  shape  the  emerging  hair.         Surrounding   the   hair   fibre   is   the   inner   root   sheath  which   is   composed   of  three  distinct  cell  lineages,  the  Henle  and  Huxley  layers  as  well  as  the  cuticle,  the  latter   of   which   is   in   direct   contact   with   the   cuticle   of   the   hair.      The   inner   root  sheath   surrounds   the   hair   fibre   from   the   bulb   up   to   the   level   of   the   sebaceous  gland  allowing  the  hair  fibre  elasticity  (Forslind,  2000).    The  cuticle  cells  of  the  hair  fibre  interconnect/interdigitate  with  the  cuticle  cells  of  the  inner  root  sheath  like  a  zip,   consequently   fastening   the   hair   fibre   to   the   follicle.      The   outer   root   sheath  surrounds   the   inner   sheath,   and   is   continuous   with   the   epithelial   surface.      The  outer  root  sheath  is  surrounded  by  the  vitreous  membrane  outside  which  lies  the  connective/dermal  tissue  sheath,  which  surrounds  the  whole  of  the  follicle.                      
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Figure  1.1    The  structure  of  the  hair  follicle  An  isometric  view  of  the  lower  part  of  a  human  hair  follicle  cut  away  to  show  component  parts  (drawn  by  Richard  J.  Dew).    Reproduced  from  Randall  (1994),  
ǯǤ      




The   mesenchyme-­‐derived   dermal   papilla   plays   an   important   role  throughout   hair   follicle   development   and   its   life   cycle.      It   contains   specialised  fibroblast   cells   called   dermal   papilla   cells   and   extracellular  matrix,  within  which  mucopolysaccharides  and  basement  membrane  proteins  are  present   (Couchman,  1986;  Couchman  et  al.,  1990;  Messenger  et  al.,  1991)  as  well  as  blood  vessels  and  nerves.     The  number  of  dermal  papilla  cells  is  proportional  to  the  size  of  the  hair  follicle,  and  therefore  the  hair   fibre  produced  (Van  Scott  and  Ekel,  1958;   Ibrahim  and  Wright,  1982;  Elliott  et  al.,  1999).    The  hair  matrix  almost  completely  encloses  the  dermal  papilla,  with  the  exception  of  a  gap  at  the  base  of  the  follicle  bulb,  which  permits   the   entrance   of   blood   vessels   and   nerves   into   the   papilla.      A   trilaminar  basement   membrane   efficiently   separates   the   epithelial  matrix   from   the   dermal  papilla  (Nutbrown  and  Randall,  1995).     The  hair  matrix  gives  rise  to  all  epithelial  compartments  except  the  outer  root  sheath  (Schlake,  2007).    The  critical  level  is  a  line  that  can  be  drawn  through  the  widest  part  of  the  follicular   bulb,   separating   the   germinative   centre   of   the   follicle   below   from   the  differentiating  cells  (upper  bulb)  of  the  hair  and  root  sheath  above  (Auber,  1952).      Hair  production  entails   speedy  cell  division  of   the  epithelial  keratinocytes   in   the  hair   matrix.      Below   the   critical   level   the   matrix   cells   are   mitotically   active   and  undifferentiated,   whilst   above   the   critical   level   the   rate   of   mitotic   activity   is  decelerated   and   cells   become   differentiated   into   either   the   inner   root   sheath   or  hair  fibre  cells.    The  movement  of  cells  from  the  bulb  into  the  more  narrowed  part  of   the   follicle   elongates   the   cells,   and   keratinisation   takes   place.      This   process  continues   as   the   cells   migrate   through   the   follicle,   ultimately   becoming   fully  keratinised  by  the  time  they  reach  the  surface  of  the  skin.      
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The   hair   follicle   is   often   referred   to   as   the   pilosebaceous   unit,   due   to   its  association  with  the  sebaceous  gland.    Sebaceous  glands  emit  a  waxy  secretion  into  the   follicle   via   the   sebaceous   duct,   inducing   a   waterproof   coating   over   the   hair  fibre.    In  some  follicles,  such  as  those  found  in  axillae  and  genital  regions,  apocrine  sweat   glands   are   also   present   above   the   sebaceous   ducts   (Hurley,   2001).      The  apocrine  glands  discharge   into   the   superior  portion  of   the  hair   follicle  and  are   a  possible   origin   of   pheromones   (Spielman   et   al.,   1995).      The   follicle   is   also  associated  with  the  arrector  pili  muscle,  a  smooth  muscle  bundle  that  attaches  to  the  bulge  region  of  the  follicle  and  extends  to  its  superior  attachment  in  the  upper  dermis.      This   muscle   allows   adjustment   of   the   hair   for   thermoregulation,   for  example  erection  of  hairs  on  skin  in  response  to  cold  temperatures.  
  




Figure  1.2    The  hair  growth  cycle  Stages   of   the   hair   growth   cycle.      Reproduced   from   Randall   (1994),   with   the  
ǯǤ  
  
     During  the  anagen  phase,   the  matrix  keratinocytes   in  the  hair   follicle  bulb  proliferate  rapidly;  conversely  at  the  end  of  anagen,  matrix  keratinocytes  abruptly  cease   proliferating   and   pigmentation,   and   become   fully   keratinised   producing   a  
   ǲǳ ǡ  ǡ      transition  into  the  catagen  phase.    During  the  catagen  phase  the  hair  stops  growing  and   there   is   extensive  apoptosis,   resulting   in   regression  of   the   lower   follicle  and  the  dermal  papilla.     The  hair  moves  upwards  and  comes  to  rest  at  the  base  of  the  sebaceous  gland,  commonly  referred  to  as  the  bulge.    This  phase  lasts  for  about  2-­‐3  weeks   in  human  scalp  and   leads  to  the  telogen  phase,   the  resting  phase  of  a  hair  follicle.  (Kligman,  1959a).    At  the  end  of  catagen,  if  the  dermal  papilla  fails  to  reach  the  bulge  level,  the  site  of  the  follicle  stem  cells,  during  catagen,  the  cycle  stops  and  the   hair   is   lost   (Paus   and   Cotsarelis,   1999).      A   telogen   hair   has   a   club-­‐shaped  
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proximal   end,   which   is   surrounded   by   a   thick   epithelial   sac,   lasting   around  approximately  3  months  on  the  human  scalp  before  re-­‐entering  the  anagen  phase  (Kligman,  1959a).    The  anagen  phase  has  been  divided  into   six  subphases  (Chase  et  al.,  1951;  Chase,   1954;   Paus   and   Cotsarelis,   1999).      Stages   IȂV   of   anagen   are   the  developmental   stages   at   which   point   the   follicle   regenerates,   and   the   length   of  these   subphases   does   not   differ   substantially   between   follicles   from   different  regions,  unlike  the  last  subphase,  anagen  VI  the  duration  of  which  dictates  the  shaft  length,  (Trotter,  1924;  Saitoh  et  al.,  1970).  The   initial   subphase   (I)   commences   with   the   activation   of   the   dermal  papilla   and   the   onset   of  mitotic   activity   in   the   epithelial   cells   beneath   the   bulge  region,  known  as  the  germ.    Following  this  the  germ  instigates  a  downward  growth  (subphase   II),   enveloping   the   dermal   papilla   and   the   matrix   cells   begin  differentiation.      Subphase   (III)   follows   with   the   bulb   matrix   cells   showing   a  differentiation   into   most   follicular   components,   until   the   follicle   reaches   its  deepest   level.      Subsequently   the  matrix  melanocytes   activate,   and   the   hair   fibre  reaches  the  level  of  the  sebaceous  gland;  subphase  (IV).    Upward  growth  continues  until   subphase   (V)   the   new   shaft   emerges   from   the   skin,   this   may   dislodge   the  telogen  hair.    The  new  hair  shaft,  ultimately  at  stage  VI,  proceeds  to  grow  until  the  follicle   re-­‐enters   catagen.     The   length  of   the  hair   is  proportional   to   the   length  of  anagen   and   it   differs   depending   on   the   location   of   the   follicle   (Kligman,   1959a;  Saitoh   et   al.,   1970;   Paus   and   Cotsarelis,   1999).      The   last   phase   within   the   hair  growth  cycle   is  exogen,  an   independent  and  active  shedding  phase,  during  which  the  original  hair   is  enzymatically  released  and  falls  out   (Stenn  et  al.,  1998;  Stenn  and  Paus,  2001;  Milner  et  al.,  2002;  Stenn,  2005;  Higgins  et  al.,  2009).      
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1.5   Embryogenesis  of  the  hair  follicle  The   embryonic   development   of   the   hair   follicle   is   initiated   as   a   result   of   an  interaction   between   epithelial   and   mesenchymal   tissues.      The   initial   event   in  embryonic  development  is  the  formation  of  the  pre-­‐germ  that  begins  as  a  result  of  localized   thickening   of   the   basal   layer   of   the   epidermis   and   an   aggregation   of  mesenchymal   cells   at   the   junction   between   the   epidermis   and   dermis   (Pinkus,  1958;   Holbrook   and   Minami,   1991)   (See   figure   1.3).      Following   this   epidermal  placode  formation,  epidermal  and  mesenchymal  cells   then  continue  development  into  the  dermis   forming  the  hair  germ.     The  hair  germ  then  elongates  and  grows  deeper  into  the  dermis  to  form  the  hair  peg.    The  proximal  end  of  the  peg  flattens,  forming  an  elongated  concave-­‐shaped  structure  (bulbous  hair  peg),  which  eventually  will  enclose  the  mesenchymal  cells  to   form   the   dermal   papilla.      The   epidermal   cells   surrounding   the   dermal   papilla  form  the  matrix,  which  differentiates  to  form  the  inner  root  sheath  and  hair  fibre.    The  epithelial  cells  connecting  the  matrix  cells  to  the  interfollicular  epidermis  form  the  outer  root  sheath  and  mesenchymal  cells  alongside  form  a  connective/dermal  tissue  sheath.    In  addition,  two  epithelial  protrusions  develop  on  the  posterior  side  of  the  follicle.    The  uppermost  epithelial  protrusion  will  develop  into  the  sebaceous  gland  and  the  lower  protrusion  forms  the  bulge,  at  this  precise  site  the  arrector  pili  muscle  attaches  to  the  follicle.    At  some  regions  of  the  body  (such  as  the  axilla  and  groin)  a  third  protrusion  can  develop  above  the  sebaceous  gland,  developing  into  the  apocrine  gland.      The  middle  cells  of  the  bulbous  hair  peg  degenerate  to  form  the  hair  canal,  whilst   the   dermal   papilla   is   completely   surrounded   by   epithelial   cells.      At   this  stage,  the  hair  follicle  components  will  continue  to  proliferate,  increasing  hair  fibre  
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length,   until   the   hair   emerges   from   the   epidermis.      The   follicle  will  maintain   its  elongation   into  the  dermis  until   it  reaches   its   full  depth  within  the  skin.     Most  of  the   stages   identified   above   are   repeated   in   the   early   stages   of   anagen,  with   the  exception   of   the   starting   point   occurring   at   the   base   of   the   telogen   hair   follicle  rather   the   actual   epidermis   (Holbrook   and   Minami,   1991;   Muller   et   al.,   1991;  Hardy,  1992;  Randall,  1994;  Paus  et  al.,  1999;  Wu-­‐Kuo  and  Chuong,  2000).  
  
Figure  1.3    Embryology  of  the  hair  follicle  The   different   stages   of   hair   follicle   embryogenesis.      Reproduced   from   Randall  
ȋͳͻͻͶȌǡǯission.  
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1.6   Hair  disorders  
1.6.1   Hirsutism  Hirsutism  refers  to  excessive  and  increased  hair  growth  in  women,  in  areas  where  there  is  typically  only  fine  hair  or  no  hair  at  all,  for  example  above  the  lip,  on  the  chin,  chest,  and  abdomen  (Figure  1.4).    This  growth  may  be  triggered  by  excess  androgen   production   (male   sex   hormones).      Androgen   modifies   vellus   follicles  producing   fine  hairs   to   form   thick,  pigmented  hairs.      Several  different   conditions  can   lead   to   hirsutism.   The   two  most   common   causes   of   hirsutism   are   polycystic  ovary   syndrome   (PCOS)   and   idiopathic   hirsutism   (Bardin   and   Lipsett,   1967;  Franks,  1989;  Martin  et  al.,  2008).        Both   cosmetic   and   pharmacological   approaches   can   be   taken   to   treat  hirsutism.   The   pharmacological   approach   includes   antiandrogen   drugs,   e.g.  cyproterone   acetate   (CPA),   which   inhibits   hirsutism   (Hammerstein,   1987)   and  
  ͷȽ-­‐  reductase   type  2  preventing  androgen  action   (Randall,   2008).      A   cosmetic   approach   employs   various   methods   which  physically   remove   or   lighten   excess   hair   to   make   it   less   conspicuous;   such  treatments   include   shaving,   chemical   depilation,   waxing,   and   bleaching,  electrolysis  and  laser  hair  removal.                                                                                                          
1.6.2   Androgenetic  alopecia    Androgenetic   alopecia   is   a   common   form  of   hair   loss   in   the   region   of   the  scalp  for  both  men  and  women  (Figure  1.4)    (Ludwig,  1977).    In  men,  this  condition  is   also  known  as  male-­‐pattern  baldness   (Hamilton,  1942).     This   form  of  disorder  entails   the   gradual   transformation   of   thick,   pigmented   hairs   to   thinner,   shorter,  non  pigmented  vellus  hairs,  in  both  men  and  women.    As  the  disorder  progresses,  
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the  anagen  phase   shortens  with  the  telogen  phase  remaining  constant.        The   loss  occurs   in   a   precise,   distinctive   pattern   on   the   scalp,   first   described   by   Hamilton  (Figure   1.5)   (Hamilton,   1951;   Norwood,   1975;   Randall,   2005).      Hamilton  highlighted  the  severity  of  the  hair  loss,  grading  it   from  prepubertal  scalp  (type  I)  through  to  the  progressive  recession  of  the  bitemporal  hairline  and  thinning  on  the  vertex   (type  VII).     To   improve   the  grading  of   the  middle  balding   types,  Norwood  modified   this   classification   system   (Figure   1.4)   (Norwood,   1975).      Though   it   is  possible  for  male  pattern  balding  to  occur  in  women,  a  different  pattern  of  hair  loss  is  more  common,  described  and  graded  by  Ludwig   (Ludwig,  1977)  as  the  gradual  hair   loss   in   the   crown,  with   preservation   of   the   frontal   hair   line   (Sinclair   et   al.,  1999;  Price,  2003).    







Figure  1.5    The  pattern  of  hair  loss  in  androgenetic  alopecia  in  men  The   Hamilton   scale   (as   modified   by   Norwood)   is   used   to   classify   the   type   and  extent   of   common   baldness   in   men.      Reproduced   from   Randall   (2000),   with  permission.                       Androgens   and   genetic   disposition   are   the   two   main   factors   in   the  pathogenesis   of   androgenetic   alopecia.      Research   evidence   supports   the  involvement  of  local  androgens  in  the  development  of  androgenetic  alopecia.     For  example  androgenetic  alopecia  does  not  occur   in  men  castrated  prior  to  puberty,  and  for  men  castrated  after  puberty  baldness  ceases  to  progress  (Hamilton,  1942;  Hamilton,   1958;   Hamilton,   1960).      Although   a   number   of   genes   have   been  investigated  for  an  association  with  androgenetic  alopecia,  no  specific  gene  or  set  of  genes  have  been  identified  (Randall,  2005).  A  range  of  treatments  for  androgenetic  alopecia  can  be  undertaken,  such  as  wigs  and  hairpieces,  surgery,  hormonal  and  non-­‐hormonal   therapy.     The  surgical  treatment   involves   the   relocation   of   follicles   from   the   non-­‐balding   areas   to   the  sites  that  are  bald,  relying  on  the  intrinsic  responses  of  hair  follicles  to  androgens  
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(Orentreich  and  Durr,  1982).     Though  this  treatment  endures  for  a  long  time,  it  is  expensive  and  painful;  furthermore  it  may  require  further  surgery  as  the  hair  loss  develops   around   the   transplanted   region.      Hormonal   treatments   include  
  ͷȽ-­‐reductase   inhibitors.      Antiandrogen   treatment   blocks   the  androgen  binding  to  the  androgen  receptor,  which  has  impractical  effects  on  male  
Ǥ  ͷȽ-­‐reductase   inhibitors,   however,   such   as   finasteride,   block   the  conversion   of     ͷȽ-­‐dihydrotestosterone,   which   has   been   found   to  both  slow  down  gradual  hair  loss,  and  promote  hair  growth  in  men  under  42  years  of  age  with  stage  II  to  V  hair  loss  (Figure  1.4)  (Kaufman  et  al.,  1998)ǤͷȽ-­‐reductase  inhibitors  remain  as  the  main  hormonal   treatment   for  hair   loss   in  men,  however  similar  to  all  hormonal  treatments,  it  is  subject  to  continuation.          The  most  commonly  used  non-­‐hormonal  treatment  is  minoxidil,  which  is  a  widely   used   topical   treatment   for   hair   loss   in  men   and  women.      It   belongs   to   a  group  of  drugs  known  as  potassium  (K+)  channel  openers.    Initially  developed  as  a  treatment   for   hypertension,   it   was   however,   discovered   to   have   the   interesting  side   effect   of   hypertrichosis   (excessive   hair   growth)   (Shapiro   and   Price,   1998;    Dawber,  2000),  making  it  unacceptable  to  patients  and  it  was  remarketed  as  a  hair  loss  treatment.    Nevertheless  it  is  unclear  how  minoxidil  functions  to  stimulate  hair  growth.      
1.6.3   Alopecia  areata  Alopecia  areata  is  a  form  of  hair  loss,  characterised  by  loss  of  hair  in  single  or  multiple  localised  patches,  typically  on  the  scalp,  intermittently  in  the  eyebrows,  beard,   or   other   hair-­‐bearing   areas   of   the   body.      There   are   a   range   of   hair   loss  patterns   resulting   from  alopecia  areata;  most   commonly  a   circular  patch  pattern  transpires  (Madani  and  Shapiro,  2000;  Papadopoulos  et  al.,  2000).    There  are  two  
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more  extensive   forms  of  alopecia  areata,  alopecia  universalis,  a  more  generalised  pattern  of   total  body  hair   loss,  and  alopecia  totalis,  which  although   less  common,  can  spread  to  the  entire  scalp  (Hordinsky,  2003).     Males  and  females  are  affected  alike,  and  it  occurs  in  all  ethnic  groups  (Muller  and  Winkelmann,  1963;  Sharma  et  
al.,  1996;  Epstein,  2001).        The   exact   cause   of   alopecia   areata   is   still   unknown,   though   it   is   generally  believed   to   be   an   autoimmune   disease   (Randall,   2001),   but   several   factors   have  been   recognised   in   its   pathogenesis,   e.g.,   genetic,   neurological   factors,   possible  emotional   stress   and   infectious   agents   (Madani   and   Shapiro,   2000).      A   range   of  treatments  have  been  undertaken   for   the   treatment  of   alopecia  areata,   including  contact   sensitizers,   immunomodulators   and   biologic   response   modifiers  (Hoffmann  et  al.,  1996;  Gilhar  et  al.,  1998).  There   is   no   definitive   treatment   available   for   alopecia   areata   as   yet  (Epstein,  2001),  although  a  series  of  therapies  are  available,  which  include  immune  enhancers,  immune  inhibitors,  non-­‐specific  irritants  and  minoxidil  (Messenger  and  Simpson,  1997;  Ross  and  Shapiro,  2005).    Although  these  treatments  have  all  had  varying  success  rates,  they  have  also  all  had  negative  side  effects,  and  there  is  no  fully  satisfactory  treatment  available  for  alopecia  areata.      The   lack   of   a   precise   treatment   for   hair   loss   is  mainly   due   to   insufficient  knowledge  of  normal  hair  follicles  and  the  mechanism  of  action  of  potassium  (K+)  channel  openers  and  blockers.    Thus  this  thesis  aims  to  enhance  knowledge  of  this  field  by  investigating  further  into  the  roles  of  potassium  channels  in  hair  growth.                  
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1.7   Adenosine  triphosphate  (ATP)  Ȃ  sensitive  potassium  channels  (K+ATP)    K+ATP  channels  are  formed  by  two  distinct  protein  subunits:  a  sulfonylurea  receptor   (SUR)   and   an   inwardly   rectifying   potassium   channel   subunit   (Kir6.x).    They  were  first  discovered  in  cardiac  myocytes  (Noma,  1983),  and  subsequently  in  
   Ⱦ-­‐cells   (Ashcroft  et  al.,   1984;  Cook  and  Hales,  1984;  Rorsman  and  Trube,  1985),  skeletal  muscle  (Spruce  et  al.,  1985),  neurones   (Ashford   et   al.,   1988;   Bernardi   et   al.,   1988),   arterial   smooth   muscle  (Standen   et   al.,   1989),   kidney   (Wang   and   Giebisch,   1991)   and   in   the   inner  mitochondrial  membrane  (Inoue  et  al.,  1991)  and  secretory  granules  (Thevenod  et  
al.,   1992).      The   SUR   protein   acts   as   a   regulatory   subunit,   which   is   the   site   of  interaction   for  a  majority  of  drugs,  whilst  Kir6.x  subunits   form  the  channel  pore,  through   which   ions   pass   (Nichols,   2006).      The   expression   of   both   sub-­‐units   is  necessary  to  form  a  functional  channel   (Inagaki  et  al.,  1995a;  Gribble  et  al.,  1997;  Yamada  et  al.,  1997).      K+ATP   channels   are   regulated   physiologically   by   the   levels   of   intracellular  nucleotides  and  pharmacologically  by  K+ATP  channel  openers  and  blockers  such  as  sulphotransferase   (Meisheri   et   al.,   1993).      Intracellular   nucleotides   create   polar  reactions  in  K+ATP  channels.     Intracellular  ATP  (ATPi)  inhibits  the  channels,  whilst  intracellular  Mg+2   bound   adenosine   diphosphate   (MgADPi)   activates   the   channel  (Cook   and   Hales,   1984;   Ashcroft   and   Rorsman,   1989;   Gier   et   al.,   2009;   Girard,  2009).  The  function  of  K+ATP  channels  is  best  characterised  in  the  insulin-­‐secreting  
Ⱦ(Cook  et  al.,  1988;  Ashcroft  and  Rorsman,  1989),  where  they  play  a   key   role   in   insulin   secretion.      At   low   plasma   glucose   levels   (2-­‐3mM),   in   the  
Ⱦ-­‐cells,  the  K+ATP  channels  are  open,  therefore  allowing  K+  to  leave  the  
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cell.     This  action  hyperpolarises  the  voltage-­‐gated  calcium  (Ca2+)  channels,  which  remain  closed,  thereby  setting  the  resting  membrance  potential  to  approximately  -­‐70  mV,  and  effectively  reducing  excitability  and  insulin  secretion.    In  contrast  a  rise  in  the  plasma  glucose  level  (5-­‐7  mM)  increases  the  intracellular  ATP  concentration  due   to   the  metabolism,   closing   the   K+ATP   channels.      This   closure   depolarises   the  plasma  membrane,   leading  to  the  opening  of  voltage-­‐gated  Ca2+  channels  and  the  subsequent  Ca2+  influx  results  in  insulin  secretion  (Seino,  1999)  (Figure  1.6).    
Figure  1.6    Illustration  of  insulin  secretion  in  the  plasma  membrane  of  













1.7.1   Potassium  channel  structure    Structurally,  K+ATP  channels  have  been  shown  to  comprise  hetero-­‐octameric  complexes   of   four   pore-­‐forming   (Kir6.x)   and   four   regulatory   sulphonylurea  receptor  (SUR)  subunits  (Figure  1.7)  (Clement  et  al.,  1997;  Inagaki  et  al.,  1997).      
  











1.7.1.1  SUR  proteins    The  sulfonylurea  receptor  (SUR)   is  an  ATP-­‐binding  cassette  (ABC)  protein  comprising   one,   five-­‐helix   transmembrane   domain   (TMD0)   and   two,   six-­‐helix  transmembrane  domains   (TMD1  and  TMD2),  positioned  at   the  N   terminal   and   is  the  key  regulatory  subunit  of  ATP-­‐sensitive  K+  channels  (Inagaki  et  al.,  1995a)  as  indicated   in   Figure   1.7.      In   addition   the   SUR   holds   two   intracellular   loops,  nucleotide  binding  domains  1  and  2  (NBD1  and  NBD2);  NBD1  connects  TMD1  and  TMD2,   NBD2   follows   TMD2   (Nichols,   2006).      The   NBDs   are   comprised   of   two  nucleotide  binding  motifs  (Walker  A  and  B  concensus  motifs)  which  are   involved  in  channel  regulation  by  ATP  and  MgADP  (Jahangir  and  Terzic,  2005).  There   are   three   forms   of   the   sulfonylurea   receptor   (Aguilar-­‐Bryan   et   al.,  1995;   Gribble   and   Reimann,   2003),   SUR1   coded   by   the   ABCC8   gene  mapped   on  chromosome   11p15.1   (Inagaki   et   al.,   1995a)   which   includes   a   high   affinity  sulphonylurea  receptor  (Aguilar-­‐Bryan  et  al.,  1995);  SUR2A  and  SUR2B  which  are  splice  variants  arising  from  a  single  ABCC9  gene  mapped  to  chromosome  12p12.1  (Chutkow   et   al.,   1996)   and   include   a   lower-­‐affinity   sulphonylurea   receptor  (Inagaki  et  al.,  1996).     The  SUR1  gene  is  made  up  of  39  exons  in  its  open  reading  frame  and   the      SUR2  gene  of  38  exons,   the   lower  exon  number   consequent   from  the  removal  of  exon  18  from  the  SUR1  gene  (Aguilar-­‐Bryan  et  al.,  1998).    Alternate  splicing  at   exon  38   in   the  SUR2  gene,   results   in  SUR2A  containing  exon  38A  and  SUR2B;   containing   exon   38B;   these   variants   vary   by   42   amino   acids   at   the   C-­‐terminal  (Isomoto  et  al.,  1996).    
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1.7.1.2  Kir6.x  proteins  The   pore-­‐forming   Kir6.x   proteins   are  members   of   the   inwardly   rectifying  K+   channel   family,   Kir.      Crystallisation   of   the   bacterial   K+   channel   revealed   its  structure   (Doyle  et  al.,   1998).     Two  subunits  of  Kir6.x  proteins   that  have  already  been   identified   are   Kir6.1   (also   known   as   u-­‐KATP-­‐1)   and   Kir6.2   (also   known   as  BIR/K+ATP),   which   have   approximately   70%   homology   with   each   other,   and   40-­‐50%   with   other   Kir   channels   (Inagaki   et   al.,   1995a).      These   proteins   are  responsible   for   the   pore   formation   in   K+ATP   channels,   and   consist   of   2  transmembrane  domains,  M1  and  M2,   that   confer   channel   sensitivity   to  ATP  and  ADP,   and   other   cell   metabolites   (Baukrowitz   and   Fakler,   2000;   Schulze   et   al.,  2003).      Forming   the   narrow   section   of   the   pore,   is   an   extracellular   loop   that  effectively  connects  the  two  domains,  and  controls  ion  selectivity   (Nichols,  2006).    This  model  is  accepted  in  both  eukaryotic  and  prokaryotic  Kir  structures   (Antcliff  
et  al.,  2005;  Haider  et  al.,  2005).    The  human  Kir6.1  gene  KCNJ8,  is  composed  of  3  exons  and   is  based  on  the  chromosome  12p11.23   (Inagaki  et  al.,  1995b);  and  the  intronless  Kir6.2  gene  KCNJ11,  composed  of  1  exon,  is  situated  on  the  short  arm  of  chromosome  11  at  11p15.1  (Inagaki  et  al.,  1995a).        
1.8   Different  combinations  of  K+ATP  channel  subunits  generates  channel  
diversity  Different  combinations  of  K+ATP  channel  subunits  (SUR1,  SUR2A,  or  SUR2B  and   Kir6.1   or   Kir6.2)   form   channels   in   different   tissues   with   diverse  electrophysiological,  nucleotide  and  pharmacological  properties  (Table  1.1)  (Seino  and  Miki,  2003).    Interaction  between  K+ATP  channel  openers  and  the  SUR  subunit  
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enables   K+   ions   to   exit   the   cell,   instigating   hyper-­‐polarisation   of   the   plasma  membrane,  and  as  a  consequence  reduces  electrical  activity  (Ashcroft  and  Gribble,  2000).        
Table  1.1  K+ATP  channel  combinations  and  their  tissue  distributions      Table  modified  from  Seino  and  Miki  (2003).  










    SUR1/Kir6.1         Not  physiologically  relevant       (Babenko  et  al.,  1998a)      SUR1/  Kir6.2       Ⱦ      Brain    
  (Inagaki  et  al.,  1995b)  (Sakura  et  al.,  1995)    (Babenko  et  al.,  1998a)    SUR2A  /Kir6.1         No  cellular  activity       (Babenko  et  al.,  1998a)      SUR2A  /Kir6.2       Cardiac  muscle    Skeletal  muscle    
  (Inagaki  et  al.,  1996)    (Babenko  et  al.,  1998a)    SUR2B/Kir6.1         Vascular  smooth  muscle       (Yamada  et  al.,  1997)      SUR2B/Kir6.2         Non-­‐vascular  smooth  muscle     (Isomoto  et  al.,  1996)  
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openers  varies.    For  example  SUR1/Kir6.2  channels  expressed  in  pȾare   significantly   sensitive   to  diazoxide,   to   some  extent   sensitive   to  pinacidil,   and  not  at  all  responsive  to  cromakalin  and    nicorandil  (Trube  et  al.,  1986;  Ashcroft  and  Rorsman,  1989;  Ashcroft  and  Ashcroft,  1990;  Seino  and  Miki,  2003).    On  the  other  hand,   SUR2A/Kir6.2   channels,   expressed   in   cardiac   and   skeletal   muscles,   are  sensitive  to  pinacidil  and  cromakalin,  and  only  slightly  to  diazoxide.    SUR2A/Kir6.2  channels  can  be  sensitive  to  diazoxide,  when  in  the  presence  of  MgADP   (D'Hahan  
et   al.,   1999b),   while   SUR2B/Kir6.2   channels   expressed   in   non-­‐vascular   smooth  muscle  are  sensitive  to  all  the  K+ATP  channel  openers  named  above  (Inagaki  et  al.,  1995a;  Isomoto  et  al.,  1996;  Babenko  et  al.,  1998;  Gribble  et  al.,  1998;  D'Hahan  et  
al.,  1999a).      The   sensitivity   to  K+ATP   channel   inhibitors   is   similarly   tissue   specific.      For  
ͳȀ͸Ǥʹ  Ⱦ  concentrations   of   tolbutamide   than   channels   in   cardiac   and   smooth   muscle  (Ashcroft   and   Ashcroft,   1990;   Faivre   and   Findlay,   1990;   Venkatesh   et   al.,   1991;  Allard  and  Lazdunski,  1993;  Zhang  and  Bolton,  1996;  Quayle   et  al.,   1997).     All  of  these   varying   sensitivities   to   K+ATP   channel   openers   and   blockers   support   the  model   that   the  K+ATP   channel  opener   binding   site   is   situated   on   the   SUR   subunit  (Nichols,  2006).      
  
1.9   Minoxidil  stimulates  hair  growth  Minoxidil   is   classified   as   a   K+ATP   channel   opener,   alongside   diazoxide,  chromakalim,   nicorandil   and   pinacidil   (Koblenzer   and   Baker,   1968;   Goldberg,  1988).    Different  K+ATP  channel  openers  have  varying  effects  on  the  prevalence  and  
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severity   of   hypertrichosis.      For   example   following   oral   minoxidil   treatment   60-­‐80%   of   adults   reported   hypertrichosis   (Burton   and  Marshall,   1979;   Zins,   1988),  whereas,  pinacidil  treatment  caused  hypertrichosis  in  13%  of  females  and  only  2%  of   males   (Goldberg,   1988).      During   diazoxide   treatment   most   children   reported  increased   hair   growth,   however   only   an   insignificant   1%   of   adults   reported  hypertrichosis  (Koblenzer  and  Baker,  1968;  Burton  et  al.,  1975).        The   majority   of   K+ATP   channel   openers   were   initially   developed   for  treatment  of  hypertension  and  hypoglycaemia.    Minoxidil  was  one  of  the  first  to  be  introduced   into   the  market,   in   the   early   1970s,   in   the   form  of   an  oral   treatment  directed  at  hypertension.      It  was   reported   to   lower  arterial  blood  pressure,   via  a  relaxation   of   vascular   smooth   muscle,   most   likely   through   the   opening   of   the  vascular  K+ATP  channels  (Weston  and  Edwards,  1992),  although  there  was  no  direct  evidence  for  this  (Seino  and  Miki,  2003).  Patients  taking  minoxidil  reported  hypertrichosis,  as  a  common  side-­‐effect,  in  particular  on  the  face,  across  the  upper  back  and  limbs  (Limas  and  Freis,  1973;  Mehta  et  al.,  1975;  Sica,  2004),  additionally,  re-­‐growth  of  hair  in  male  balding  was  also  noted  (Zappacosta,  1980).     Due  to  the  key  role  that  hair  plays   in  society  and  social   communication,   the   high   frequency   of   hypertrichosis,   was   deemed   an  unacceptable   side-­‐effect   of   systemic   minoxidil   treatment   (Girman   et   al.,   1998;  Jansen  and  van  Baalen,  2006).    Consequently  this  encouraged  the  development  of  a  topical  preparation  of  minoxidil  for  the  treatment  of  androgenetic  alopecia.    At  its  introduction   into   the  market   in   the  United   States   in   1986,   the   topical   treatment  only  contained  2%  of  minoxidil  solution.     Using  this  approximately  a   third  of   the  men   with   androgenetic   alopecia   reported   an   increase   in   hair   density,   with   no  significant  difference  between  2  and  3%  minoxidil  (Olsen  et  al.,  1985;  Olsen  et  al.,  
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1987).      However   in   1993   the   solution   of   minoxidil   was   increased   to   5%  (Messenger  and  Rundegren,  2004).    Topical  minoxidil  prolongs  the  anagen  growth  phase   and   causes   premature   termination   of   telogen.      Resting   hair   follicles   are  induced  into  the  anagen  phase  and  small  follicles  produce  longer,  more  pigmented  hairs  with  a  larger  diameter  (Messenger  and  Rundegren,  2004).        In   a   48   week   study,   the   5%   and   2%   topical   minoxidil   solutions   were  compared.    The  study  found  the  5%  solution  to  be  considerably  superior  to  the  2%  solution  and  the  placebo  in  increasing  hair  re-­‐growth.    Furthermore  the  5%  caused  an  earlier  increase  in  hair  count  (Olsen  et  al.,  2002).    A  related  study,  concentrating  on  female  pattern  hair  loss,  also  compared  5%  and  2%  topical  minoxidil,  rendering  similar   results   to   the   previous   study   as   the   5%   solution   produced   significantly  higher  non-­‐vellus  hair  counts  than  the  2%  minoxidil  solution  (Lucky  et  al.,  2004).    Currently   the  5%  concentration   is   licensed   for   treatment  of  men   in   the  USA,   but  only   the   2%   concentration   for  women.      Six  months   following   discontinuation   of  topical  minoxidil  solution  hair  loss  occurs,  the  gravity  of  which  is  equivalent  to  that  of   untreated   patients.      This   means   that   hair   growth   is   not   maintainable   once  minoxidil  treatment  stops  (Olsen  and  Weiner,  1987;  Price  et  al.,  1999).      Despite  the  popularity  of   topical  minoxidil  as  a   form  of   treatment   for  over  25   years,   and   much   research   in   its   field,   the   mechanism   of   action   by   which  minoxidil  stimulates  hair  growth  remained  uncertain.     The  general  accepted  view  was   that   it  worked  via  effects  on   the  vasculature   to   increase  blood  supply   to   the  follicles  (Messenger  and  Rundegren,  2004).      Recent  studies  by  Shorter  et  al  (2008)  have  shown  that  human  hair  follicles  express  both  the  genes  and  proteins   for  at   least   two  K+ATP  channels,  SUR1/Kir6.2  and   SUR2B/Kir6.1.      They   showed   that   the   expression   was   variable   within   the  
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follicle  with  the  dermal  papilla  having  genes  and  protein  for  SUR2B  and  Kir6.1  and  epithelial  matrix  SUR1  and  Kir6.2.     There  was  no  detection  of  SUR2A  subunits   in  human   hair   follicles.      Minoxidil   has   a   specific   affinity   to   K+ATP   channels   which  contain  SUR2A/B  subunits,  but  not  those  with  SUR1.    Shorter  et  ǯ  (2008)  finding  of   SUR2B   in   the   dermal   papillae   suggests   that   minoxidil   affects   the   human   hair  follicle   via   the   dermal   papillae.      This   is   supported   by   their   observation   that  minoxidil   increased   anagen   in   human   hair   follicles   in   organ   culture,   an   effect  inhibited  by  the  potassium  channel  blocker,  tolbutamide,  and  similar  to  the  effects  on  the  growth  of  deer  follicles  in  organ  culture  reported  by  Davies  et  al  (2005).  This  confirms  that  minoxidil  can  act  directly  on  hair  follicle  K+ATP  channels  in  human  hair   follicles  and  means  that   its  mechanism  of  action  within  the   follicle  merits   more   investigation   to   facilitate   the   development   of   new   treatments   to  replace  the  relatively  poor  effects  of  minoxidil  treatments  used  currently.    Shorter  
et  al   (2008)  also   located   the  genes  and  proteins  SUR1  K+ATP   channels   in   the  hair  bulb  matrix  in  human  hair  follicles.    This  is  particularly  interesting  since  Davies  et  
al  (2005)  found  that  a  selective  SUR1  channel  opener  also  stimulated  the  growth  of  red  deer  follicles  in  organ  culture.    This  suggests  that  SUR1  K+ATP  channels  may  also  be   able   to   play   a   role   in   human   hair   follicle   growth.      If   true,   this   opens   up   the  possibility  of  new  therapeutic  options  with  which  to  treat  hair  loss.    It  is  important  to   verify  whether   SUR1   channels   can   be   actively   involved   in   human  hair   follicle  regulation.      
 -40- 
 
1.10          Aims       Therefore,  the  overall  aim  of  this  thesis  was  to  expand  our  understanding  of  K+ATP  channels  in  hair  follicles.    The  initial  specific  aim  was  to  confirm  the  presence  of   K+ATP   channel   subunit   genes   and   proteins   in   growing   (anagen)   red   deer   hair  follicles   to   determine   whether   this   matched   that   of   human   hair   follicles.      This  would  support  the  observations  by  Davies  and  colleagues  (2005)  that  drugs  which  selectively   open   either   SUR2   (minoxidil)   or   SUR1   (NNC55-­‐0118)   K+ATP   channels  stimulate   deer   follicle   growth   in   organ   culture.      This   is   important   for   future  potential   investigations   on   novel   K+ATP   channel   opening   drugs   as   the   limited  availability   of   human   hair   follicles   prevents   their   use   as   a   drug   testing   system  involving  dose  response  analysis.    Red  deer  follicles  are  a  well  established  model  in  
ǯ  ȋet  al.,   1996;  Thornton  et  al.,   2001;  Randall  et  al.,  2003;  Croft  et  al.,  2003)  and,   if   the  genes   and  protein   correspond,  they  would  offer  an  appropriate  model  system  for  examining  future  K+ATP  channel  opening  drugs  on  hair  growth.     If   the   genes   and   proteins  were   expressed   in   the   deer   follicles,   the   studies  were  to  be  expanded  to  telogen  follicles  to  compare  expression  in  stages  of  the  hair  cycle.     Deer   follicles  are  particularly  suited  to  this  because  of   their   large  size  and  their  seasonal  cyclic  growth  pattern,  which   facilitates  obtaining  sufficient   telogen  follicles.     The   second   aim   was   to   enhance   the   understanding   of   K+ATP   channels   in  human  hair   follicles  by  determining  whether  human  hair   follicles  would  respond  to   a   selective   SUR1   K+ATP   channel   opening   drug   in   organ   culture   by   increasing  growth,  as  in  the  study  by  Davies  and  colleagues  (2005),  on  deer  hair  follicles.     If  so,  this  would  suggest  that  further  investigation  into  the  SUR1  channel  mechanism  
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2.1   Introduction  Investigations   have   offered   evidence   suggesting   that   potassium   channel  regulators   influence   hair   growth   via   the  mechanism  of   action   on  K+ATP   channels.    Davies   et   al   (2005)   investigated   the   effects   of   minoxidil   and   other   potassium  channel   modulators   on   red   deer   (Cervus   elaphus)   follicles   in   vitro.      Minoxidil  stimulated  hair  follicle  growth  at  all  concentrations  (0.1,  1,  10  and  100  µM),  with  the   highest   stimulation   occurring   at   100   µM.      Similarly   other   potassium   channel  openers,  diazoxide  (10  µM)  and  NNC  55-­‐0118  (0.1,  1,  10  and  100  µM)  induced  an  increase  in  hair  follicle  length  during  culture.    The  stimulatory  effect  on  hair  follicle  growth   was   inhibited   with   co-­‐incubation   of   potassium   channel   blockers,  tolbutamide  and  glibenclamide;  this  provides  support  to  the  hypothesis  that  K+ATP  channels  are  expressed  in  red  deer  anagen  hair  follicles.                        The   recent   study   in   our   laboratory   by   Shorter   et   al   (2008)   demonstrated  that  minoxidil   (1mM)  advanced  anagen   in  human  hair   follicle  organ  culture,   and  tolbutamide  (1mM)  suppressed  this  effect.     Shorter  et  al   (2008)  also   investigated  the   gene   and   protein   expression   of   K+ATP   channels   in   human   hair   follicles   using  reverse   transcription-­‐polymerase   chain   reaction   (RT-­‐PCR)   and  immunohistochemistry   techniques.      RT-­‐PCR   confirmed   the   expression   of   K+ATP  channel   sub-­‐unit   genes   SUR1,   SUR2B,   Kir6.1   and   Kir6.2   in   anagen   human   hair  follicles;  SUR2A  was  not  expressed.    Immunohistochemistry  further  confirmed  the  protein  expression  of  K+ATP  channels  in  the  hair  follicle:  SUR1  and  Kir6.2  in  the  hair  matrix,   and   SUR2B   and   Kir6.1   in   the   dermal   papilla   and   dermal   sheath.      These  findings  hold  the  potential  of  advocating  the  development  of  better  targeted  drugs  using  the  particular  channel  type  present,  achieving  more  enhanced  stimulation  or  inhibition  of  hair  growth.      
 -44- 
 
To  investigate  the  regulation  of  human  hair  growth,  the  human  hair  follicle  would   be   the   preferred  model.  However,   sample   sizes   and   ethical   approvals   can  limit  experimental  design.    Red  deer  hair  follicles  offer  a  practical  model  system  for  studying   hair   growth   in   vitro   as   they   are   big   follicles,   readily   available   in   large  numbers   (Randall   et   al.,   2003).      Furthermore,   the   red   deer   model   has   ethical  advantages,   as   it   is  bred  and  harvested   for   food   in   the  United  Kingdom  and   thus  skin   is   readily   available.      Therefore,   to   validate   the   use   of   the   deer   follicle   as   a  model   for   the  human  follicle,   the  gene  expression  of  deer  must  be  established  as  the   same   as   that   of   human.      This   would   mark   deer   as   a   good   model   system,  enabling  screening  of  potential  new  therapies.  The   mammalian   hair   follicle   is   subject   to   transformations   throughout   its  growth  cycle  (as  discussed  in  Section  1.4).    Starting  from  a   resting  phase,  telogen,  to   the   growth   phase,   anagen,   this   is   characterised   by   cell   proliferation   and  keratinocyte  differentiation  with  the  production  of  the  hair  shaft,  then  undergoing  the  transitional  regression  phase,  catagen,  and  finally  leading  again  to  the  resting  phase.    The  last  phase  within  the  hair  growth  cycle  is  exogen,  an  independent  and  active  shedding  phase,  during  which  the  original  hair  is  enzymatically  released  and  falls  out  (Higgins  et  al.,  2009).    In  order  to  fully  comprehend  the  role  of  potassium  channels   in   the   hair   follicle,   it   is   necessary   to   investigate   the   presence   of   these  channels  in  both  the  anagen  and  telogen  phases.    The  recent  study  by  Shorter  and  colleagues  demonstrated  the  presence  of  K+ATP  channels  in  the  human  anagen  hair  follicle  (Shorter  et  al.,  2008).    It  is  almost  impossible  to  investigate  the  presence  of  K+ATP   channels   in   a   human   telogen  hair   follicle,   unless  methods   are   employed   to  induce  the  telogen  phase.      
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Figure  2.1    A  photograph  of  a  mature  red  deer  stag  with  full  grown  antlers  
and  mane  (arrow)  (Davies  2001)  
       





2.2   Aims  and  experimental  design  The  overall  aim  of  this  chapter  was  to  validate  the  deer   follicle  as  an  ideal  model   system   for   investigating   the   presence   of   K+ATP   channel   subunit   genes   in  varied  phases  of  the  hair  cycle.    The   initial   stage   of   this   investigation   involved   a   histological   comparison  between  human  and  deer  hair  follicles,  followed  by  the  histological  comparison  of  deer  hair  follicles  in  varied  stages  of  the  hair  cycle.    To  do  this  human  skin  samples  and  red  deer  skin  samples  were  collected.    The  deer  skin  samples  were  from  both  seasonal  productions  of  pelage,   this  presented  hair  samples  at  different  stages  of  the  hair  cycle.    These  samples  were  frozen,  sectioned  and  stained.  The   first   aim   was   to   investigate   whether   the   expression   of   K+ATP   channel  genes   in   red   deer   anagen   hair   follicles  were   the   same   as   that   in   human   follicles  (Shorter  et  al.,  2008),  as  suggested  by  the  deer  pharmacological  studies  (Davies  et  
al.,  2005),  using  a  molecular  biological  approach:  RT-­‐PCR.     To  do  this  a  total  of  60  anagen   hair   follicles   were   micro-­‐dissected,   and   then   RNA   extracted.      After   RNA  isolation,  poly(A)+RNA  extraction  and  treatment  with  DNase,  cDNA  was  synthesised.    The  expression  of  the  genes  for  the  sulphonylurea  receptor  subunits   SUR1,  SUR2A  and   SUR2B   and   the   pore   forming   subunits   Kir6.1   and   Kir6.2   were   all   examined.    Gene   identity   was   confirmed   by   size   on   gel   electrophoresis   and   gene   product  sequence  analysis.    The  NCBI  BLAST  programme  was  used  to  align  the  homology  of  the  sequenced  deer  product  against  the  known  human  sequence.    The  second  aim  was   to   attempt   immunohistochemistry   on   the   frozen   anagen   deer   sections   to  confirm  the  presence  of  the  K+ATP  channel  subunit  proteins  within  the  hair  bulb,  as  was  done  on  human  follicles  by  Shorter  et  al  (2008).    The  final  aim  was  to  investigate  the  gene  expression  of  K+ATP  channel  sub-­‐units  in  telogen  stage  of  the  hair  cycle.    
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2.3  Materials  and  Methods  
2.3.1  Histological  staining  of  human  and  red  deer  hair  follicles  
2.3.1.1  Biological  material    
2.3.1.1.1  Red  deer  skin  Deer  skin  samples  were  gathered,  as  a  waste  product,  from  the  neck/mane  region   (Figure   2.1)   of   healthy   red   deer,   bred   and   harvested   for   sustenance   in  Yorkshire.      The   animals   used   were   young   male   adults,   ranging   from   12   to   18  months   old,   for   both   the   anagen   and   telogen   samples.      The   skin   samples   were  cleaned   and   the   hairs   cut   off   using   sterile   scissors   and   dissected   into   strips  immediately   after   death,   and   transferred   to   50ml   falcon   tubes,   containing  transport  media  RPMI  1640   (RPMI   supplemented  with:  10%   fetal   calf   serum,  10  units/ml   penicillin/streptomycin,   100   ng/ml   fungizone   (amphotericin   B),   and  2mM  L-­‐glutamate)  (Gibco,  Paisley,  UK),  that  had  been  pre-­‐cooled  on  ice  (4°C).    The  tubes   were   stored   in   ice   for   the   duration   of   transportation,   and   once   at   the  University   the   samples   were   washed   in   sterile   PBS   to   remove   all   traces   of   cell  debris  and  blood.     Samples   for  histology  were  dissected   into  1cm2  pieces  (Figure  2.2),  washed  thoroughly  in  sterile  phosphate  buffered  saline  (PBS;  137  mM  NaCl,  2.7  mM  KCl,  10  mM  Na2HPO4,  1.8  mM  KH2PO4),  and  placed  individually  into  1.5  ml  eppendorfs   (Sarsted,  Numbrecht,   Germany)   in   cryoprotectant   Sakura  Tissue-­‐Tek  O.C.TTM  (Raymond  A  Lamb  Ltd,  Sussex,  UK)  at  -­‐80oC  until  further  use.        
  




Figure  2.2    Sample  of  deer  skin    A   deer   neck   skin   sample   was   placed   in   a   petri   dish,   washed   in   sterile   PBS   to  remove   all   traces   of   cell   debris   and   blood   and   dissected   into   1cm2   pieces.    Photographed  on  dissecting  microscope  (Leica  MZ8,  Leica,  Germany)  using  a  Nikon  Coolpix4500  (Nikon  E4500)  digital  camera  (Bar=2mm).      
  
  
2.3.1.1.2  Human  skin    Human  scalp  skin  samples  from  non-­‐balding  areas  (occipital  and  temporal  regions)   were   obtained   from   healthy   individuals   aged   between   24-­‐64   years  undergoing   elective   cosmetic   facelift   surgery.   All   Ethical   Committee   approval  requirements   were   met   and   donors   gave   fully   informed   written   consent.      As  described   above   the   human   skin   samples   were   collected   in   RMPI   transport  medium  and  dissected   into  1cm2   pieces   (Figure  2.3).     The   sections  were  washed  thoroughly  in  sterile  PBS  and  stored  in  O.C.TTM  at  -­‐80°C  until  used.    
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Figure  2.3    Sample  of  human  skin    A  human  facelift  skin  sample  was  placed   in  a  petri  dish,  washed   in  sterile  PBS  to  remove   all   traces   of   cell   debris   and   blood   and   dissected   into   1cm2   pieces.    Photographed  on  light  dissecting  microscope  (Leica  MZ8,  Leica,  Germany)  using  a  Nikon  Coolpix4500  (Nikon  E4500)  digital  camera  (Bar=1.8mm).         
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2.3.1.2  Preparation  of  slides    To  assist  sections  to  adhere  to  twin-­‐frost  glass  slides  (76  x  26  x  1  mm;  BDH,  Lutterworth,   UK)   the   slides   were   cleaned   and   coated   in   poly-­‐l-­‐lysine   (Sigma-­‐Aldrich   Ltd,   Dorset,   UK).   The   slides  were   placed   individually   into   a   plastic   slide  carrier,  before  being  immersed  in  pyroneg  (Diversey  Lever  Ltd,  Northampton,  UK)  and  distilled  water  for  30  minutes.    To  remove  traces  of  detergent  the  slides  were  first   rinsed   in   distilled   water   then   immersed   in   absolute   ethanol   (Sigma)   for   5  minutes.      The   slides  were   allowed   to   dry   in   the   drying   cupboard   at   60C,   before  being  immersed  in  10%  (v/v)  poly-­‐l-­‐lysine  in  distilled  water  for  10  minutes.    Once  dry,  the  slides  were  stored  in  the  original  box  and  remained  at  room  temperature  until  required.        
  
2.3.1.3  Preparation  of  sections  Skin  samples  were  removed  from  -­‐80oC  and  placed  in  a  cryostat  (Leica  CM  1800  Cryostat,  Germany)  at  Ȃ27oC.     ǤǤ̻an  even  disc  to  freeze  solid,  ensuring  all  ǤǤǤ̻disc  was  then  placed   into  the  sample  holder  of   the  cryostat  and  sliced  until  even.    
       ǤǤ̻     longitudinal  follicles  could  be  sectioned.     The  sample  was  orientated  to  its  side  to  




Figure  2.4    Cryostat  machine  with  mounted  skin  sample  The  picture  of  cryostat  (Leica  CM  1800  Cryostat,  Germany)  is  taken  using  a  Nikon  Coolpix4500  (Nikon  E4500)  digital  camera.  
  
                  
2.3.1.4  Histological  investigation  using  Sacpic  staining  Sections   of   deer   and   human   skin   samples   were   stained   with   the   Sacpic  staining   technique   (Nixon,   1993;   Nutbrown   and   Randall,   1996).      This   technique  employs  different  dyes  applied  to  stain  and  distinguish  the  different  components  of  hair  follicles.    The  frozen  slides  were  removed  from  -­‐20°C,  and  allowed  to  air-­‐dry  at  room  temperature  for  30  minutes;  gradual  defrosting  would  prevent  temperature  shock.      The   sections   were   then   fixed   in   ice-­‐cold   acetone   4°C   (Fisher   Scientific  Loughborough,  UK)   for   15  minutes   and   rinsed  with  distilled  water,   to   rehydrate  the   slides.      The   sections   were   immersed   in   Celestine   blue   stain   solution   for   5  minǢ




tap  water  and  placed   in  2%  safranin   for  5  minutes  at   a   time.     The   sections  were  then   dehydrated   via   1  minute   immersions   in:   tap  water;   70%  ethanol;   and   95%  ethanol.   The   sections   were   differentiated   in   absolute   picric   acid/ethanol   for   5  minutes   before   rehydration   via   1   minute   immersions   in:   95%   ethanol;   70%  ethanol;  and  tap  water.    The  sections  were  then  placed  in  picro-­‐indigo  carmine  for  1  minute  and  rinsed   in  tap  water,  before  dehydration  by   immersion   in  ascending  ethanol  solutions  from  70%  ethanol  to  absolute  ethanol,  for  5  minutes  each.     The  sections  were   cleared   in   histoclear:   ethanol   (50:50   v/v)   and   absolute   histoclear  (National   Diagnostics,   Hull,   UK)   for   4   minutes   at   a   time.      Coverslips   (VWR  International,   Leicester,   UK)   were   then   mounted   using   histomount   (VWR  International,  Leicester,  UK).      
  
2.3.1.5  Histological  investigation  using  haematoxylin  and  eosin  staining  The   frozen   sections  were   removed   from   -­‐20°C,   and   allowed   to   air-­‐dry   at  room  temperature  for  1  hour.    The  sections  were  then  fixed  in  ice-­‐cold  acetone  4°C  (Fisher  Scientific  Loughborough,  UK)  for  10  minutes,  and  washed  with  PBS  thrice  for   3  minutes   at   a   time,   to   rehydrate.      They  were   placed   in   haematoxylin   (Merk  Ltd)   for  2-­‐5  minutes  depending  on  how  the  stain  seemed  to  penetrate  the  tissue,  followed  by  a   rinse   in  distilled  water  until   all   traces  of   excess  haematoxylin  was  
Ǥ ǯʹcounter-­‐stained   by   soaking   in   1%  w/v   eosin   (Merck   Ltd)   for   5  minutes.      Excess  eosin   was   removed   by   rinsing   in   distilled   water;   the   water   was   removed   by  dehydrating   sections   in   ascending   alcohol   50%,   70%   and   95%   ethanol   through  
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immersion   for   1   minute   in   each.      Coverslips   (VWR   International,   Leicester,   UK)  were  then  mounted  using  histomount  (VWR  International,  Leicester,  UK).      
  
2.3.1.6  Visualising  the  staining    The   stained   slides  were   examined   using   the  Orthodox   II   light  microscope  (Leitz,  Germany).      Images  of  good  sections  were  captured  digitally  using  a  Nikon  Coolpix   4500   camera,   and   transferred   to   the   computer   using   Nikon   View   5  software.    The  pictures  were  measured  using  a  stage  micrometer  (Figure  2.5).  
  
Figure  2.5    Stage  micrometer  A  picture  of  a   stage  micrometer,   taken  using  Orthodox  II   light  microscope  (Leitz,  Germany),  captured  digitally  using  a  Nikon  Coolpix  4500  camera.          
 -55- 
 
2.3.2    Reverse  Transcription  -­  Polymerase  Chain  Reaction  (RT-­PCR)      PCR  amplifies  a  specific  region  of  template  DNA,  which  can  include  genomic,  plasmid   and  phage  DNA  or  RNA   converted   to   complementary  DNA   (cDNA)   (Cha  and  Thilly,  1995).     Investigating  mRNA  expression  reveals  the  genes  expressed  in  the   cell   or   tissue   from   which   RNA   was   extracted.      The   enzyme   reverse  transcriptase   is  used  alongside   oligo   (dT)  primers,  binding   to   the  poly   (A)   tail  of  mRNA,   synthesising   cDNA   from   mRNA.      The   cDNA   is   then   applied   in   the   PCR  reaction,   and   the   gene   of   interest   is   amplified   from   this   cDNA   by   using   specific  forward  and  reverse  primers  (Kawasaki,  1990).  Specific   forward   and   reverse   primers   are   designed   (see   table   2.1   for  reference)   to   correspond   to   the   regions   bordering   the   target   DNA   sequence   for  PCR  amplification.     The  primers  anneal   to  polar  ends  of   the  target  DNA  sequence  spanning   the   entire   target   DNA   region   for   amplification.      A   PCR   reaction   also  requires   thermostable   Taq   DNA   polymerase,   buffers   and   a   mixture   of  
  ȋǯȌ     ired   for  synthesis  of  new  DNA  strands.    DNA  amplification  is  achieved  using  a  thermocycler  set   at   specific   temperatures   in  which   the  PCR   reaction  mix   is  placed.     The   initial  high  temperature  denatures  the  DNA  template,  and   if  double  stranded,  separates  it.      The   temperature   is   then   lowered   allowing   the   oligonucleotide   primers   to  anneal  to  the  complementary  single-­‐stranded  target  DNA  sequence.     However  the  temperature   is   subject   to   the   primer   used,   generally   at   a   few  degrees   below   the  average   melting   temperature   of   the   primers,   determined   from   the   base  composition  of  the  oligonucleotides.    The  annealing  temperature  must  be  perfectly  adjusted   both   to   allow   for   efficient   annealing,   therefore   not   too   high,   and,   to  minimise   non-­‐specific   binding,   not   too   low.      At   the   final   stage   the   Taq   DNA  
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polymerase  extends  the  annealed  oligonucleotide  primers,  at  a  high  temperature,  typically  at  72-­‐74°C.    The  PCR  cycle  produces  a  new  strand  DNA  if  cDNA  was  used,  or   two   new   strands   when   double   stranded   DNA   was   used.      This   cycle   of  temperatures  is  repeated  between  25-­‐40  times,  with  the  amplified  products  from  each  PCR  cycle  acting  as  template  for  the  next  cycle,  resulting  in  a  significant  rise  in  the  number  of  target  DNA  sequences  (McPherson  and  Møller,  2000).    If   the  MgCl2  concentration   is   too  high  mismatches   in  primer  hybridisation  may  occur  resulting  in  undesired  amplicons,  however,  if  it  is  too  low  a  lower  yield  of   amplification  occurs.     Thus   the  PCR  mix  and   thermocycling   conditions  require  careful  optimisation  and  are  specific  to  each  primer  set  used  (Table  2.1).        
  
Expression  of  K+ATP  channel  subunits  in  deer  hair  follicle  using  RT-­PCR          For  the  purposes  of   investigating  the  expression  of  K+ATP  channel  subunits  in  deer  hair   follicles,   in  both   the  anagen  and   telogen   stages  of   the  hair   cycle,   the  following  materials  and  methods  were  employed.    All  work  areas  were  thoroughly  cleaned  prior  to  the  undertaking  of  any  procedure  using  70%  ethanol  and  RNAse  Zap  solution  (Sigma-­‐Aldrich  Ltd,  Dorset,  UK)  to  prevent  contamination,  as  well  as  gloves   being   changed   regularly.      Only   sterilised  materials  were   used   throughout  the  experiment,  including  plastics  and  glassware.  
2.3.2.1  Tissue  collection    The  tissues  were  collected  as  per  the  description  in  section  2.3.1.1,  with  the  exception   that   the   50ml   falcon   tubes   held   30ml   RNA   stabilisation   solution  RNAlaterTM,   to   inhibit   RNAses   (Sigma).      The   tubes   were   stored   in   ice   for   the  duration  of   transportation,  and  once  at   the  University  they  were  placed   in  to  the  
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fridge   (4°C)  overnight   to  allow   the  RNAlaterTM   to  penetrate   the   tissue.     The  next  day  these  samples  were  transferred  into  clean  RNAlaterTM  and  stored  at  -­‐80  ºC.  
2.3.2.2  Microdissections    For   this   process   all   containers   holding   skin   samples   and   dissected   hair  follicles   that  were  not  being  worked  on  were  kept  on   ice   throughout.     The  Leica  MZ8   (Leica,   Germany)   dissecting  microscope  was   used,   at   x20  magnification   for  the  dissection  of  whole  hair  follicles  from  the  skin  samples  gathered.     Initially  the  skin   samples   were   defrosted   in   an   ice   box,   at   -­‐4°C,   transferred   to   a   petri   dish  (35x10mm)  holding  RNAlaterTM  that  had  been  previously  placed   in  the   icebox,   to  ensure  equal   temperature  to  the  skin   sample.     The  petri  dish  containing  the  skin  sample   was   placed   beneath   the   dissecting   microscope   and   the   follicles   were  dissected   from   the   skin,   transferred   into   another   petri   dish   containing   fresh  RNAlaterTM   and   examined   at   a   higher   magnification   (x50).      The   freshly   isolated  follicles   were   then   cleaned   of   any   dermis   or   fat   debris   using   needles   (27G1/2  tuberculin   syringe;   Sigma)   before   transfer   to   a   1.5ml   eppendorf   containing   1  ml  RNAlaterTM  placed  on   ice.     A  total  of  60  hair   follicles  were  collected  prior  to  total  RNA  isolation.  Photographs  of  the  dissection  steps  are  displayed  in  figure  2.6.      
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Figure  2.6    Isolation  of  deer  hair  follicles  by  microdissection  The  skin  sample  was  cut  into  small  sections  to  promote  conspicuousness  of  individual  hair  follicles  (a)  (Bar=667µm),  which  were  isolated  from   the   skin   sample   and   transferred   to   a   new  dish   of   RNA   laterTM   (b)   (Bar=291µm).      The   isolated   follicles   then   required  meticulous  cleaning,  to  remove  any  dermis  and  subcutaneous  fat,  with  syringe  needles  (c)  (Bar=340µm).    The  clean  isolated  hair  follicles  (d)  from  the  sample  were  then  combined  for  total  RNA  isolation  (Bar=385µm).                  
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2.3.2.3  RNA  isolation,  purification  and  cDNA  synthesis      Following  dissection  of  the  required  number  of  hair  follicles,  the  process  of  total  RNA  isolation  was  carried  out.    The  total  RNA  samples  were  further  purified  to   isolate  poly(A)+RNA.     DNase   treatment  of  RNA  was  carried  out   to   remove  any  contaminating  DNA  from  mRNA,  then  converted  into  single  stranded  cDNA,  before  PCR  amplification.      
  
2.3.2.3.1  Total  RNA  isolation  Total   RNA   isolation   was   carried   out   in   accordance   to   manufacturer  instructions  provided  with   the  GenElute  Mammalian  Total  RNA  kit   (Sigma).     The  microdissected  hair  follicles  were  transferred  into  a  homogeniser  with  the  lysis/2-­‐mercaptoethanol   solution.      The   sample   was   homogenised   until   the   hair   follicles  became   undetectable   and   the   homogenate   was   then   transferred   to   a   GenElute  filtration   column.     The   sample  was   centrifuged   (Eppendorf  5415  R)  at  13000x  g,  for   2   minutes,   effectively   removing   any   cellular   debris   and   shearing   the   DNA.    Following  centrifugation,  the  filtration  column  was  discarded,  and  an  equal  volume  of   70%  ethanol   (made   using   0.05%   (v/v)   diethyl   pyrocarbonate   (DEPC);   Sigma)  treated  water  was  added  to  the  filtered  lysate.     The  sample  was  mixed  thoroughly  by  vortexing.  The   lysate/ethanol   mixture   700   µl   was   then   added   to   the   clear   binding  column   and   centrifuged   at   13000x   g,   for   15   seconds.      The   flow   through   was  discarded,   and   the   total   RNA   would   be   bound   to   the   binding   column.      The  remaining  sample  was  added  to  the  binding  column,  and  the  procedure  repeated.    The  binding  column  was  then  transferred  to  a  new  collection  tube.      
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The   wash   solution   1   was   added   to   the   binding   column   500   µl,   and  centrifuged   for   15   seconds.      Once   again   the   column   was   transferred   to   a   new  collection  tube.     Next  500  µl  of  wash  solution  2  was  added  and  centrifuged  for  15  seconds.    The  flow-­‐through  was  discarded  and  the  binding  column  was  placed  back  into  the  collection  tube.    A  second  500  µl  of  wash  solution  2  was  added  to  column  and   centrifuged   for   2   minutes,   removing   the   ethanol.      The   column   was   then  transferred  to  a  new  collection  tube  to  elute  the  RNA  from  the  binding  column.    50  µl   of   elution   solution   was   added   to   the   centre   of   the   binding   column   and  centrifuged  for  a  minute.    A  second  50  µl  of  elution  solution  was  added  to  column  and  centrifuged  for  a  minute.     The  flow  through  containing  the  purified  total  RNA  was  collected,  and  could  be  used  immediately  or  stored  at  -­‐80°C  until  further  use.  
  
2.3.2.3.2  Poly  (A)+  RNA  isolation  mRNA  isolation  was  carried  out  in  accordance  to  manufacturer  instructions  provided  with   the  GenElute  mRNA  Miniprep  kit   (Sigma).      The   total   RNA   sample  was  brought  up  to  a  volume  of  250  µl  using  RNase-­‐free  water,  mixed  with  250  µl  of  2X  binding  solution  and  15  µl  of  oligo  (dT)  beads,  and  vortexed  thoroughly.     The  sample  was  incubated  for  3  minutes  at  70°C  for  RNA  denaturing,  and  then  left  for  10  minutes  at  room  temperature  before  centrifuging  for  2  minutes  at  13000x  g  to  pellet  the  beads:  mRNA  complex.    At  this  point  the  supernatant  was  removed.    The  pellet   was   resuspended   in   500   µl   of   wash   solution,   transferred   to   a   spin  filter/collection  tube  and  centrifuged  for  2  minutes  at  13000x  g.    The  flow  through  was  discarded  and  the  pellet  washed  again  with  a  second  500  µl  of  wash  solution.  The  column  was  transferred  into  a  fresh  collection  tube  and  50  µl  elution  solution  (preheated  to  70°C)  was  added  to  the  centre  of  the  filter  and  incubated  at  70°C  for  
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5  minutes,   followed  by   centrifugation   for  1  minute.      This   elution   procedure  was  repeated   with   an   additional   50   µl   elution   solution.      The   pure   mRNA   was   then  either  used  immediately  or  stored  at  -­‐80°C  until  further  use.  
  
2.3.2.3.3  DNase  treatment  of  mRNA  samples  Prior  to  cDNA  synthesis  by  reverse  transcription,  the  mRNA  samples  were  treated  with  the  enzyme  dideoxynuclease  I  (DNase  I)  to  remove  any  contaminating  DNA.      A   reaction   mix   was   prepared   inside   a   0.5   ml   eppendorf   tube   (Alpha  Laboratories,   Ltd,   Eastleigh,   UK),   containing   8µl   of   mRNA,   1µl   DNase   I  amplification  grade  and  1µl  10X  reaction  buffer  (Invitrogen  Ltd,  Paisley,  UK).    The  reaction   mix   was   mixed   thoroughly   and   incubated   at   room   temperature   for   15  minutes.     1µl  EDTA  (25mM;  Invitrogen)  was  added  and   incubated  at  65°C  for  10  minutes  to  inhibit  enzyme  activity.    The  DNase  treated  mRNA  could  then  either  be  used  immediately  or  stored  at  -­‐80°C  until  further  use.  
  
2.3.2.3.4  cDNA  synthesis  by  reverse  transcription    The   Avian   Myeloblastosis   Virus   (AMV)   reverse   transcription   system  (Promega,  Southampton,  UK)  was  used  to  convert  DNase  treated  mRNA  into  cDNA.    A   reaction  mix  was   prepared,   in   an   0.5  ml   eppendorf   tube   (Alpha   Laboratories),  containing   2µl   dNTP  mix   (10mM),   1µl   Oligo   (dT)15   primer      (0.5   µg/µl),   2µl   10X  reaction   buffer,   0.5µl   recombinant   RNasin®   ribonuclease   inhibitor   (40   units/µl)  and   0.75µl  AMV  reverse   transcriptase   (high   concentration   25   units/µl,).      To   this  mixture  a  further  3.75µl  nuclease  free  water  was  added  bringing  the  total  volume  to   10µl   (all   provided   by   Promega).      This   reaction   mix   was   added   to   a   0.5   ml  eppendorf   tube   containing   10µl   of   DNase   treated  mRNA,   and  mixed   thoroughly.    
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The  eppendorf   tubes  were  then  placed   in  the  PCR  Sprint   thermal  cycler  (Thermo  Hybaid,   Ashford,   UK)   and   set   to   run   the   reverse   transcription   programme:  incubation   for   1   hour   at   42°C   to   allow   cDNA   synthesis   from   mRNA   by   reverse  transcription,   followed  by   5  minutes   at   99°C   to   inhibit   the   reverse   transcriptase  and  5  minutes  at  4°C.      A   centrifugation  of  5   seconds,   ensured   that   all   cDNA  was  collected  at   the  base  of   the  eppendorf   tube.     This  sample  was  then  aliquoted   into  0.5   ml   eppendorf   tubes   (Alpha   Laboratories)   at   10µl   cDNA   sample   per   tube,  labelled  and  stored  at  -­‐20°C.  
  
2.3.2.4  PCR      A   reaction   mix   was   prepared,   inside   an   0.5   ml   eppendorf   tube   (Alpha),  using  3µl  of  cDNA  in  a  50  µl  reaction  volume  containing  0.5  µM  concentrations  of  forward   and   reverse   target   primers;   200   µM   concentrations   of   each   dNTP  (Promega,   Southampton,   UK);   5µl   of   10X   reaction   buffer   [200  mM   Tris-­‐HCI   (pH  8.4),  500  mM  KCI;   Invitrogen];  ʹǤͷȋȾ-­‐actin,  SUR1,  and  SUR2  reactors)  or  1.5  mM  (Kir6.1  and  Kir6.2)  MgCl2  depending  upon  target  primer  set  (Invitrogen)  (For  details  for  each  target  primer  set  see  table  2.1);  and  2.5  U  of  recombinant  Taq  DNA  polymerase  (Invitrogen).    Using  nuclease  free  water  the  volume  of  the  mixture  was  brought  up  to  50  µl,  and  then  mixed  thoroughly.    For  every  PCR  reaction  a  negative  control  was   prepared,   replacing   the   3   µl   cDNA  with   3   µl   of   nuclease   free  water.    One  drop  of  mineral  oil  (Sigma)  was  added  on  the  top  of  each  reaction  mixture,  to  prevent  evaporation  of  reaction  components  during  PCR  thermocycling.     The  PCR  products   were   then   placed   on   ice   for   immediate   analysis   by   agarose   gel  electrophoresis  or  could  be  stored  at  -­‐20°C.  
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Table  2.1  Specific  forward  (F)  and  reverse  (R)  primers  for  each  cDNA  target  sequence  and  optimised  conditions  used  in  RT-­PCR  




















2.3.2.4.2  Sequencing  of  PCR  products  To   verify   and   confirm   the   PCR   products,   they  were   sent   to   a   commercial  company  for  sequencing.    The  PCR  products  were  prepared  as  described  in  section  2.3.2.4  except  that  only  small,  thin  walled  PCR  tubes  were  used  (VWR  International  Ltd,   Poole,   UK)   and   a   hot   lid  was   applied   in   the   thermocycler   instead   of   adding  mineral   oil,   as   it   may   interfere   with   the   sequencing.      The   PCR   products   were  separated  on  a   low-­‐melting  point  agarose  gel  (Invitrogen),   to  permit   the  use  of  a  lower   temperature   for   dissolving   the   gel,   at   the   purification   stage   of   the   PCR  products,   preventing   the   possibility   of   DNA   degradation.      The   commercial  sequencing   service   requires   approximately   50   ng/µl   of   DNA   therefore   30   µl   of  weaker  PCR  products  were  loaded  onto  the  gel  allowing  for  sufficient  product  for  sequencing.      Using   the   MinElute   Gel   Extraction   kit   (Qiagen,   Crawley,   UK),   these  products   were   first   purified   in   accordance   with   the   instruction   set   by   the  manufacturer.     The  target  DNA  fragment  was  cut  out   from  the  gel  using  a  scalpel  blade,  and  transferred  into  a  pre-­‐weighed  1.5  ml  eppendorf  tube.    The  tube  was  re-­‐weighed  to  obtain  the  gel  weight.    Buffer  QC  was  then  added  in  the  proportion  of  3  volumes   of   buffer   to   1   of   gel   (300   µl   of   Buffer   QC   to   100  mg   of   gel).      This  was  incubated   for   10   minutes   at   50°C,   with   vortexing   every   3   minutes   during   this  incubation,  to  dissolve  the  gel  slice.    One  volume  of  isopropanol  (Sigma)  was  added  after  the  gel  was  fully  dissolved,  and  mixed  by  inversion.    The  mixture  was  added  to  a  MinElute  column  and  centrifuged  (13000  x  g)  for  1  minute  to  bind  the  DNA  to  the   column.      After   the   flow-­‐through   from   the   column   was   discarded,   500   µl   of  Buffer  QC  was   added  and   the   column  was  centrifuged   (13000  x  g)   for  1  minute.    The   flow-­‐through  was  discarded  and   the   column  returned   to   the   collection   tube.    The  column  was  washed  with  750  µl  of  buffer  PE  with  incubation  for  5  minutes  at  
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2.3.3  Immunohistochemistry  Immunohistochemistry  was  attempted  to  investigate  protein  expression  to  
Ƥ+ATP  channel  subunits   in  deer  hair   follicles.     Slides  were  coated  with  poly-­‐l-­‐lysine  (as  described  in  section  2.3.1.2)  and  5µm  cryosections  of  deer  hair   follicle  were  mounted  upon  them  (as  described   in  section  2.3.1.3).     The  sections   underwent   1   hour   of   air   drying   at   room   temperature,   followed   by   10  minutes   fixation   in   ice-­‐cold   acetone   and   10   minutes   of   rehydration   in   PBS.    Endogenous   peroxide   activity   was   blocked   by   30   minutes   of   incubation   in   3%  hydrogen  peroxide   in  methanol  and  a   subsequent   rinse   in   PBS.      Incubation  with  normal  mouse   serum   (5%)   (Sigma-­‐Aldridge   Ltd)   in   PBS   for   20  minutes   blocked  potential   non-­‐Ƥ  ȋ        antibody)   (Ramos-­‐Vara   2005).      Sections   were   incubated   with   the   primary  polyclonal   goat   antibody   SUR1   1:5   (sc-­‐5789),   SUR2A   1:5   (sc-­‐32461),   SUR2B  1:5  (sc-­‐5793),   Kir6.1   1:5   (sc-­‐11225),   and   Kir6.2   1:5   (sc-­‐11228)   (Santa   Cruz  Biotechnology,  Santa  Cruz,  CA,  USA)   in  a  moist  chamber  to  prevent  sections   from  dehydrating  at  4°C   for  18  hours.     Antibodies  were  diluted   in  1.5%  normal  mouse  serum  in  PBS.     Unbound  primary  antibody  was  removed  from  the  slides  with  two  rinses   in  PBS   for  20  minutes,  prior   to   incubation  with  a  mouse  monoclonal   anti-­‐goat  biotin-­‐conjugated  secondary  antibody  (Sigma-­‐Aldrich    Ltd)    diluted    1:20    with    5%    normal    mouse  serum  in  PBS  for  30  minutes.    The  sections  were  washed  twice  in   PBS   before   ExtraAvidin   horseradish   peroxidise   (Sigma-­‐Aldridge   Ltd)   was  applied  diluted  1:20  with  PBS  for  30  min.    The  sections  were  washed  twice  in  PBS.    Peroxide   substrate,   3-­‐amino-­‐9-­‐ethylcarba-­‐zole   (AEC;   Vector   Laboratories   Ltd.,  Peterborough,   UK)   visualised   antibody   binding.      Chromogen   formation   was  monitored  under   the   light  microscope  and  when  sufficient   colour  had  developed  
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the  reaction  was  halted  by  placing  the  slides  in  distilled  water.    The  sections  were  











2.4.1  Histological  investigation  of  human  and  red  deer  hair  follicles  










Figure  2.7    Histology  of  human  scalp  skin  
(a)  The  intact  skin  sample  displays  a  longitudinal  hair  follicle  (HF),  extending  into  the   subcutaneous   far   layer   (SF),  with  a   thin  epidermis   (E)  and  dermis   (D)   (Scale  bar   =   500µm),   and   at   higher   magnification   of   an   isolated   hair   follicle   (HF)   the  connective/dermal  sheath  (DS),  pigmented  and  non-­‐pigmented  matrix  (M)   in   the  hair  bulb  are  clear.    Large  sebaceous  gland  (SG)  can  be  seen  on  the  left  of  the  upper  follicle  and  the  dark  pigmented  hair  is  visible  from  the  upper  bulb  upwards  (Scale  bar  =  220µm).      
(b)  The  Sacpic  staining  further  emphasises  the  histology  of  the  intact  skin  sample.    At   the   higher   magnification   the   staining   visibly   highlights   the   longitudinal   hair  
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2.4.1.2  A  comparison  of  red  deer  hair  follicles  at  different  stages  of  the  hair  







Figure  2.10    Deer  hair  follicles  in  different  growth  cycle  stages              Stained  hair  follicle  in  anagen  (a)  (Bar=443µm),  (b)  (Bar=49µm);  stained  catagen  hair  follicle  showing  the  regressing  lower  follicle  (c)  (Bar=59µm),  (d)  (Bar=30µm).     Stained  telogen  hair   follicle  showing  the   fully  keratinised  hair   fibre  base   interdigitated  with   inner  root  sheath   (e)   (Bar=151µm),   (f)   (Bar=21µm);   (g)   showing   dissected   hair   follicle   in   mid   anagen   showing   original   and   new   hair   follicle  (Bar=159µm).  
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2.4.2  RT-­PCR  analysis  of  K+ATP  channel  sub-­units  in  anagen  red  deer  hair  
follicles  To   investigate   anagen   red   deer   hair   follicles,   five   different   red   deer   stags  were   used   to   gather   the   neck/mane   skin   samples.      Individual   hair   follicles  were  microdissected   &   pooled   separately   for   each   individual   deer   for   poly   (A)   RNA  extraction,   cDNA  preparation  and   identification  of  5  K+ATP   channel   subunit   genes  (as   described   in   section   2.3.2.2).         Gene   identity   was   confirmed   by   size   on   gel  electrophoresis  and  gene  product  sequence  analysis.    The  NCBI  BLAST  programme  was  used  to  align  the  homology  of  the  sequenced  deer  product  against  the  known  human  sequence.  Prior  to  investigating  the  expression  of  K+ATP  channel  sub-­‐units,  RT-­‐PCR  was  
 Ⱦ-­‐actin.     The  detection   of   this   housekeeping   gene   would   indicate   that   the   isolated   RNA   is   of  sufficient   quality   for   RT-­‐PCR   to   be   performed   effectively   (Croft,   2002;   Davies,  2001).    PCR  products  from  all  hair  follicle  samples  corresponded  to  the  anticipated  
Ⱦ-­‐actin  (Figure  2.11).      In  the  negative  control,  in  which  the  template  cDNA  was  excluded  from  the  reaction  mix,   no   PCR  products  were   present,   indicating   that   the   amplification   of  the   cDNA   synthesised   from   the   mRNA   samples   produced   the   PCR   products.  Furthermore,   it   also   demonstrated   that   no   DNA   contamination   occurred   in   the  reaction  mix.      
Ⱦ-­‐actin  PCR  product  sequence  analysis  was  used   (as   described   in   section   2.3.2.4.2).      Through   the   use   of   the   NCBI   BLAST  programme   the   homology   of   the   sequenced   PCR   product   was   compared   to   the  
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kn   Ǥ   Ⱦ-­‐actin   PCR   product   of   the   deer   hair  follicle,   exhibited   94%   homology   to   the   known   human   sequence   (accession  






















Figure  2.11    Ⱦ-­actin  in  anagen  red  deer  hair  follicles  The  quality  of  the  cDNA  samples  for  anagen  (A)  follicles  were  investigated  by  PCR  
  Ⱦ-­‐actin   (see   table  2.1);  5µl  of   cDNA  was  used   for  each  reaction   mix.      The   PCR   products   were   separated   by   1.5%   agarose   gel  electrophoresis   and   visualised   with   ethidium   bromide   staining.     M-­‐   DNA   ladder  (The   DNA   ladder   ranges   from   100Ȃ1,500bp;   in   100bp   increments,   10µl   of   DNA  ladder   was   loaded);   Lanes   A1-­‐ͷ    Ⱦ-­‐actin   in   anagen   follicles  
 ͷ   ȋ͵Ͳ Ɋ   ȀȌǢ -­‐negative   control:   cDNA   was  
ǤȾ-­‐actin  is  838  bp.  
  
  











Figure   2.12         Ⱦ-­actin   RT-­PCR   product,   following  
amplification   from   deer   hair   follicle   cDNA,   compared   to   known   human  
sequence             To  ascertain  the  identity  of  the  PCR  product  the  expected  amplicon  size  band  (838  base   pairs)  was   cut   out   from   the   gel,   purified   and   sequenced.      The  NCBI  BLAST  programme  was  used  to  align  the  homology  of  the  sequenced  deer  product  (black;  
Ȍ   Ⱦ-­‐actin   sequence   (blue;   query).      The   bases   that  match  in  the  two  sequences  are  shown  by  a  vertical  linǤȾ-­‐actin  PCR  product  of   the   deer   hair   follicle   exhibited   94%  homology   to   the   known  human   sequence  (accession  number:  NM_001101).        
Query    247    GAGGGGTATGCCCTCCCCCATGCCATCCTGCGTCTGGACCTGGCTGGCCGGGACCTGACT    306  
                        ||||||||  |||||||||||  ||||||||||||||||||||||||||||||||||||||    
Sbjct    556    GAGGGGTACGCCCTCCCCCACGCCATCCTGCGTCTGGACCTGGCTGGCCGGGACCTGACA    498  
  
Query    307    GACTACCTCATGAAGATCCTCACCGAGCGCGGCTACAGCTTCACCACCACGGCCGAGCGG    366  
                        |||||||||||||||||||||||  ||  ||  ||  ||||||||  ||||||||  |||||||||  
Sbjct    497    GACTACCTCATGAAGATCCTCACGGAACGGGGTTACAGCTTTACCACCACAGCCGAGCGG    438  
  
Query    367    GAAATCGTGCGTGACATTAAGGAGAAGCTGTGCTACGTCGCCCTGGACTTCGAGCAAGAG    426  
                        |||||  |||||||||||  ||||||||||||||||||||||||||||||||||||||  |||  
Sbjct    437    GAAATTGTGCGTGACATCAAGGAGAAGCTGTGCTACGTCGCCCTGGACTTCGAGCAGGAG    379  
  
Query    427    ATGGCCACGGCTGCTTCCAGCTCCTCCCTGGAGAAGAGCTACGAGCTGCCTGACGGCCAG    486  
                        ||||||||  |||||  |||    |||||||  |||||||||||||  |||||||||||  ||  |||  
Sbjct    378    ATGGCCACTGCTGCATCCTCCTCCTCCTTGGAGAAGAGCTATGAGCTGCCTGATGGTCAG    320  
  
Query    487    GTCATCACCATTGGCAATGAGCGGTTCCGCTGCCCTGAGGCACTCTTCCAGCCTTCCTTC    546  
                        ||  ||||||||||||||||||||||||||  ||  ||  ||||||||||||||||||||||||  
Sbjct    319    GTGATCACCATTGGCAATGAGCGGTTCCGGTGTCCCGAGGCACTCTTCCAGCCTTCCTTC    260  
  
Query    547    CTGGGCATGGAGTCCTGTGGCATCCACGAAACTACCTTCAACTCCATCATGAAGTGTGAC    606  
                        |||||  ||||||||||||||||||||||||||  |||||||||||||||||||||||||||    
Sbjct    259    CTGGGTATGGAGTCCTGTGGCATCCACGAAACCACCTTCAACTCCATCATGAAGTGTGAC    200  
  
Query    607    GTGGACATCCGCAAAGACCTGTACGCCAACACAGTGCTGTCTGGCGGCACCACCATGTAC    666  
                        |||||||||||||||||||||||  ||||||||  |||||||||||  ||  ||||||||||||  
Sbjct    199    GTGGACATCCGCAAAGACCTGTATGCCAACACGGTGCTGTCTGGTGGGACCACCATGTAC    140  
  
Query    667    CCTGGCATTGCCGACAGGATGCAGAAGGAGATCACTGCCCTGGCACCCAGCACAATGAAG    726  
                        ||||||||  |||||||||||||||||  |||||||||||||||||  |||||||||||||||  
Sbjct    139    CCTGGCATCGCCGACAGGATGCAGAAAGAGATCACTGCCCTGGCTCCCAGCACAATGAAG    80  
  
Query    727    ATCAAGATCATTGCTCCTCCTGAGCGCAAGTACTCCGTGTGGATCGGCGGCTCCATCCTG    786  
                        |||||||||||||||||||||||||||||||||||  ||||||||||||||||||||||||  
Sbjct    79      ATCAAGATCATTGCTCCTCCTGAGCGCAAGTACTCGGTGTGGATCGGCGGCTCCATCCTG    20  
  
Query    787    GCCTCGCTGTCCACCTTCC    805  
                        |||||  |||||||||||||  
Sbjct    19      GCCTCCCTGTCCACCTTCC    1      
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The  expression  of  regulatory   sulphonylurea   sub-­‐units  of  K+ATP   channels   in  red   deer   anagen   hair   follicles  was   investigated,   using   specific   primers   for   SUR1,  SUR2A  and  SUR2B.    A  single  pair  of  primers  was  used  to  investigate  the  expression  of  the  SUR2  genes,  as  SUR2A  and  2B  are  different  splice  variants  of  the  SUR2  gene  (Isomoto  et  al.,  1996).    All  cDNA  samples  from  anagen  hair  follicles  produced  PCR  products  of  the  expected  size  291  bp  for  the  SUR1  gene  (Figure  2.13)  and  312  bp  for  SUR2B  gene  (Figure  2.15).      The  gene  expression  for  SUR2A  was  not  detected  in  anagen  follicles  (Figure  2.15).      However,   deer   skeletal   muscle   cDNA   used   as   a   positive   control   for   the  SUR2A   gene   did   produce   an   appropriately   sized   band   at   451   bp   (Figure   2.15)  validating  the  method  used.    The  negative  control  (N)  for  all  PCR  products,  where  the   template   cDNA  was   excluded   from   the   reaction  mix,  was   clear   of   any   bands,  indicating   the   PCR   products   are   a   direct   result   of   cDNA   amplification,   and  demonstrating  an  absence  of  contamination.    The  identity  of  SUR1  and  SUR2B  gene  products   was   confirmed   via   sequencing.      The   SUR1   PCR   product   of   deer   hair  follicle  cDNA  exhibited  95%  homology  to  the  known  human  sequence  (accession  number:  AF087138)  (Figure  2.14),  while   the  SUR2B  PCR  product  correlated  with  91%  homology  with  the  known  human  sequence  (accession  number:  AF087138)  (Figure  2.16).  These   results   indicate   that   red   deer  hair   follicles   express   the   genes   for   at  least   two   forms   of   sulphonylurea   subunits   of   K+ATP   channels   in   anagen   hair  follicles.        
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Figure  2.13    PCR  detection  of  SUR1  in  red  deer  anagen  hair  follicles  The   PCR   products   were   separated   by   1.5%   agarose   gel   electrophoresis   and  visualised   with   ethidium   bromide   staining.      M-­‐   DNA   ladder   (The   DNA   ladder  ranges  from  100Ȃ1,500bp;  in  100bp  increments,  10µl  of  DNA  ladder  was  loaded);  Lanes  A1-­‐ͷͳͷȋ͵ͲɊof   PCR   product/lane);   N-­‐negative   control:   cDNA   was   omitted   from   the   PCR  reaction,  B-­‐  blank.    The  expected  amplicon  size  for  SUR1  is  291bp.    











Figure   2.14      Sequencing   results   for   SUR1   RT-­PCR   product,   following  
amplification   from   deer   hair   follicle   cDNA,   compared   to   known   human  
sequence          To  ascertain  the  identity  of  the  PCR  product  the  expected  amplicon  size  band  (291  base   pairs)  was   cut   out   from   the   gel,   purified   and   sequenced.      The  NCBI  BLAST  programme  was  used  to  align  the  homology  of  the  sequenced  deer  product  (black;  sbjct)   against   the   known   human   SUR1   sequence   (blue;   query).      The   bases   that  match  in  the  two  sequences  are  shown  by  a  vertical  line.    The  SUR1  PCR  product  of  the   deer   hair   follicle   exhibited   95%   homology   to   the   known   human   sequence  (accession  number:  AF087138).        
  
Query    1        CGATGCCATCATCACAGAAGGCGGGGAGAATTTCAGCCAGGGACAGAGGCAGCTGTTCTG    60  
                        ||||||||||||||||||||||||||||||  |||||||||||  |||||||||||||||||  
Sbjct    242    CGATGCCATCATCACAGAAGGCGGGGAGAACTTCAGCCAGGGCCAGAGGCAGCTGTTCTG    183  
  
Query    61      CCTGGCCCGGGCCTTCGTGAGGAAGACCAGCATCTTCATCATGGACGAGGCCACGGCTTC    120  
                        |||||||||  ||||||||||||||||||||  |||||||||||||||||  |||||  |||||  
Sbjct    182    CCTGGCCCGAGCCTTCGTGAGGAAGACCAGTATCTTCATCATGGACGAAGCCACAGCTTC    123  
  
Query    121    CATTGACATGGCCACGGAAAACATCCTCCAAAAGGTGGTGATGACAGCCTTCGCAGACCG    180  
                        |||  ||||||||||||||||||||||||||  ||  |||||||||||  ||||||||||||||  
Sbjct    122    CATCGACATGGCCACGGAAAACATCCTCCAGAAAGTGGTGATGACGGCCTTCGCAGACCG    63  
  
Query    181    CACTGTGGTCACCATCGCGCATCGAGTGCACACCATCCTGAGTGCAGACCTGGTGA    236  
                        |||  |||||||||||||||||  ||  |||||||||||||||||||||||||||||||  
Sbjct    62      CACCGTGGTCACCATCGCGCACCGCGTGCACACCATCCTGAGTGCAGACCTGGTGA    7        
              
 -86- 
 
Figure  2.15    PCR  detection  of  SUR2A/B  in  red  deer  anagen  hair  follicles  The   PCR   products   were   separated   by   1.5%   agarose   gel   electrophoresis   and  visualised   with   ethidium   bromide   staining.      M-­‐   DNA   ladder   (The   DNA   ladder  ranges  from  100Ȃ1,500bp;  in  100bp  increments,  10µl  of  DNA  ladder  was  loaded);  Lanes  A1-­‐A5  show  expression  of  SUR2A/B  in  anagen  follicles  from  5  deer  stags  (30  













Figure   2.16      Sequencing   results   for   SUR2A/B   RT-­PCR   product,   following  
amplification   from   deer   hair   follicle   cDNA,   compared   to   known   human  
sequence    To  ascertain  the  identity  of  the  PCR  product  the  expected  amplicon  size  band  (312  base   pairs)  was   cut   out   from   the   gel,   purified   and   sequenced.      The  NCBI  BLAST  programme  was  used  to  align  the  homology  of  the  sequenced  deer  product  (black;  sbjct)  against  the  known  human  SUR2A/B  sequence  (blue;  query).    The  bases  that  match   in   the   two   sequences   are   shown   by   a   vertical   line.      The   SUR2A/B   PCR  product   of   the   deer   hair   follicle   exhibited   91%   homology   to   the   known   human  sequence  (accession  number:  NM_005691).          
  
Query    8        AATATGGTCAAATCTCTACCTGGAGGTCTAGATGCGGTTGTCACTGAAGGTGGGGAGAAT    67  
                        ||||||||||||||||||||  ||||||||||||||  ||||||||||||||||||||||||  
Sbjct    280    AATATGGTCAAATCTCTACCAGGAGGTCTAGATGCAGTTGTCACTGAAGGTGGGGAGAAT    221  
  
Query    68      TTTAGCGTTGGACAGAGACAGCTATTTTGCCTTGCCAGGGCCTTTGTCCGCAAAAGCAGC    127  
                        |||||||||||||||||||||||  ||  ||||||||||||||||||||||||||||||||    
Sbjct    220    TTTAGCGTTGGACAGAGACAGCTGTTCTGCCTTGCCAGGGCCTTTGTCCGCAAAAGCAGT    161  
  
Query    128    ATTCTTATTATGGATGAGGCAACAGCTTCCATTGACATGGCCACAGAGAATATTTTGCAA    187  
                        |||||  ||  ||||||||  |||||  ||||||||  |||||||||||  ||  ||  ||||||||    
Sbjct    160    ATTCTCATCATGGATGAAGCAACGGCTTCCATCGACATGGCCACGGAAAACATTTTGCAG    101  
  
Query    188    AAAGTAGTAATGACAGCCTTTGCAGACCGGACCGTGGTGACAATAGCTCATCGAGTACAC    247  
                        |||||  ||  ||||||||  ||||||||  ||  |||||  ||  ||||||||||||||  ||  |||  
Sbjct    100    AAAGTGGTCATGACAGCTTTTGCAGATCGCACCGTTGTTACAATAGCTCATCGGGTTCAC    41  
  
Query    248    ACTATTCTGACGGCAGACCTGGTTATTGTGA    278  
                        ||||||||||||||||||||  ||||||||||  
Sbjct    40      ACTATTCTGACGGCAGACCTAGTTATTGTGA    10                    
 -88- 
 



















Figure  2.17    PCR  detection  of  Kir6.1  in  red  deer  anagen  hair  follicles  The   PCR   products   were   separated   by   1.5%   agarose   gel   electrophoresis   and  visualised   with   ethidium   bromide   staining.      M-­‐   DNA   ladder   (The   DNA   ladder  ranges  from  100Ȃ1,500bp;  in  100bp  increments,  10µl  of  DNA  ladder  was  loaded);  Lanes  A1-­‐ͷ͸Ǥͳͷȋ͵ͲɊof   PCR   product/lane);   N-­‐negative   control:   cDNA   was   omitted   from   the   PCR  reaction,  B-­‐  blank.    The  expected  amplicon  size  for  Kir6.1  is  336bp.    










Figure   2.18      Sequencing   results   for   Kir6.1   RT-­PCR   product,   following  
amplification   from   deer   hair   follicle   cDNA,   compared   to   known   human  
sequence          To  ascertain  the  identity  of  the  PCR  product  the  expected  amplicon  size  band  (336  base   pairs)  was   cut   out   from   the   gel,   purified   and   sequenced.      The  NCBI  BLAST  programme  was  used  to  align  the  homology  of  the  sequenced  deer  product  (black;  sbjct)   against   the   known   human   Kir6.1   sequence   (blue;   query).      The   bases   that  match  in  the  two  sequences  are  shown  by  a  vertical  line.     The  Kir6.1  PCR  product  of   the   deer   hair   follicle   exhibited   91%  homology   to   the   known  human   sequence  (accession  number:  NM_004982).            
Query    33      TGCTCTTCGCTATCATGTGGTGGCTGGTGGCCTTTGCCCATGGGGACATCTATGCTTACA    92  
                        ||||||||||    ||||||||||||||||||||||||||||  |||||||||||||||||||  
Sbjct    1        TGCTCTTCGCC-­TCATGTGGTGGCTGGTGGCCTTTGCCCACGGGGACATCTATGCTTACA    59  
  
Query    93      TGGAGAAAAGTGGAATGGAGAAAAGTGGTTTGGAGTCCACTGTGTGTGTGACTAATGTCA    152  
                        ||||||||||  ||  ||||||||||||||  ||||||  ||||  ||||||||||||||  ||||  
Sbjct    60      TGGAGAAAAGCGGGATGGAGAAAAGTGGCTTGGAGGCCACCGTGTGTGTGACTAACGTCA    119  
  
Query    153    GGTCTTTCACTTCTGCTTTTCTCTTCTCCATTGAAGTTCAAGTTACCATTGGGTTTGGAG    212  
                        ||||||||||  |||||  ||  |||||||||||||||||||||||  ||  |||||  |||||||  
Sbjct    120    GGTCTTTCACCTCTGCCTTCCTCTTCTCCATTGAAGTTCAAGTGACAATTGGATTTGGAG    179  
  
Query    213    GGAGGATGATGACAGAGGAATGCCCTTTGGCCATCACGGTTTTGATTCTCCAGAATATTG    272  
                        ||||  ||||||||  ||||||||||||  ||||  |||||  ||    |||||||  |||||  ||||  
Sbjct    180    GGAGAATGATGACTGAGGAATGCCCTCTGGCTATCACAGTCCTGATTCTACAGAACATTG    239  
  
Query    273    TGGGTTTGATCATCAATGCAGTCATGTTAGGCTGCATTTTCATGAAAACAGCTCAGGCTC    332  
                        |||||||||||||||||||  ||||||||  |||||||||||||||||||||||||||||||  
Sbjct    240    TGGGTTTGATCATCAATGCGGTCATGTTGGGCTGCATTTTCATGAAAACAGCTCAGGCTC    299  
  
Query    333    ACA    335  
                        |||  
Sbjct    300    ACA    302                
 -91- 
 
Figure  2.19    PCR  detection  of  Kir6.2  in  red  deer  anagen  hair  follicles  The   PCR   products   were   separated   by   1.5%   agarose   gel   electrophoresis   and  visualised   with   ethidium   bromide   staining.      M-­‐   DNA   ladder   (The   DNA   ladder  ranges  from  100Ȃ1,500bp;  in  100bp  increments,  10µl  of  DNA  ladder  was  loaded);  Lanes  A1-­‐A5  show  expression  of  Kir6.2  in  anagen  follicles  ͷȋ͵ͲɊof   PCR   product/lane);   N-­‐negative   control:   cDNA   was   omitted   from   the   PCR  reaction.    The  expected  amplicon  size  for  Kir6.2  is  301bp.    
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Figure   2.20      Sequencing   results   for   Kir6.2   RT-­PCR   product,   following  
amplification   from   deer   hair   follicle   cDNA,   compared   to   known   human  
sequence          To  ascertain  the  identity  of  the  PCR  product  the  expected  amplicon  size  band  (301  base   pairs)  was   cut   out   from   the   gel,   purified   and   sequenced.      The  NCBI  BLAST  programme  was  used  to  align  the  homology  of  the  sequenced  deer  product  (black;  sbjct)   against   the   known   human   Kir6.2   sequence   (blue;   query).      The   bases   that  match  in  the  two  sequences  are  shown  by  a  vertical  line.     The  Kir6.2  PCR  product  of   the   deer   hair   follicle   exhibited   94%  homology   to   the   known  human   sequence  (accession  number:  D50582).            
Query    34      CCCACAAGAACATCCGGGAGCAGGGCCGCTTCCTGCAGGACGTGTTCACCACGCTGGTGG    93  
                        |||||||||||||||||||||  ||||||||||||||  |||||||||||    |||    |||||  
Sbjct    1        CCCACAAGAACATCCGGGAGCNGGGCCGCTTCCTGCNGGACGTGTTCANNACGNNGGTGG    60  
  
Query    94      ACCTCAAGTGGCCACACACATTGCTCATCTTCACCATGTCCTTCCTGTGCAGCTGGCTGC    153  
                        |||||||||||||||||||||||  ||||||||||||||||||||||||||||||||||||  
Sbjct    61      ACCTCAAGTGGCCACACACATTGNTCATCTTCACCATGTCCTTCCTGTGCAGCTGGCTGC    120  
  
Query    154    TCTTCGCCATGGCCTGGTGGCTCATCGCCTTCGCCCACGGTGACCTGGCCCCCAGCGAGG    213  
                        ||  ||||||||||||||||||||  ||||||||||||||||||||||||||||||||||||  
Sbjct    121    TCNTCGCCATGGCCTGGTGGCTCNTCGCCTTCGCCCACGGTGACCTGGCCCCCAGCGAGG    180  
  
Query    214    GCACTGCTGAGCCCTGTGTCACCAGCATCCACTCCTTCTCGTCTGCCTTCCTTT    267  
                        |||||||||||||||||||||||  ||||||||||||||  ||||||||||  ||||  
Sbjct    181    GCACTGCTGAGCCCTGTGTCACCNGCATCCACTCCTTCNCGTCTGCCTTNCTTT    234                  
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2.4.3  Immunohistochemical  localisation  of  K+ATP  channel  subunits  in  anagen  





Figure  2.21    Immunolocalisation  of  K+ATP  channel  subunits  in  the  anagen  red  deer  hair  follicle  bulb  Immunohistochemical   analysis   of   deer   cryosections   localised   same  K+ATP   channel   subunits;   SUR2B   and  Kir6.1  were   expressed   in   the  dermal  papilla  and  dermal  sheath  (h  &  i).    No  staining  occurred  in  the  hair  bulb  with  the  antibody  to  SUR2A  (g)  similar  to  the  negative  controls  when  the  primary  antibody  was  omitted  (a-­‐e).    No  staining  was  evident  in  the  dermal  sheath  or  papilla  with  the  antibodies  to  SUR1  and  Kir6.2   (f  &   j),   but   the  upper  matrix  appeared   to  have   some  red   staining  associated  with  pigmented   regions.     Normal  dark  pigment  (melanin)  is  visible  in  the  hair  bulb.     CTS/DS-­‐  connective  tissue/dermal  sheath;  RS-­‐  developing  root  sheaths;  HM-­‐  hair  matrix  and  DP-­‐  dermal  papilla  (Bar=50µm).    
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2.4.4   RT-­PCR   analysis   of   K+ATP   channel   sub-­units   in   telogen   red   deer   hair  
follicles  To  investigate  K+ATP  channel  sub-­‐units  in  telogen  red  deer  hair  follicles  the  same  procedures  were   followed  as  detailed   in   section  2.4.2,   for  anagen   red  deer  hair  follicles.    PCR  products  from  all  telogen  hair  follicle  samples  corresponded  to  














Figure  2.22    Ⱦ-­actin  in  telogen  red  deer  hair  follicles  The  quality  of  the  cDNA  samples  for  telogen  (T)  follicles  were  investigated  by  PCR  
  Ⱦ-­‐actin   (see   table  2.1);  5µl  of   cDNA  was  used   for  each  reaction   mix.      The   PCR   products   were   separated   by   1.5%   agarose   gel  electrophoresis   and   visualised   with   ethidium   bromide   staining.     M-­‐   DNA   ladder  (The   DNA   ladder   ranges   from   100Ȃ1,500bp;   in   100bp   increments,   10µl   of   DNA  ladder  was   loaded);   Lanes   T1-­‐ͷ    Ⱦ-­‐actin   in   telogen   follicles  
ͷȋ͵ͲɊȀȌǢ-­‐  anagen  sample,  was  used  parallel  with   telogen   samples   as   positive   control;   N-­‐negative   control:   cDNA  was   omitted  
ǤȾ-­‐actin  is  838  bp.  
  
  
     












Figure  2.23    PCR  detection  of  SUR1  in  red  deer  telogen  hair  follicles  The   PCR   products   were   separated   by   1.5%   agarose   gel   electrophoresis   and  visualised   with   ethidium   bromide   staining.      M-­‐   DNA   ladder   (The   DNA   ladder  ranges  from  100Ȃ1,500bp;  in  100bp  increments,  10µl  of  DNA  ladder  was  loaded);  Lanes  T1-­‐ͷͳͷȋ͵ͲɊof  PCR  product/lane);  A-­‐  anagen  sample,  was  used  parallel  with  telogen  samples  as  positive   control;   N-­‐negative   control:   cDNA   was   omitted   from   the   PCR   reaction;  PDs-­‐  Primer  dimers.    The  expected  amplicon  size  for  SUR1  is  291bp.      














Figure  2.24    PCR  detection  of  SUR2A/B  in  red  deer  telogen  hair  follicles  The   PCR   products   were   separated   by   1.5%   agarose   gel   electrophoresis   and  visualised   with   ethidium   bromide   staining.      M-­‐   DNA   ladder   (The   DNA   ladder  ranges  from  100Ȃ1,500bp;  in  100bp  increments,  10µl  of  DNA  ladder  was  loaded);  Lanes  T1-­‐T5  show  expression  of  SUR2A/B  in  telogen  follicles  from  5  deer  stags  (30  
ɊȀȌǢ-­‐  anagen  sample,  was  used  parallel  with  telogen  samples  as  positive  control;  N-­‐negative  control:  cDNA  was  omitted  from  the  PCR  reaction;  PDs-­‐  Primer  dimers.     The  expected  amplicon  size   for  SUR2A  is  451bp  and  312bp  for  SUR2B.    
  






























2.5  Discussion  The  main  aim  of  this  study  was  to  confirm  the  pharmacological  responses  of  red  deer  (Cervus  elaphus)  follicles  in  organ  culture  reported  by  Davies  et  al  (2005),  which   suggested   the   presence   of   K+ATP   channels   in   deer   hair   follicles,   by  investigating   the   gene   expression   of   K+ATP   channel   sub-­‐units   using   RT-­‐PCR   in  anagen  red  deer  whole  hair  follicles.    This  would  improve  its  practicality  as  a  hair  growth   model   system.      The   second   aim   was   to   determine   whether   the   gene  expression   of   K+ATP   channel   sub-­‐units   occurred   in   the   telogen   stage   of   the   hair  cycle.    Red  deer  hair  follicles  were  selected  for  this  study  because  deer  hair  growth  is  synchronous,  which  meant  that   in  any  given  area  the  hair   follicles  would  be  at  the   same   hair   cycle   stage.      This   allowed   for   a   sufficient   amount   of   hair   follicles,  approximately  60,  to  be  pooled  for  RNA  isolation  from  the  same  deer.          At  the  initial  stage  of  the  investigation  a  histological  comparison  was  drawn  between   human   and   red   deer   hair   follicles.            The   deer   hair   follicles   were   then  further  investigated  at  the  different  stages  of  the  hair  cycle.    To  do  this  human  skin  samples  and  red  deer  anagen  and  telogen  skin  samples  were  frozen,  sectioned  and  stained  using  Sacpic  staining,  which  provides  an  excellent  visualisation  of  the  hair  follicle  structure  (Nixon  1993;  Nutbrown  and  Randall  1996).    The  large  size  of  deer  hair   follicles   allowed   for   ease   in   tissue   sectioning,   serving   better   in   sample  orientation  within   the   cryostat.      Human   scalp   hair   follicles   are   smaller   and   less  densely   packed,   compared   to   deer   hair   follicles,   proving   both   more   difficult   to  section  and  also  reducing  room  for  error  because  of  the  diminished  sample  size.      The   Sacpic   staining   technique   employed  was  more   complex   but   offered   a  superior   result   in   comparison   to   the   other   staining  methods   attempted,   such   as  haematoxylin   and   eosin   histochemical   staining.      The   staining   provided   clear  
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visualisation  of  the  hair  follicle  structure,  highlighting  the  various  layers  of  the  hair  follicle.    The  histological  staining  of  the  human  scalp  skin  exhibited  the  hair  follicle  extending  down  into  subcutaneous  fat  layer  (Figure  2.7)  and  the  staining  results  of  the  red  deer  skin  showed  hair  follicles  extending  deep  into  the  dermis  (Figure  2.8).    Though   the   human   hair   follicle   was   smaller   in   structure   than   that   of   the   deer,  rendering   the   medulla   visible   in   the   deer   hair   follicle,   the   structure   was   on   the  whole  similar,  thereby  reinforcing  the  deer  hair  follicle  as  a  good  model  system  for  the  research.    Following   histological   staining,   the   gene   expression   of   all   components   of  potassium   channel   sub-­‐units   in   isolated   red   deer   anagen   hair   follicles   was  investigated.      Detection      Ⱦ-­‐actin   (Figure   2.11)   confirmed    that  the  isolated  RNA  from  each  red  deer  sample  was  of  sufficient  quality  for  RT-­‐PCR   to   be   performed   effectively   (Croft,   2002;   Davies,   2001).      Negative   controls  without  the  template  cDNA  in  all  RT-­‐PCR  investigations  yielded  no  PCR  products,  indicating  that  the  amplification  of  the  cDNA  synthesised  from  the  mRNA  samples  produced   the   PCR   products.   Furthermore,   it   also   demonstrated   that   no   DNA  contamination  occurred  in  the  reaction  mix.        The  expression  of  both  types  of  sub-­‐units,  the  sulphonylurea  sub-­‐unit  (SUR)  and   the   pore-­‐forming   (Kir6.x),   are   necessary   to   form   a   functional   K+ATP   channel  (Gribble   et   al.,   1997;   Inagaki   et   al.,   1995a;   Yamada   et   al.,   1997).   Red   deer   hair  follicles   expressed   SUR1   (Figure   2.13)   and   SUR2B   (Figure  2.15)   regulatory   units  and   both   pore   forming   units   Kir6.1   (Figure   2.17)   and   Kir6.2   (Figure   2.19)   in  anagen  follicles.    The  identity  of  these  PCR  products  were  confirmed  by  sequencing  with  over  91%  homology  with  the  human  genes  (Figures  2.14,  2.16,  2.18  and  2.20).    Therefore  red  deer  hair  follicles  expressed  the  genes  for  both  components  of  K+ATP  
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channels  in  the  anagen  phase  of  the  hair  cycle.    The  gene  expression  for  SUR2A  was  not  detected,  although   it  was  seen   in  the  positive  control  of  deer  skeletal  muscle  (Figure  2.15).      The   immunohistochemical   localisation   K+ATP   subunits   in   deer   hair   bulb,    
Ƥʹ͸Ǥͳǡdermal   papilla   and   connective   tissue/dermal   sheath   (Figures   2.21h   &   2.21i  respectively)   similar   to   the   human   (Shorter   et   al.,   2008),   therefore   it   is   most  probable  that  SUR2B  forms  a  K+ATP  channel  with  Kir6.1;  and  SUR1  can  form  a  K+ATP  channel   with   Kir6.2,   thereby   suggesting   the   existence   of   a   possible   two   K+ATP  channels,  in  deer  hair  follicles.    Furthermore  such  K+ATP  channel  combinations  have  been   indicated   in   different   tissues,   such   as   SUR1/Kir6.2   K+ATP   channel   in   the  
Ⱦȋet  al.,  1995b;  Sakura  et  al.,  1995;  Babenko  et  
al.,   1998a),   supporting   the   suggestion   that   SUR1/Kir6.2   are   likely   to   combine   to  form   a   K+ATP   channel.      SUR2B/Kir6.1   have   been   identified   in   vascular   smooth  muscle  and  SUR2B/Kir6.2B  in  non-­‐vascular  smooth  muscle  (Babenko  et  al.,  1998;  Inagaki   et   al.,   1995b;   Isomoto   et   al.,   1996;   Yamada   et   al.,   1997).      Further  investigation  may  be  required  to  indisputably  establish  that  the  staining  exhibited  in   the   dermal   papilla   is   not   vascular   smooth  muscle   cells.      This   can   be   done   by  culturing  dermal  papilla  cells  and  performing  immunocytochemistry.    These  findings  are  similar  to  a  recent  study  in  human  anagen  hair  follicles,  which   also   indicated   the   detection   of   SUR1,   SUR2B,   Kir6.1   and   Kir6.2   subunits  (Shorter   et   al.,   2008).      They   also   correspond   strongly   with   pharmacological  observations  in  red  deer  hair  follicles,  where  it  was  found  that  both  minoxidil  and  the   selective  SUR1  channel  opener,  NNC  55-­‐0118   (Novo  Nordisk),   stimulate  hair  follicle  growth   in  vitro  (Davies  et  al.,  2005),  indicating  the  presence  of  both  SUR1  
 104 
 
and  SUR2   types  of   channel,  both  playing  a   role   in  hair  growth.     The  detection  of  
ʹǯ  ʹ (Schwanstecher  
et   al.,   1998).      Taken   together   these   results   confirm   the   existence   of   at   least   two  types  of  K+ATP  channels  with  SUR1  and  SUR2B  sulphonylurea  receptors  in  deer  hair  follicles  in  the  anagen  phase.    This  is  analogous  with  the  findings  of  both  SUR1  and  SUR2B  K+ATP  channels  in  pig  urethra  (Yunoki  et  al.,  2003).     SUR1/Kir6.1  channels  have  been  suggested  not  to  be  physiologically  relevant  (Babenko  et  al.,  1998).    An  advantage   to   the   fact   that   SUR2A   was   not   detected   in   the   anagen   hair   follicle,  suggests   that   the   K+ATP   channels   found   in   the   cardiac   tissue,   formed   by  SUR2A/Kir6.2,   are   not   expressed   in   the   hair   follicle,   therefore   allowing   for   the  development   of   treatments   for   heart   conditions,   with   the   employment   of   the  SUR2A  sulphonylurea  receptor,  that  would  eliminate  the  undesirable  side  effect  of  hair  growth.      Investigations  into  K+ATP  channel  sub-­‐units  in  telogen  red  deer  hair  follicles  detected   no   expression   of   any   of   the   regulatory   sulphonylurea   sub-­‐units:   SUR1  (Figure  2.23),  SUR2A/B  (Figure  2.24).     Similarly,   the  PCR  products  of  telogen  red  deer   hair   follicles   rendered   no   expression   of   the   pore   forming   sub-­‐unit   Kir6.1  (Figure  2.25)  or  Kir6.2  (Figure  2.26).      To   conclude,   there   is   a   strong   correlation   in   the   RT-­‐PCR   and  immunohistochemical  staining  analysis  of  K+ATP  channel  sub-­‐units   in  deer  anagen  hair   follicles   with   those   found   in   human   hair   follicles.      Both   express   the   genes  SUR1,   SUR2B,   Kir6.1   and   Kir6.2.      Thereby   exhibiting   that   both   of   the   essential  components,   the   sulphonylurea   receptor   and   the   pore   forming   sub-­‐unit   (Kir6.x)  are  expressed,  enabling  a  functional  channel  to  be  present  at  the  anagen  phase  of  the  hair  cycle.    This  strengthens  the  use  of  deer  hair  follicles  as  a  model  system  for  
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understanding   hair   follicle   biology   or   screening   new   hair   growth   treatments.    Furthermore,   the   absence   of   gene   expression   in   telogen   follicles   supports   the  importance  of  K+ATP  channels  in  the  normal  anagen  processes.      Several  investigations  have  reported  that  minoxidil  may  modulate  the  hair  
Ǥ    ǯ ȋͳͻͻ͸Ȍ     minoxidil   induced   anagen.         Minoxidil   has   also   been   reported   to   prolong   the  duration  of   the  anagen  phase   (Messenger  and  Rundegren,  2004).     An   increase   in  the  anagen/telogen   follicle  ratios   in  the  scalp  of  balding  men,  after  12  months  of  minoxidil   treatment  was   reported   using   histological   staining   (Abell,   1988).      The  application   of   topical   minoxidil   (2%)   did   not   prevent   alopecia   as   a   result   of  chemotherapy  (Granai  et  al.,  1991),  but  it  did  reduce  the  severity  and  duration  of  chemotherapy-­‐induced  alopecia  (Duvic  et  al.,  1996;  Wang  et  al.,  2006),  suggesting  that  minoxidil  promotes  renewed  anagen  in  resting  follicles.    Shorter  et  alǯȋʹͲͲͺȌinvestigations   showed   that   minoxidil   prolonged   anagen   in   human   hair   follicle  organ  culture.      Several  of  these  studies  suggest  that  minoxidil  advances  anagen,  suggesting  an   active   K+ATP   channel   sub-­‐unit   in   telogen,   presumably   by   acting   on   telogen  follicles.     The  absence  of  K+ATP  channels  in  the  red  deer  telogen  hair  follicles  here  indicate   that   they   are   possibly   expressed   at   the   end   of   the   telogen   phase,   when  exogen  takes  place.  The   detection   of   SUR1   subunit   gene   expression   in   the   deer   anagen   hair  follicle  is  of  key  interest,  as  SUR1  receptors  are  unaffected  by  minoxidil  and  Davies  
et  al  (2005)  showed  that  the  selective  SUR1  K+ATP  channel  opening  drug  NNC  55-­‐0118  stimulated  deer  follicle  growth  in  organ  culture.     This  raises  the  prospect  of  novel  pharmaceutical  developments  that  stimulate  hair  growth  via  the  SUR1  K+ATP  
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channels   or   combined   treatment  with  minoxidil   acting   via   SUR2B   channels   that  enhance  treatments  for  hair  growth.        The   red   deer   hair   follicles   model   therefore   appears   to   offer   a   useful,  practical  model  for  testing  new  molecules  for  treatment  of  hair  growth  disorders.    This  system  should  aid  the  development  of  better  therapies  for  hair  disorders.        









The  role  of  SUR1  containing  ATP-­sensitive  














3.1   Introduction  With   the   introduction   of   hair   follicle   organ   culture,   researchers   were  offered  an  in  vitro  assay  for  the  investigation  of  hair  follicles  (Philpott  et  al.,  1989).    Previous   research   employed   full-­‐depth   skin   organ   culture;   this   process   involved  the   culture   of   both   embryonic   and   post-­‐embryonic   skin   plugs   containing   hair  follicles   (Tammi  and  Maibach,  1987).     Due   to  the  nature  of   the  model  associated  skin   cells   surrounding   the   hair   follicles   were   also   made   available   thus   proving  excellent   in   resembling   in   vivo   conditions.      However,   using   skin   plugs   also  presented   some   limitations;   biochemical   or  morphological   analysis   of   individual  hair   follicles  was   not   possible,   furthermore,   analysis   of   hair   growth  was   further  complicated  due  to  epithelial  outgrowths  from  the  skin  plugs  (Kollar,  1966;  Frater  and   Whitmore   1973;   Tammi   and   Maibach   1987).      The   development   of   organ  culture   of   individual   hair   follicles   overcame   these   limitations   (Buhl   et   al.,   1989;  Philpott  et  al.,  1989;  Kondo  et  al.,  1990;  Philpott  et  al.,  1990).      Research  by  Philpott  et  al  (1990)  established  the  most  successful  method  of  isolated  hair  follicle  culture.     Micro-­‐dissected  human  hair  follicles  were  incubated  
 ǯ    ͳΨ   ǡ   -­‐glutamine,   insulin,   hydrocortisone,   transferrin   and   antibiotics.      The   hair   follicles  showed  an  increase  in  length  at  a  rate  of  0.3mm/day  when  grown  in  the  presence  of   insulin   at   10ng/ml,   closely   similar   to   the   in   vivo   growth   rate   of   0.32   -­‐   0.35  mm/day   of   hairs   at   the   vertex   of   the   scalp   (Myers   and   Hamilton,   1951).    Furthermore   the   growth   of   the   hair   follicle  was   attributed   to   an   increase   in   the  length   of   the   keratinised   hair   shaft,   and   not   as   a   result   of   degeneration   during  culture.    Since  then  this  model  system  has  been  used  to  investigate  several  factors  that  influence  hair  growth  e.g  IGF-­‐1  (Randall  et  al.,  2003;  Randall,  2008).            
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3.1.1   Effect  of  minoxidil  on  hair  follicles  in  vitro  A  series  of  investigations  have  looked  into  the  effects  of  minoxidil  on  single  whole   hair   follicles   in   organ   culture.      However,   the   research   has   rendered  inconsistent   results,  which   at   times   conflict.      Table   3.1   is   a   summary  of   relevant  literature   on   the   effects   of   minoxidil   on  whole   hair   follicles   in   vitro.      There   are  several  possibilities  as  to  how  such  disparities  could  have  arisen.    Different  studies  have   concentrated   on  different   species   for   their   research,   thus   growth   rates   and  cycle   lengths   in   vivo   would   naturally   be   dissimilar.      Furthermore,   the  concentrations   at   which   minoxidil   has   been   applied   varies   widely.   Culture  conditions  utilised  are  a   further  cause  of  extensive  variation  between  results,   the  choice  of  medium  type,   incubation  conditions  and  supplements  are  also  variable.    Thus,   with   such   variations   between   the   studies   documented   in   this   field,   it   is  difficult   to   realistically  make  direct   comparisons  between   them  and   to  draw  any  firm  conclusion  on  the  effect  of  minoxidil  on  the  hair  follicle  in  vitro.    Minoxidil  and  other  potassium  channel  openers  like  diazoxide  and  a  novel  diazoxide   analog,   NNC   55-­‐0118,   induced   a   dose-­‐responsive   stimulation   of   hair  follicle  growth   in  organ  culture  of  red  deer  hair   follicles   (Davies  et  al.,  2005).     Of  particular   interest   was   the   finding   that   co-­‐incubation   with   potassium   channel  blockers,   tolbutamide   and   glibenclamide,   inhibited   the   inductiveness   of   10µM  minoxidil,  diazoxide  and  NNC  55-­‐0118,  on  deer  hair  follicle  growth.    This  strongly  supported   the   role   of   the   potassium   channel   openers   was   actually   via   K+ATP  channels  within    
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Table  3.1  Hair  follicle  organ  culture  studies  using  minoxidil  Summary  of  relevant  literature  on  the  effects  of  minoxidil  on  whole  hair  follicles  in  vitro.  
Species     Culture  period   Minoxidil  Conc.   Effect   Culture  conditions   Reference 
Mouse     72  hours   0.5  mM     Significantly  stimulated  hair  follicle  growth   DMEM  medium  supplemented    With:    
 20%  FCS    
 12.5  µg/ml  gentamicin  




 Facelift  skin    
 donor  ages  between:    35-­‐55  yrs    
      72  hours          5  days    
       0.95  µM  48  µM  0.95  mM     0.95  µM  48  µM  0.95  mM  
  
 Measured  every  24  hrs    No  effect  on  hair  follicle  growth  No  effect  on  hair  follicle  growth  Inhibition  of  hair  follicle  growth    Stimulation  of    hair  follicle  growth  No  effect  on  hair  follicle  growth  Inhibition  of  hair  follicle  growth  
ǯsupplemented  with:  
 1%    FCS,  
 10    ng/ml  hydrocortisone,  
 10    ng/ml  insulin,  
 2    mM  L-­‐glutamine,  
 2.5    µg/ml  transferrin,  
 2.5  µg/ml  amphotericin  B,  
 50  U/ml  /  50  µg/ml  penicillin/streptomycin.  
Philpott et 
al., 1990   
Mouse   3  days   5  mM   No  effect  on  hair  length  (days  0-­‐3)  Inhibitory  effect  after  day  3.   DMEM  medium  supplemented    With:    
 20%  FCS     Waldon  et  al.,  1993    
Human    
 Only  3  patients      
  10  days         0.01  mM  0.1  mM  1  mM   No  effect  on  hair  follicle  length  Stimulation  of  hair  follicle  growth  Stimulation  of  hair  follicle  growth      
ȈͳmM     
Williams  E  medium  supplemented  with  :  
 10  µg/ml  insulin,    
 10  ng/ml  hydrocortisone,    
 100  µg/ml  streptomycin,  
 100  U/ml  penicillin  
 2  mM  L-­‐glutamine,          






 36  donors,  
 mean  40  years    
    12  days          1  µM  100  µM           1  µM  100  µM    
Ȉ͵    Cultured  in  the  presence  of  insulin:  No  effect  on  hair  follicle  growth  No  effect  on  hair  follicle  growth    Ȃ  catagen  promoting  effect  towards  end  of  culture  period    Cultured  in  the  absence  of  insulin:  Inhibition  of  hair  follicle  growth  Inhibition  of  hair  follicle  growth       
Williams  E  medium  supplemented  with:  
 10  µg/ml  ciprofloxacin,  
 10  µg/ml  insulin,    
 10  ng/ml  hydrocortisone,    
 2  mM  L-­‐glutamine,    




Red  deer    
    8  days       0.1  µM  1  µM  10  µM  100  µM        10  µM    
 Measured  every  24  hrs    Stimulation  of  hair  follicle  growth    Stimulation  of  hair  follicle  growth    Stimulation  of  hair  follicle  growth  Stimulation  of  hair  follicle  growth  Ȃ  greatest  elongation  occurred  at  100  µM    When  incubated  in  combination  with  1  mM  tolbutamide  or  10  µM  glibenclamide,  stimulatory  effects  of  minoxidil  were  inhibited.  
Williams  E  medium  supplemented  with:  
 100  U/ml  penicillin,  
 2  mM  L-­‐glutamine,    
 2.5  µg/ml  amphotericin  B,    





 2  donors    
 25  year  old  males  
6  days   10  µM     Stimulates  hair  follicle  growth  only  in  those  follicles  which  showed  the  fastest  growth  rate  in  vivo.   ǯmedium  supplemented  with:  
 0.01%  DMSO    vehicle,  
 10  µg/ml  insulin,    
 10  µM  ciprofloxacin,  
 10  ng/ml  hydrocortisone,  
 100  U/ml  penicillin  





      
Human    
 Scalp  skin,  from  nonbalding  areas  
 1  women  &  12  men  
 Aged  between  21  and  40  year      
   9  days            1mM             10µM  1mM    
Anagen  follicles  were  assessed  daily  for  changes  in  morphology.      Cultured  in  the  presence  of  insulin:  Minoxidil  alone  had  no  effect,  but  combined  with  Tolbutamide  (1mM),  it  abolished  the  inhibitory  effects  of  Tolbutamide.      Cultured  in  the  absence  of  insulin:  Minoxidil  increased  the  number  of  follicles  maintaining  anagen;  this  effect  was  greatest  at  1mM.    
Williams  E  medium  supplemented  with:  
 10  µg/ml  insulin,    
 10  µg/ml  phenol  red  
 10  ng/ml  hydrocortisone,    
 10  U/ml  penicillin  
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the   cultured   follicles.      In   addition,   when   incubated   with   only   tolbutamide,   hair  follicles  grew  at  a  slower  rate  in  comparison  to  follicles  incubated  with  the  vehicle  control   suggesting   that   K+ATP   channels  may   be   actually   at   least   partially   open   in  normal  culture  medium  (Davies  et  al.,  2005).    In  a  study  by  Shorter  et  al  (2008)  on  the   effects   of   minoxidil   (1mM)   and   tolbutamide   (1mM),   on   the   morphology   of  human  hair  follicles  in  the  presence  of  insulin.    Minoxidil  alone  was  found  to  have  no   effect,   however   when   combined   with   tolbutamide   (1mM),   it   hindered   the  inhibitory   effects   of   tolbutamide.      Whereas,   in   the   absence   of   insulin,   minoxidil  (10µM,   1mM)   increased   the   number   of   follicles   maintaining   anagen   in   a   dose-­‐responsive  manner;   tolbutamide   (1mM)   blocked   this   stimulation   (Shorter   et   al.,  2008).    This  suggested  that  stimulation  of  K+ATP  channels  was  also  able  to  increase  hair   follicle  growth   in  human  follicles,  an  observation  supported  by  the  detection  of   the   genes   and   proteins   of   one   type   of   K+ATP   channel   that   would   be   able   to  respond  to  minoxidil,  SUR2B/Kir6.1.              On  the  whole  when  considering  the  results  of  all   these  studies,   there   is  an  indication  that  several  potassium  channel  openers  can  alter  hair  follicle  growth   in  
vitro.     As  all   investigations  were  conducted   in  vitro,  no  vascular   interaction  could  have  taken  place,  thereby  reinforcing  the  premise  that  potassium  channel  openers  have  a  direct  effect  on  the  follicle,  presumably  via  potassium  channels  in  the  hair  follicle.  In   deer   follicles,   NNC   55-­‐0118,   a   drug   which   would   only   open   SUR1  containing  channels,  had  also  stimulated  hair  follicle  growth   (Davies  et  al.,  2005).    Since  both  human  (Shorter  et  al.,  2008)  and  deer  (see  Chapter  2)  follicles  express  the  genes  for  such  SUR1  channels,  it  seems  likely  that  SUR1  channel  openers  may  also  stimulate  hair  growth  in  human  follicles.     This  is  an  important  area  to  clarify  
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because  if  SUR1  channels  are  related  to  hair  growth  this  could  offer  a  novel  route  for  new  hair  promoting  therapies.                    
  
3.2  Aims  and  experimental  design  




3.2.2  Experimental  design  This   human   hair   follicle   organ   culture   study   followed   closely   the   culture  conditions   described   by   Philpott   et   al   (1996),   with   the   exception   of   the   use   of  streptomycin   in   the  medium,   as   it   has   been   shown   to   inhibit   the   opening   of   K+  channels  by  minoxidil  (Sanders  et  al.,  1996)Ǥǯ͵͵
in  vitro  was  unaffected  by  penicillin  and  therefore  penicillin  was  included  (Sanders  
et  al.,  1996).    Serum  was  not  added  to  the  culture  medium,  as  research  has  shown  it  to  have  an  inhibitory  effect  on  hair  growth  in  vitro  (Philpott  et  al.,  1991).  Human   hair   follicles   were   incubated   in   organ   culture   with   1   mM   of  minoxidil,   as   this   concentration   of  minoxidil   has   been   shown   to   increase   human  hair  follicle  growth  (Han  et  al.,  2004)  and  maintain  them  in  anagen  in  organ  culture  (Shorter  et  al.,  2008).    Though,  typically  a  2-­‐5%  topical  concentration  of  minoxidil  is   applied   to   the   scalp   clinically   (Olsen   et   al.,   2002),  only  1.7%  of   it   is   absorbed,  apparently  equating   to  1  mM   (Han   et  al.,   2004;  Magerl   et  al.,   2004).     A   study  by  Davies   and   colleagues   (2005),   in   red   deer   hair   follicles   in   vitro,   showed   that  tolbutamide   at   the   dose   of   1mM   counteracted   the   stimulatory   effects   of   several  potassium  channel  openers.    This  concentration  was  selected  as  it  has  been  shown  to   inhibit   native   (Trube   et   al.,   1986;   Ashcroft   et   al.,   1989)   and   recombinant  (Gribble  et  al.,  1997a)  K+ATP  channels.    It  also  prevented  human  follicles  responding  to  minoxidil   (Shorter  et  al.,   2008)  and   is   able   to   inhibit   SUR2  channels  with   low  affinity  binding  (Hambrock  et  al.,  2001).    As  previous  studies  have  shown  that  low  concentrations   of   tolbutamide   selectively   inhibit   the   SUR1/Kir6.2   channel  (Zunkler   et   al.,   1988),      1µM   of   tolbutamide   was   chosen   to   investigate   the  mechanism   of   action   of   the   novel   diazoxide   analog,   NNC55-­‐9216.      NNC55-­‐9216  was  used  at  100µM  as  described  in  a  previous  functional  study  of  the  SUR1/Kir6.2  
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3.3  Materials  and  Methods    
3.3.1  Investigation  into  the  effects  of  potassium  channel  modulators  on  
human  hair  follicles  in  organ  culture.  
3.3.1.1  Samples  Human  skin  samples  were  collected  from  non-­‐balding  occipital  scalp.     The  donors   were   healthy   males   undergoing   elective   cosmetic   hair   transplantation  surgery.    All  Ethical  Committee  approval  requirements  were  met  and  donors  gave  fully   informed,   written   consent.      Samples   were   obtained   from   20   donors   aged  between  24-­‐64  years  (albeit  only  two   individuals  were  aged  above  60).     Samples  were  collected  as  whole  skin  specimens  or  as  individual  follicles  into  50  ml  falcon  
  ͵Ͳ   ǣ ǯ   ȋ10µg/ml   phenol   red)   (Sigma-­‐Aldrich   Ltd,   Dorset,   UK)   supplemented   with   100  ng/ml  hydrocortisone  (Sigma-­‐Aldrich  Ltd),  2  mM  L-­‐glutamine  (Gibco,  Paisley,  UK)  and   10   units/ml   penicillin   (Sigma-­‐Aldrich   Ltd).      Each   tube   was   identified   by  
ǯǡǤin   an   information   sheet   accompanying   the   tube   with   further   particulars   of   the  donor,  such  as  date  of  sample  collection  and  sample  site.     The  samples  were  then  
       ǡ    ͶǏǤ  -­‐dissection  of  the  hair  follicles  was  performed  within  24  hours  of  removal.      
  
3.3.1.2  Isolation  of  human  hair  follicles  Using   the   Leica   MZ8   dissecting   microscope   anagen   hair   follicles   were  micro-­‐dissected  from  skin  samples.    Plastic  ware  was  rinsed  in  PBS  thrice  prior  to  use   and   all   equipment   sterilised   by   autoclaving.      Each   sample  was   placed   into   a  
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petri  dish  of  PBS  at  40C  (Figure  2.4).     The  skin  was  cut  at  the  level  of  the  dermal-­‐subcutaneous  fat  interface  with  a  scalpel  blade  (Figure  3.1a).    Undamaged  anagen  hair   follicles  were   removed   from   the   subcutaneous   fat  with   great   delicacy   using  fine  forceps  (110mm  length,  0.05mm  width,  0.01mm  thick,  straight);  great  finesse  was  necessary   to  ensure   the   follicles   remained   intact,   as  undamaged   follicles  are  essential   for  successful  culture   (Philpott  et  al.,  1990).     The   isolated  follicles  were  then   placed   into   another  dish   of   sterile   PBS   at   40C   (Figure   3.1b).      The   dissected  follicles  were   further   cleansed  of   any   attached  dermis  or   subcutaneous   fat  using  27½  gauge  sterile  syringe  needles  (Figure  3.1c).      Each  isolated  human  anagen  hair  follicle  was  then  gently  transferred  to  an  individual   well   of   a   24-­‐  ȋ ǤȌ  ͳ   ǯ medium   supplemented   as   described   in   section   3.3.1.1   above.      At   least   10   hair  follicles  were  cultured  for  each  condition.     Follicles  were  maintained  free-­‐floating  
͵͹ǏͷΨ2  and  95%  air  in  a  humidified  incubator  over  a  period   of   nine   days.      Fresh  medium  was   introduced   at   three   day   intervals,  with  particular  care  being  taken  to  leave  follicles  undamaged.      
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3.3.1.3  Hair  growth  culture  conditions  
ǯ   ȋ ͳͲρȀ  Ȍ ȋȌsupplemented  with,  2mM  L-­‐glutamine  (Gilbco),  10units/ml  penicillin  (Sigma)  and  100ng/ml   hydrocortisone   (Sigma),   was   prepared.      This   culture   medium   was  further  supplemented  depending  on  which  experiment  was  being  conducted,  with  
ǣȋͳǢǯE    medium;    Sigma),    tolbutamide    (1mM  or  1µM;    dissolved    into    a    stock    solution    of      dimethyl      sulfoxide   (DMSO);   Sigma),   both  minoxidil   (1  mM)   and   tolbutamide  (1mM  or  1µM),  NNC  55-­‐9216   (100µM;  dissolved   into  a   stock   solution  of  DMSO),  both   tolbutamide   (1µM)   and   NNC   55-­‐9216   (100µM),   both  minoxidil   (1mM)   and  NNC   55-­‐9216   (100µM),   minoxidil   (1mM)   and   NNC   55-­‐9216   (100µM)   and  tolbutamide   (1µM).      Stock   solutions  of  minoxidil,   NNC  55-­‐9216   and   tolbutamide  were  dissolved  using  a  sonicating  water  bath  (Dawe  Instruments  Ltd.,  Middlesex,  UK).    Control  medium  was  prepared  without  supplements,  but  the  vehicle  (0.001%    DMSO)    was    added    to    each    medium.    Depending  on  which  experiment  was  being  conducted   insulin   (10   µg/ml;   Sigma)  was   included   as   a   supplement.      All   culture  media  were  sterile-­‐ƤȋͲǤʹρǢǡǃǡ
ȌǤ    
3.3.1.4  Measurement  of  hair  follicles  in  culture  Hair  follicles  were  examined  for  increase  in  follicle  length  and  morphology  of   the  hair  bulb,   at  24  hour   intervals  using  a  Leitz  Labovert   inverted  microscope  fitted  with  an  eyepiece  graticule.     Measurements  were  made  at  x50  magnification  (eyepiece  x12.5  &  objective  x4)  and  converted  to  mm  by  comparison  with  a  stage  micrometer.     To  ensure  that  variations  between  hair  follicles  were  accounted  for,  the  initial  length  of  hair  follicle  was  deducted  from  the  measurements  obtained  at  
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every   point   of   examination.      Therefore,   the   results   reflected   the   increase   in   hair  follicle  length  over  time.    Follicles  that  showed  no  sign  of  growth  by  the  third  day  in   culture   were   classed   as   non-­‐viable   samples   and   thus   excluded   from   further  study.      Measurements   of   follicle   elongation   and   the   state   of   follicle  morphology  were   recorded   daily   over   a   period   of   nine   days.      A   Nikon   Coolpix   4500   digital  camera  was  also  used  to  photograph  the  follicles  daily.  
  
3.3.1.5  Statistical  analysis  Prior  to  calculating  the  group  mean,  the  mean  growth  of  follicles  per  person  in  each  group  was  ascertained.     The  elongation  of  hair   follicles   in  each   individual  treatment  group  was  expressed  as  the  mean  increase  in  length  (mm)  ±  SEM  of  the  number   of   individuals   used.      The   Kolmogorov-­‐Smirnov   test  was   used   to   analyse  data  for  normal  distribution.    The  General  Linear  Model  for  Repeated  Measures  by  a   two-­‐factor,   within-­‐subjects   ANOVA   using   the   SPSS   statistical   analysis   program  (SPSS   Inc.,   Chicago,   Illinois),   was   used   to   determine   the   effect   of   the   different  treatments  on  hair  length  and  percentage  of  follicles  in  anagen  with  time  in  culture  and  the  total  increase  in  hair  follicle  length  during  the  experiment.    
3.3.2  Histological  investigation  of  individually  cultured  human  hair  follicles  Hair  follicles  were  cultured  for  a  period  of  nine  days,  and  assessed  daily  for  any   changes   in  morphology.      To   visualize   these   changes   follicles  were   taken   out  from   the   culture   media,   placed   individually   into   1.5   ml   eppendorfs   (Sarsted,  Numbrecht,   Germany)   containing   the   cryoprotectant   Sakura   Tissue-­‐Tek   O.C.TTM  (Raymond  A  Lamb  Ltd,  Sussex,  UK)  and  stored  at  -­‐80oC  until  further  use.        
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3.4.1  The  effect  of  insulin  in  the  medium  in  organ  culture  on  the  response  of  
human  hair  follicles  to  potassium  channel  regulators          Micro-­‐dissected   anagen   scalp   hair   follicles   were   maintained   in   organ  culture,  and  observed  daily  in  the  presence  and  absence  of  insulin,  over  a  period  of  nine  days.     Hair  follicles  in  media  containing  insulin  generally  increased  in  length  and  most  maintained  anagen.    The  increase  in  hair  follicle  length  was  a  result  of  the  growth  of  hair  fibre,  and  the  inner  and  outer  root  sheaths.    The  connective/dermal  tissue   sheath   remained   at   the   constant   length   of   day   0   throughout   the   culture  period  (Figure  3.2a  &  3.2c).     When  follicles  displayed  catagen-­‐like  changes   in  the  hair   bulb   region,   pigmentation   ceased,   the   hair   moved   upwards   and   the   matrix  became  detached  from  the  dermal  papilla  (Figure  3.2c,  3.2d  &  3.2e).    Hair  follicles  that  had  not  grown  by  day  2  were  rejected  from  the  calculations.    The  hair  follicles  were  monitored  daily  for  both  the  follicles  remaining  in  anagen  and  daily  increase  in   growth.      However,   the   results   were   plotted   for   the   percentage   of   follicles  remaining  in  anagen  and  the  overall  increase  in  hair  follicle  length  over  9  days,  as  so  many  follicles  entered  telogen  in  some  conditions  that  the  rate  of  growth  by  day  9  would  be  due  to  relatively  few  follicles,  rendering  it  meaningless.    Therefore  the  rate  of  growth  was  discarded  for  analysis.              After   three  days   in  culture  the  number  of   follicles  remaining   in  anagen,   in  the   absence   of   insulin,   declined   to   about   17%,  whilst   in   the   presence   of   insulin  86%  were   still   growing.      By   day   5   all   follicles   in   the   insulin-­‐free  media   entered  catagen.     However,   a   significant   (p<0.001)  number  of   follicles   in   the  presence  of  insulin   remained   in   anagen   (Figure   3.3a).      Overall,   the   increase   in   hair   follicular  
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length  in  the  absence  of  insulin  was  only  0.3  mm,  whilst  in  the  presence  of  insulin  there  was  a  significant  growth  of  1.9  mm  over  9  days  (p<0.001)  (Figure  3.3b).    The  overall  increase  in  hair  follicular  length  was  calculated  by  taking  the  mean  average  of  the  overall  growth  of  all  follicles  over  the  9  day  culture  period,  i.e.  the  increase  in  length  of   each   follicle  on  day  9  or  on   the   last  day   that   the   follicle  was   in  anagen,  were   taken  and   the  average   total   growth   in   length  of   follicles,  during   the   culture  period,  was  calculated  to  deduce  the  overall  increase  in  length.      
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Figure  3.2    Sequential  photomicrographs  of  human  hair  follicles  cultured  in  the  presence  or  absence  of  insulin  in  organ  culture  
ǯͳͲρȀǡͳͲͲȀortisone,  2  mM  L-­‐glutamine,  10  units/ml  penicillin,  0.001%  DMSO  and  with,  and  without,  10  µg/ml  insulin.      Photomicrographs  taken  under  an  inverted  microscope,  at  24  hour  intervals,  exhibit  the  changes  in  an  individual  scalp  hair  follicle  cultured  for  9  days  in  the  presence  and  absence  of  insulin.      
(a)    An  anagen  hair  follicle  cultured  in  presence  of  10µg/ml  of  insulin.    The  sequential  photomicrographs  show  the  synthesis  of  new  hair  fibre  (HF),   but   no   growth   of   the   connective   tissue   sheath/dermal   sheath   (CTS/DS).   Hair   follicles   increased   in   length   regularly   at   a   rate   of  0.2mm/day.    At  the  end  of  the  culture  period  the  follicle  was  sectioned  and  stained  with  Sacpic  stain  to  examine  the  morphological  state  of  the  individual  hair  follicle  during  the  culture  period  (last  photomicrograph).  Scale  bar  =  0.3  mm  
(b)  Enlarged  photomicrographs  of  the  hair  follicle  bulb  (HB)  (pictured  in  a),  showing  anagen  morphology  throughout  the  9  days  in  culture.    
(c)  A  hair  follicle  cultured  in  the  absence  of  insulin  showed  a  much  smaller  increase  in  the  length  than  those  in  insulin  containing  medium  (see  
a),   at   a   rate  of  0.12mm/day.     The  photomicrographs  only  extend  up   to  day  5,   as   the  hair   follicle  had  entered  a   catagen-­‐like   state,   showing  catagen-­‐like  changes  in  its  hair  bulb  morphology.    The  follicle  was  sectioned  and  stained  with  Sacpic  stain  to  examine  the  morphological  state  of  the  hair  bulb  (far  right  photomicrograph).  The  hair  had  moved  up  and  left  the  dermal  papilla  at  the  bottom  of  the  hair  bulb.     Scale  bar  =  0.3mm.  
(d)  Enlarged  photomicrographs  of  the  hair  follicle  bulb  (pictured  in  c),  showing  changes  in  hair  bulb  morphology  during  the  5  days  in  culture.  
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(c)     
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Figure  3.3    Human  hair  follicle  growth  in  organ  culture  The   percentage   of   follicles   remaining   in   anagen   over   the   length   of   the   culture  period  was  calculated  from  day  0.    In  the  presence  of  insulin  the  follicles  remaining  in   anagen   gradually   decreased   throughout   the   culture   period.      Follicles   in   the  absence   of   insulin   rapidly   entered   catagen   after   day   two   in   culture,   and   the  number  of   follicles  remaining   in  anagen  was  significantly   lower   (p<0.001***)   (a).      Increase  in  hair  follicle  length  was  measured  consecutively  over  the  9  day  culture  period  using  an   inverted  microscope  fitted  with  an  eyepiece  graticule,   in   follicles  which   remained   in   anagen.   The   overall   increase   in   hair   follicle   length   over   the  experiment  was  calculated  from  the  maximum  increase  in  length  in  anagen  or  the  length  on  day  9  if  the  follicle  was  still  growing,  at  the  end  of  the  culture  period.    In  the  presence  of  insulin  the  average  final  hair  follicle  length  significantly  increased  (p<0.001***)  (b).     Mean  values  ±  S.E.M  of  5  people  are  plotted;  a  minimum  of  10  hair  follicles  were  isolated  per  person  for  each  condition.     Statistical  analysis  was  performed  using  a  two-­‐factor  within-­‐subjects  ANOVA  using  SPSS  after  confirming  normal  distribution.            










(b)  The  overall  increase  in  hair  follicle  length  over  9  days                                  
 
 
































































3.4.2  The  effect  of  potassium  channel  regulators  on  human  hair  follicles  in  
organ  culture  
3.4.2.1  Response  of  human  hair  follicles  incubated  with  minoxidil  in  the  
presence  and  absence  of  insulin  in  organ  culture  Isolated  human  hair  follicles  were  cultured  in  the  presence,  and  absence,  of  insulin  with  minoxidil.    The  addition  of  1mM  of  minoxidil  to  the  culture  medium,  in  the   presence   of   insulin,   had   no   affect   on   the   percentage   of   follicles   remaining   in  anagen   (p=0.525)   (Figure   3.4a),   however   it   significantly   decreased   the   overall  increase  in  hair  follicle  length  over  the  9  day  culture  period,  in  comparison  to  the  control   (p=0.016)   due   to   inhibition   of   the   daily   growth   rate   (Figure   3.5a).    Whereas,   in   the   absence   of   insulin,   minoxidil   significantly   stimulated   the  percentage  of  follicles  remaining  in  anagen  (p<0.001)  (Figure  3.4b)  and  the  overall  hair   follicle  growth   (p<0.001)   (Figure  3.5b).     When  expressed  as  a  percentage  of  the   control   hair   follicle   growth   over   the   9   days,   minoxidil   showed   a   significant  (p<0.05)  inhibition  of  hair  follicle  growth  in  the  presence  of  insulin  and  significant  (p<0.001)  stimulation  in  the  absence  of  insulin  (Figure  3.6).                                
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Figure  3.4    The  effect  of  minoxidil  in  the  presence  and  absence  of  insulin  on  
the  percentage  of  follicles  remaining  in  anagen  in  organ  culture  Minoxidil  had  no  notable  effect  on  the  proportion  of  follicles  remaining  in  anagen  in   the   presence   of   10µg/m   insulin   (p=0.525)   (a),   but   in   the   absence   of   insulin,  minoxidil   had   significantly   stimulated   the   proportion   of   follicles   remaining   in  anagen   (p<0.001***)   (b).     The percentage of follicles remaining in anagen over the 
length of the culture period was calculated from day 0.  Mean   values   ±   S.E.M   of   5  people  are  plotted;  a  minimum  of  10  hair  follicles  were  isolated  per  person,  n=50.    Statistical  analysis  was  performed  using  a  two-­‐factor  within-­‐subjects  ANOVA  using  SPSS,  after  confirming  normal  distribution.            
(a)    With  insulin  
                                



































































Figure  3.5    The  effect  of  minoxidil  on  hair  follicle  growth  in  the  presence  and  
absence  of  insulin  in  organ  culture    In   the   presence   of   insulin   minoxidil   significantly   decreased   follicle   length  (p=0.016*)   (a),   but   in   the   absence   of   insulin,   minoxidil   significantly   increased  follicle   length   (p<0.001***)   (b).      Mean   values   ±   S.E.M   of   5   people   are   plotted;   a  minimum   of   10   hair   follicles   were   isolated   per   person.      Statistical   analysis   was  performed  using  t-­‐test.      
































































































Figure   3.6      Alterations   of   hair   follicle   growth   in   the   presence   of  minoxidil  
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3.4.2.2  Response  of  human  hair  follicles  incubated  with  tolbutamide  in  the  








Figure   3.7      Tolbutamide   inhibited   the   percentage   of   follicles   remaining   in  




Statistics:      
 







(b)  Percentage  of  follicles  remaining  in  anagen  in  the  absence  of  insulin  
  








Tolbutamide (1µM)   0.004    **  





Tolbutamide (1µM) P=0.063  (NS)  
Tolbutamide (1mM) P=0.064  (NS)  
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Figure   3.8      The   effect   of   tolbutamide   on   hair   growth   in   the   presence   and  
absence  of  insulin  in  organ  culture  Increase   in   hair   follicle   growth   was   measured   each   day   for   each   follicle   that  remained   in  anagen  over   the  9  day  culture  period  using  an   inverted  microscope,  fitted   with   an   eyepiece   graticule.      Tolbutamide   was   excluded   from   the   vehicle  control.      In   the   presence   of   insulin   (a),   both   the   high   (1mM)   and   low   (1µM)  concentrations   of   tolbutamide   significantly   decreased   follicle   length.      In   the  absence  of   insulin  (b),  neither  concentrations  of   tolbutamide  significantly  altered  the  hair  growth  length.    Mean  values  ±  S.E.M  of  5  people  are  plotted;  a  minimum  of  10  hair  follicles  were  isolated  per  person.    Statistical  analysis  was  performed  using  a   two-­‐factor   within-­‐subjects   ANOVA   using   SPSS,   after   confirming   normal  distribution.            
  
Statistics:     
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Tolbutamide (1mM) 0.001***  
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Figure  3.9      The   effect   of   tolbutamide  on   the   increase   in  hair   follicle   length  
expressed  as  a  percentage  of  their  control  values    The  increase  in  hair  follicle  length  over  the  9  day  culture  period  was  calculated  as  a  percentage  of  the  samples  over  the  control  values  to  enable  comparison  between  +  insulin  conditions.     In  the  presence  of  insulin  hair  growth  decreased  significantly,  but  not  in  its  absence.    Mean  values  ±  S.E.M  of  5  people  are  plotted;  a  minimum  of  10  hair  follicles  were  isolated  per  person.    Statistical  analysis  was  performed  using  a   two-­‐factor   within-­‐subjects   ANOVA   using   SPSS,   after   confirming   normal  distribution.                  
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3.4.2.3  Response  of  human  hair  follicles  to  K+ATP  channel  regulators,  









Figure   3.10      Percentage   of   follicles   remaining   in   anagen   incubated   with  
minoxidil  and  channel  blocker  tolbutamide  in  organ  culture  Isolated  anagen  follicǯͳͲρȀphenol  red,  supplemented  with  100  ng/ml  hydrocortisone,  2  mM  L-­‐glutamine,  10  units/ml  penicillin  and  0.001%  DMSO,  in  the  absence  of  insulin.    The   stimulatory   effect   of   minoxidil   on   the   percentage   of   follicles   remaining   in  anagen   was   significantly   inhibited   with   the   high   concentration   of   tolbutamide  (1mM)   (a).      The   low   concentration   tolbutamide   (1µM)   (b)  had   also   affected   the  percentage  of   follicles  remaining   in  anagen,  however   it  did  not  block  the   channel  completely.  Mean  values  ±  S.E.M  of  5  people  are  plotted;  a  minimum  of  10  hair   follicles  were  isolated  per  person.    Statistical  analysis  was  performed  using  a  two-­‐factor  within-­‐subjects   ANOVA   using   SPSS,   after   confirming   normal   distribution.      Data   are  expressed  as  original  values.    
  
Statistics:        
(a)  Percentage  of  follicles  remaining  in  anagen,  with  a  high  concentration  of  tolbutamide  (1mM)  
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Figure  3.11    The  effect  of  minoxidil  and  channel  blocker  tolbutamide  on  hair  





















Minoxidil (1mM) P<0.001***  
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Figure   3.12      The   effects   of  minoxidil   and   different   concentrations   of   K+ATP  
channel   blocker   tolbutamide   on   hair   follicle   growth,   expressed   as   a  
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    p<0.05*  





Tolbutamide (1µM) p=0.6  (NS)  
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3.4.2.4  Human  hair  follicles  respond  to  a  selective  SUR1  K+ATP  channel  
opener,  NNC  55-­9216  and  combined  treatment  with  minoxidil  in  organ  
culture    Minoxidil   opens   SUR2   K+ATP   channels   but   not   those   with   SUR1  sulphonylurea   subunits.      To   assess  whether   SUR1   channels   regulate   human  hair  growth  the  effect  of  the  selective  SUR1  channel  opener  NNC  55-­‐9216  was  assessed  in  organ  culture.    NNC  55-­‐9216  at  100µM  effectively  maintained  follicles  in  anagen  in   insulin-­‐free   medium   (p=0.003)   (Figure   3.13a).      This   effect   was   significantly  inhibited   by   the   addition   of   channel   blocker   tolbutamide   at   the   lower  concentration   of   1µM   (p=0.008).      The   same   pattern   was   evident   in   the   overall  increase  in  hair  follicle  length  over  9  days  with  NNC  55-­‐9216  causing  a  significant  increase   of   about   72   %   (p=0.002)   (Figure   3.13b).      This   effect   was   significantly  inhibited  by  the  addition  of  1µM  tolbutamide  (p<0.001).    Since  minoxidil  and  NNC  55-­‐9216  are  able  to  open  different  K+ATP  channels,  their   effects   when   given   together   were   examined.      The   combined   treatment   of  minoxidil   and  NNC  55-­‐9216  had   the   greatest   effect   on   the   follicles   remaining   in  anagen  causing  a  very  significant  increase  (p<0.001)  (Figure  3.14a).    The  effect  of  the   combined   treatment   was   significantly   higher   than   that   with   NNC   55-­‐9216  alone  (p<0.001),  but  only  slightly  and  insignificantly  higher  than  minoxidil  (Figure  3.14b).      However,   the   combined   treatment   produced   an   overall   increase   in   hair  follicle   length   over   9   days   which   was   significantly   higher   than   either   minoxidil  (p<0.001)   or   NNC   55-­‐9216   (p=0.002)   alone.      The   overall   growth   over   9   days   in  control  medium  of  0.3  +  0.05mm  was  increased  by  0.8  +  0.04mm  while  minoxidil  caused  an   increase  of  0.4  +  0.043  mm  and  NNC55-­‐9216  by  0.37  +  0.03mm.     This  difference  appears  to  be  additive  (Figure  3.14b).      
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Figure  3.13    The  selective  SUR1  K+ATP  channel  opener  NNC  55-­9216  
stimulated  hair  follicle  growth  in  organ  culture    Isolated   anagen   follicles   were   cultured   in   insulin-­‐free   control   medium,   as  described  in  Figure  3.10,  in  the  presence  of  either:  vehicle  alone,  100  µM  NNC  55-­‐9216,   1   µM   tolbutamide,   or   both   100   µM   NNC   55-­‐9216   and   1µM   tolbutamide.    Mean  values  ±  S.E.M  of  5  people  are  plotted;  a  minimum  of  10  hair   follicles  were  isolated  per  person  per  condition.    Statistical  analysis  was  performed  using  a  two-­‐factor  within-­‐subjects  ANOVA  using  SPSS,  after  confirming  normal  distribution.  (a)  The   percentage   of   follicles   remaining   in   anagen   was   significantly   stimulated   by  NNC  55-­‐9216;  this  affect  was  inhibited  with  the  channel  blocker  tolbutamide  at  1  µm.  (b)  The  increase  in  hair  follicle  length  over  9  days  was  significantly  stimulated  with  NNC  55-­‐9216;  this  effect  was  inhibited  with  the  channel  blocker  tolbutamide  at  1µm.    
  
  
Statistics:        








(b)  The  overall  increase  in  hair  follicle  length  over  9  days    
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Figure  3.14    Response  of  human  hair  follicles  incubated  with  both  the  SUR2  
channel   opener,   minoxidil,   and   the   SUR1   opener   NNC   55-­9216   in   organ  
culture  Isolated   anagen   follicles   were   cultured   in   insulin-­‐free   control   medium,   as  described  in  Figure  3.10,  in  the  presence  of  either:  vehicle  alone,  100  µM  NNC  55-­‐9216,  1  mM  minoxidil,  or  both  100  µM  NNC  55-­‐9216  and  1mM  minoxidil.     Mean  values  ±  S.E.M  of  5  people  are  plotted;  a  minimum  of  10  hair  follicles  were  isolated  per  person.     Statistical  analysis  was  performed  using  a   two-­‐factor  within-­‐subjects  ANOVA  using  SPSS,  after  confirming  normal  distribution.    The  combined  treatment  with  minoxidil   and   NNC   55-­‐9216   stimulated   hair   growth   causing   a   significantly  higher  percentage  of  follicles  in  anagen  than  NNC  55-­‐9216  alone  (a).    Hair  follicle  length   was   also   significantly   increased   to   higher   levels   than   with   either   opener  individually  (b).    
  
  
Statistics:      
 
(a)  Percentage  of  follicles  remaining  in  anagen      
 
 Control NNC55-9216 (100µM) Minoxidil (1mM)  & 
NNC55-9216 (100µM) 
Minoxidil (1mM) p<0.001*** p=0.049* p=0.099 (NS) 
NNC55-9216 
(100µM) 
p=0.003** ------- p=0.03* 
Minoxidil (1mM) & 
NNC55-9216(100µM) 
p<0.001*** p=0.03* -------- 
   
(b)  The  overall  increase  in  hair  follicle  length  over  9  days    
 
 Control NNC55-9216 (100µM) Minoxidil (1mM)  & 
NNC55-9216 (100µM) 
Minoxidil (1mM) P<0.001*** P=0.264 (NS) P=0.006** 
NNC55-9216 
(100µM) 
P=0.002** ------- P=0.001*** 
Minoxidil (1mM) & 
NNC55-9216(100µM) 
P<0.001*** P=0.001*** -------- 
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Figure  3.15    The  effect  of    tolbutamide  on  the  combined  treatment  of  NNC  55-­
9216  and  minoxidil,  on  hair  follicle  growth  in  organ  culture  Isolated   anagen   follicles   were   cultured   in   insulin-­‐free   control   medium,   as  described  in  Figure  3.10.    Mean  values  ±  S.E.M  of  5  people  are  plotted;  a  minimum  of   10   hair   follicles  were   isolated   per   person.      Statistical   analysis  was   performed  using   a   two-­‐factor   within-­‐subjects   ANOVA   using   SPSS,   after   confirming   normal  distribution.      The   combined   effect   of   minoxidil   and   NNC   55-­‐9216   on   the  percentage   of   follicles   remaining   in   anagen   was   significantly   inhibited   by  tolbutamide  (a).     Similarly  the  effect  of  combined  minoxidil  and  NNC  55-­‐9216  on  overall   increase   in   hair   follicle   length  was   significantly   inhibited   by   tolbutamide  
(b).    
  
Statistics:    (a)  Percentage  of  follicles  remaining  in  anagen    
 





Minoxidil (1mM) & 
NNC55-9216(100µM) 
p<0.001*** p=0.002** p=0.02** 




p=0.01* ------- 0.613 (NS) 
Tolbutamide (1µM) p=0.063(NS) 0.613 (NS) -------- 
   (b)  The  overall  increase  in  hair  follicle  length  over  9  days  
 





Minoxidil (1mM) & 
NNC55-9216(100µM) 
p<0.001*** p<0.001*** p<0.001*** 




p=0.15 (NS) ------- p=0.227 (NS) 
Tolbutamide (1µM) p=0.055(NS) p=0.227 (NS) -------- 
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(a)    Percentage  of  follicles  remaining  in  anagen  
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Figure   3.16      Percentage   of   hair   follicle   growth   with   channel   blocker  
tolbutamide   on   the   combined   treatment   of   NNC   55-­9216   and   minoxidil  
against  the  control  in  organ  culture  The  increase  in  hair  follicle  length  over  the  9  day  culture  period  was  calculated  as  a  percentage  of  the  samples  over  the  control  values  to  enable  comparison  between  conditions.      The   hair   follicle   growth   decreased   significantly,   with   addition   of  tolbutamide.     Mean  values  ±  S.E.M  of  5  people  are  plotted;  a  minimum  of  10  hair  follicles  were  isolated  per  person.    Statistical  analysis  was  performed  using  a  two-­‐factor  within-­‐subjects  ANOVA  using  SPSS,  after  confirming  normal  distribution.          Percentage  of  control  hair  follicle  growth  over  9  days  
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3.5  Discussion     The  organ  culture  system  for  human  hair  follicles  pioneered  by  Philpott  et  al  (1989)   routinely   includes   supplements   such  as   insulin   in   the  medium   to   increase  hair  follicle  growth  (Philpott  et  al.,  1989;  Philpott  et  al.,  1990;  Randall  et  al.,  2003).    Since  the  overall  aim  of  this  chapter  was  to  determine  whether  the  opening  of  SUR1  K+ATP  channels  would   enable   the   stimulation   of   human   hair   growth   in   organ   culture,   a  culture   system   where   follicles   are   already   heavily   stimulated   to   achieve   good  growth  is  not  ideal.    Insulin  has  a  range  of  effects  on  cells,  dependant  on  the  cell  type,  though  on  the  whole   it  acts  as  a   stimulant   in  the   uptake  of  glucose,  by  promoting  the   translocation   of   glucose   transporter   4   (GLUT-­‐4)   proteins   from   an   intracellular  membrane  pool  to  the  plasma  membrane,  and  facilitates  the  incorporation  of  glucose  into   storage  molecules  as   glycogen   (Cushman  and  Wardzala,   1980;   Suzuki   and  Kono,  1980;  Chiang  et   al.,   2003;   Leney  and  Tavare,   2009).     The   initial   investigations  of   this  study   examined   the   effect   of   10   µg/ml   insulin   in   the   medium,   on   the   growth   of  human   scalp   anagen   hair   follicles.      Hair   follicles   were   examined   for   alteration   in  length   and   changes   in   morphology,   particularly   in   the   hair   follicle   bulb,   at   24   hour  intervals   for  9  days.     All   investigations  took  place   in  serum-­‐free  medium  as  serum  inhibits  hair  follicle  growth  in  organ  culture  (Philpott  et  al.,  1996)  and  in  the  absence  of  streptomycin  ǯ  (Sanders  et  al.,  1996).  In   follicles   which   maintained   an   anagen   morphology   the   production   of   a  hair   fibre   and   associated   inner   root   sheath   induced   gradual   hair   follicle   growth  during  organ  culture,  while  the  connective  tissue  sheath  underwent  no  change  and  remained  at   the   same   level   throughout   the   culture  period   (Figure  3.2).     This   is   in  agreement  with  previous  reports  on  human  hair  follicle  culture  (Philpott  et  al.,  1990;  
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Shorter   et   al.,   2008).      Hair   follicle   rate   of   growth   in   the   presence   of   insulin   was  0.20+0.02  (mean  +  SEM)  mm/day  (Figure_3.2a)  over  9  days,  similar  to  that  observed  by  Han  et  al  (2004)  who  reported  a  growth  of  approximately  0.25  mm/day  over  10  days,  using  the  same  concentration  of  insulin  (10µg/ml).    The  experimental  conditions  were   the   same,   except   for   the   inclusion   of   streptomycin   within   their  medium.      A  slightly  higher  growth  rate  was  noted  by  Philpott  et  al  (1996)  (approx.  0.27  mm/day  over   9   days   in   10µg/ml   of   insulin),   in   serum-­‐free   medium   supplemented   with  streptomycin.    This  is  closer  to  the  in  vivo  human  growth  rate  of    0.32-­‐0.35  mm/day  of  male  scalp  hair  (Myers  and  Hamilton,  1951).    Omitting  insulin  from  the  medium  had  a  dramatic   effect   on   hair   follicle   growth.      At   the   end   of   the   culture   period,   the   total  increase   in   hair   follicle   length   in   insulin-­‐free  medium  was   only   0.30+0.049mm,   in  contrast  to  the  1.90+0.046mm  in  the  presence  of  insulin  (p<0.001;  Figure  3.3b).    During  the  culture  period  the  hair  bulb  of  some  follicles  displayed  catagen-­‐like  morphological  changes,  where  the  hair   fibre  retracted  up  the   follicle,   leaving  behind  a  cluster  of  dermal  papilla  cells  (Figure  3.2e).    The  number  of  follicles  that  remained   in   the  anagen  growth  phase  was   calculated   for  each  day  of   the   culture  period.     In  the  presence  of  insulin,  the  proportion  of  follicles  in  the  anagen  phase  declined   slowly   and   steadily,   whereas   follicles   in   the   absence   of   insulin   rapidly  began  entering  catagen.    On  the  third  day  only  60%  of  follicles  remained  in  anagen  in  the  absence  of  insulin,  unlike  90%  of  follicles  in  the  presence  of  insulin  (Figure  3.3a).    No  follicles  remained  in  anagen  by  day  5  in  the  insulin-­‐free  medium;  in  the  presence  of  insulin  this  was  about  80%  and  43%  of  follicles  remained  in  anagen  at  day  9.  Past  research  has  indicated  that  to  maintain  anagen  in  human  hair  follicles  in  organ  culture  beyond  4  days  the  presence  of  insulin  is  essential  (Westgate  et  al.,  1993)   and   follicles   that   are   cultured   in   insulin-­‐free   medium   rapidly   enter   a  
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catagen-­‐like  state  (Philpott  et  al.,  1994).     Shorter  ǯfindings  in  2008  similarly  indicated   that  hair   follicles   in   insulin-­‐free  medium  rapidly  entered  a   catagen-­‐like  state,  and  by  day  9  no  follicles  remained  in  anagen,  whilst  in  the  presence  of  insulin  about  65%  of  follicles  remained  in  anagen.  The  effect  of  the  potassium  channel  opener,  minoxidil,  was  investigated  on  human  hair  follicles  in  organ  culture  in  both  the  presence,  and  absence,  of  insulin  (Figures   3.4   and   3.5).      The   concentrations   at   which   minoxidil   was   used   in   this  study  were  selected  with  regard  to  investigations  by  both  Shorter  et  al  (2008)  and  Han  et  al  (2004).    Shorter  et  al  (2008)  reported  that  1  mM  of  minoxidil  stimulated  anagen   in   insulin-­‐free  medium,  whilst  Han  et  al   (2004)  described  that,  during  10  days  in  serum-­‐free  culture  in  the  presence  of  10µg/ml  of  insulin,  100  µM  and  1  mM  minoxidil  significantly  increased  hair  follicle  length,  though  10  µM  did  not.    Han  et  
al  (2004)  claimed  that  the  1  mM  concentration  of  minoxidil  resembled  that  in  vivo  from   topical   applications   of   3-­‐5%  minoxidil   on   human   hair   follicles.      Therefore,  1mM  was  selected  for  this  study.     The  percentage  of  follicles  remaining  in  anagen  was   unaffected   by   1   mM   minoxidil   in   the   presence   of   insulin   (p=0.525;   Figure  3.4a);   however,   in   the   absence   of   insulin   minoxidil   significantly   increased   the  percentage  of  follicles  maintained  in  anagen  with  over  50%  of  follicles  still  growing  at   day   9   (p<0.001;   Figure   3.4b).      A   similar   prolongation   of   anagen   by   1   mM  minoxidil  was  reported  in  scalp  follicles  cultured  in  serum-­‐free  medium  by  Shorter  
et  al  ȋʹͲͲͺȌǤ ǯ in  vivo  where  anagen  is  often  prolonged  (Messenger  and  Rundegren,  2004).    The  presence  of  insulin  also  altered  the  amount  of  hair  follicle  growth  in  response  to  minoxidil.  With   insulin,   minoxidil   had   an   inhibitory   effect   on   the   average   overall  increase   in   the   length  of   the  hair   follicle   reducing   it   from  1.90   +  0.046mm  to  1.30  +  
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0.16mm   (p=0.016;   Figure   3.5a),   whilst   in   its   absence   overall   hair   follicle   length  significantly   increased   from   0.30+0.049  mm   to   0.72+0.053mm   (p<0.001;   Figure  3.5b).      Due   to   the   diverse   range   of   culture   conditions   used   in   investigations   into  
ǯǡstudies.      An   earlier   report   by   Philpott   et   al   (1990)   indicated   that   human   hair  follicle  growth  in  organ  culture  was  unaffected  by  minoxidil  at  0.95  µM  and  48  µM  or   inhibited   by   0.95   mM   in   the   presence   of   10   ng/ml   insulin,   50   µg/ml  streptomycin  and  1%  fetal  calf  serum  during  72  hours  of  culture;  there  was  also  no  effect   on   DNA   or   protein   synthesis.      However,   after   5   days   of   culture   in   the  presence  of  10  ng/ml  insulin,  50  µg/ml  streptomycin  and  1%  fetal  calf  serum,  0.95  µM  minoxidil   had   a   stimulatory   effect,  whilst   the   effects   of   48   µM   and  0.95  mM  minoxidil   remained   the   same.      The   report   also   indicated   that   serum   had   an  inhibitory  effect  on  hair  follicle  growth  following  4  days  in  culture  and  there  was  no  significant  difference  between  hair  follicles  maintained  in  1  %  and  20  %  serum.    The  group  reasoned  that   the  0.95  µM  minoxidil  seemed  to  have  counteracted  the  inhibitory   effect   of   the   serum,   resulting   in   hair   growth,   rather   than   minoxidil  having  a  stimulatory  effect  on  hair  growth  alone.    The  omission  of  serum  from  the  medium  by  Philpott  et  al  (1991)  resulted  in  steady  hair  follicle  growth  for  up  to  10  days   in   culture,   thereby   suggesting   that   serum   is   not   essential   for   hair   follicle  growth  in  vitro  and  leading  to  the  current  standard  culture  conditions.        In   order   to   overcome   the   interference   of   streptomycin   with   K+   channels  Magerl   et   al   (2004)   substituted   streptomycin   with   another   antibiotic,  ciprofloxacin.      They   showed   that   human  hair   follicle   elongation   after   12   days   in  culture   using   ciprofloxacin   (10   µg/ml)   was   unaffected   by   1   µM   and   100   µM  
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minoxidil   in   the   presence   of   10   µg/ml   insulin,   but   inhibited   in   its   absence.      In  contrast   Han   et   al   (2004)   reported   a   dose   responsive   stimulatory   effect   on   hair  follicle   growth  with   100   µM   and   1  mM  minoxidil   during   10   days   culture   in   the  presence   of   10   µg/ml   insulin   and   100   µg/ml   streptomycin;   however   10   µM  
Ǥǯ͵young  male  subjects  aged  between  20-­‐35  but  only  30  hair  follicles  were  used,  with  10  follicles  per  subject/per  condition.      In   this   study  50  hair   follicles   from  5  male  subjects  aged  between  24-­‐57  years,  were  used;  however  contrasting  results  were  observed  as  1  mM  minoxidil  in  the  presence  of  insulin  had  an  inhibitory  effect  on  hair  follicle  growth  and  no  affect  on  the  percentage  of  follicles  remaining  in  anagen  (Figures   3.5a   and   3.4a).      Philpott   et   al   (1990),   as   discussed   previously,   also  reported  that  0.95  mM  minoxidil  had  an  inhibitory  effect  on  hair  follicle  growth  in  the  presence  of  10  ng/ml  insulin,  50  µg/ml  streptomycin  and  1%  serum.    Magerl  et  
ǯ   (2004)   study   which   employed   similar   culture   conditions   to   this   thesis,  reported   that   1   and   100   µM   minoxidil   had   no   effect   on   hair   follicle   growth.      However,   the   above   studies   have   tended   to   involve   follicles   from  older   subjects.    Shorter  ǯ  (2008)  research  also  used  young  male  subjects,  aged  between  21-­‐40,  similar   to   Han   et   al   (2004),   but   with   the   larger   sample   size   of      11   donors   and  reported   that   1mM  minoxidil   had   no   effect   in  maintaining   follicles   in   anagen   in  insulin   containing   medium.      This   eliminates   the   prospect   that   the   stimulatory  effect  of  1  mM  minoxidil  reported  by  Han  et  al  (2004)  was  influenced  by  the  use  of  younger   subjects.      Thus,   Han    ǯ stimulatory   effect   on   human   hair   follicle  growth  in  the  presence  of  insulin  has  not  been  confirmed  by  any  other  researchers.  Follicles  from  other  species  have  also  been  used  to  investigate  the  effect  of  minoxidil   in  vitro.     Buhl  et  al  (1989)  carried  out  a  series  of  initial  experiments  on  
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minoxidil   action   using   neonatal   mouse   vibrissae   follicles,   in   medium   containing  20%  serum  and  12.5  µg/ml  gentamicin  (antibiotic).    Minoxidil  at  1  mM  maintained  follicular   morphology   over   48   hours   culture,   while   in   the   absence   of   minoxidil  follicular   morphology   rapidly   altered.      In   a   subsequent   study   the   K+ATP   channel  blockers,   tolbutamide  0.5  mM  and  glyburide  (0.5,  5  and  50  µM),   failed  to  prevent  the  stimulatory  effect  of  1mM  minoxidil  (Buhl  et  al.,  1993)  suggesting  this  was  not  K+  channel  mediated  effect.    Red  deer  (Cervus  elaphus)  follicles  have  also  been  used  as  a  model  system.      The  first  deer  hair  follicle  organ  culture  studies  omitted  serum,  insulin   and   hydrocortisone   as   they   were   designed   to   investigate   the   effect   of  androgens  (Thomas  et  al.,  1994;  Thornton    et    al.,    1996;  Randall  et  al.,  2003)  and  therefore  no  other  hormones  were  included.     Davies  et  al  (2005)  continued  using  these  conditions  to  investigate  potassium  channel  regulators  on  deer  hair  follicles,  though  additionally  excluding   streptomycin  due   to   its  reported   interference  with  
ǯ  (Sanders   et   al.,   1996).   Davies   et   al   (2005)   found   that   the  minoxidil  was  stimulatory  during  8  days  in  culture.     Minoxidil  (0.1,  1,  10  and  100  µM)  stimulated  deer  hair   follicle  growth   in  a  dose  responsive  manner.      Increased  hair   follicle   growth  was   also   observed  with   other   potassium   channel   openers   in  culture,   diazoxide   (10   µM)   and   NNC   55-­‐0118   (0.1,   1,   10   and   100   µM).      The  stimulatory   effect   of   hair   follicle   growth   was   inhibited   with   the   K+ATP   channel  blockers  tolbutamide  and  glibenclamide.      In   the   comparison   carried   out   in   this   study,   in   the   presence   of   insulin  minoxidil   had   no   effect,   whereas,   in   the   absence   of   insulin   it   had   a   significant  stimulatory  effect  (Figure  3.4).    Overall,  it  is  clear  that  insulin  in  the  medium  affects  follicular   responses   to   minoxidil.      Insulin   advances   the   movement   of   potassium  ions  into  the  cell  and  sodium  out  of  the  cell  via  the  activation  of  Na+  K+  ATPases  in  
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the  plasma  membrane   (Irwin  and  Rippe,  2008).     These  alterations  may   result   in  the  opening  of  K+ATP  channels,  as  inhibition  of  Na+  K+  ATPases  by  ouabain  has  been  shown  to  completely  close  K+ATP  channels  (Ding  et  al.,  1996),   i.e.   the   same  as  the  probable  main  action  of  minoxidil.     Alternatively,  as   insulin  acts  as  a  stimulant  of  glucose  uptake   into   cells   and  storage   (Cushman  and  Wardzala,  1980;  Suzuki   and  Kono,   1980;   Leney   and   Tavare,   2009),   follicles   may   have   achieved   maximum  growth  already.      The  effect  of   the  potassium  channel  blocker,   tolbutamide,  on   human  scalp  hair   follicle   growth   in   organ   culture   was   also   investigated   in   the   presence,   and  absence,   of   insulin.      Tolbutamide,   has   been   described   as   instigating   hair   loss   in  human   beings   (Litt,   2007)   and  was   patented   for   use   as   a   hair   removal   agent   in  2007  (US  patent  7160921,  issued  on  9.2.07).    This  leads  to  the  prospect  of  research  focused   on   a   different   aspect   of   hair   growth,   other   than   concentrating   on   the  stimulatory   effects   of   K+ATP   channel   openers   for   hair   loss   disorders,   as   current  research   has   done   (Ross   and   Shapiro,   2005),   by   looking   into   the   inhibition   of  excessive  hair  growth.    In  the  presence  of  insulin,  tolbutamide  induced  catagen-­‐like  morphological   changes   in   the   hair   bulb   in   both   lower   (1   µM)   and   high   (1   mM)  concentrations.     The  hair  fibre  retracted  upwards  in  the  follicle,  detaching  from  a  rounded   cluster   of   dermal   papilla   cells   left   behind.      In   the   presence   of   insulin,  tolbutamide  at  1  µM  reduced  the  percentage  of  follicles  in  anagen  to  about  30+1%  by   day   9   (p=0.004),   and   at   1  mM   to   about  10+2%   (p<0.001)   (Figure   3.7a).     The  overall   hair   follicle   growth   exhibited   a   similar   inhibitory   affect;   this   fell   from  1.68+0.06mm   in   control  medium   to   1.10+0.07mm   (p=0.01)   in   1µM   tolbutamide  and  to  0.6+0.16mm  in  1  mM  (p<0.001)  over  9  days    (Figure  3.8a).    In  the  absence  of  insulin,  the  percentage  of  follicles  remaining  in  anagen  appeared  higher  than  the  
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control  but  this  was  not  significant,  tolbutamide  (1  µM)  3+2.4%  (p=0.063)  follicles  remained  in  anagen,  while  at  1  mM  0%  (p=0.064)  (Figure  3.7b).     The  same  effect  occurred  in  the  overall  hair  follicle  growth.     In  1  µM  tolbutamide  the  follicles  had  grown   by   0.44+0.06mm   (p=0.055)   after   9   days   and   in   1   mM   tolbutamide  0.43+0.05mm   after   9   days   (p=0.061)   (Figure   3.8b)   compared   to   the   control  follicles  0.39+0.01mm.    These  results  concur  with  the  investigation  by  Shorter  et  al  (2008)  which   showed   tolbutamide   (1  mM)  shortened  anagen   in   cultured  human  hair  follicles  significantly  in  the  presence  of  insulin  during  9  days  in  culture,  while  in  the  absence  of  insulin  tolbutamide  had  no  effect.    Similarly  Davies  ǯ(2005)  study  in  insulin-­‐free  medium  reported  that  tolbutamide  (1  mM)  inhibited  deer  hair  follicle   growth   in   culture.   Whereas   Buhl   et   al   (1993)   observed   that   0.5   mM  tolbutamide  had  no  effect  on  mouse  vibrissae  follicles,  in  medium  containing  20  %  serum.    The  different  effects  of  tolbutamide  in  the  presence,  and  absence,  of  insulin  support  the  concept  that  the  K+ATP  channels  may  be  open  in  the  presence  of  insulin  
  Ǥ  ǯ       containing  medium  is  presumably  due  to  the  closing  of  the  channels,  whilst  in  the  insulin-­‐free  medium,   tolbutamide  had  no   real   effect,  presumably  as   the   channels  were   closed.  Our  understanding  of   the  effect   of   insulin  on  hair   follicle  growth   in  
vitro  is  currently  rather  inadequate  and  further  research  is  required.  To   indicate   whether   minoxidil   and   tolbutamide   were   acting   via   K+ATP  channels  they  were  used  in  combination.    All  further  investigations  omitted  insulin  in   the  medium,   because   of   its   significant   effect   in   organ   culture   on   hair   follicles.  
ǯͳͲρȀǡʹ-­‐glutamine,  10units/ml   penicillin,   0.001%  DMSO.      The  medium  was   also   supplemented  with  
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100ng/ml  hydrocortisone  as   it  has  been   reported   to  enhance   the  morphology  of  hair  follicles,  though  it  does  not  affect  the  rate  of  growth  (Westgate  et  al.,  1993).      The   stimulatory   effect   of   1mM   minoxidil   on   the   number   of   follicles  remaining   in  anagen  was   significantly   inhibited  when  co-­‐incubated  with  1mM  of  tolbutamide  reducing  from  about  50+0  %  to  0  %  after  9  days  culture  (p=  0.0043;  Figure   3.10a).      Though   the   lower   concentration   of   tolbutamide   (1µM)   also   had  some   effect   on   the   percentage   of   follicles   in   anagen   reducing   it   to   about   20+4%  (p=0.018;  Figure  3.10b),  it  did  not  block  the  minoxidil  effect  entirely.    Similarly,  the  minoxidil-­‐stimulated  increase  in  mean  overall  hair  follicle  length  to  0.80+0.043mm  was   greatly   inhibited   by   tolbutamide   at   both   concentrations;   at   1   mM   it   was  reduced  to  0.50+0.06mm  (p=0.004;  Figure  3.11a),  while  at  1  µM  it  reduced  growth  to   0.55+0.072mm   (p=0.019;   Figure   3.11b).      This   corresponds   to   Shorter    ǯ  (2008)  investigation  that  showed  1  mM  minoxidil  in  insulin  and  streptomycin-­‐free  medium   significantly   increased   the   number   of   follicles   remaining   in   anagen,   an  effect  blocked  by  1  mM  tolbutamide.    Similarly  Davies  ǯ  (2005)  study  on  deer  hair   follicles   cultured   in   serum-­‐and   streptomycin-­‐free   conditions   showed   that  minoxidil   (0.1,   1,   10   and   100   µM)   stimulated   hair   follicle   growth   in   a   dose  responsive   manner   and   that   1   mM   tolbutamide   significantly   inhibited   the  stimulatory  effects  of  10  µM  minoxidil.    The  susceptibility  of  human  hair  follicles  in  organ  culture  to  stimulation  by  the   potassium   channel   opener,  minoxidil,   and   the   inhibition   of   this   effect   by   the  potassium  channel  closer,   tolbutamide,  strongly  supports   the  hypothesis   that   the  mechanism  of  action  of  minoxidil  in  promoting  hair  growth  is  via  K+ATP  channels.  Minoxidil   opens   SUR2B   K+ATP   channels,   but   not   those   with   SUR1  sulphonylurea   subunits   (Schwanstecher   et   al.,   1998)   and   tolbutamide   selectively  
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inhibits  SUR1  K+ATP  channels  at  a  low  concentration  up  to  100  nM  and  SUR2B  K+ATP  channels  at   a  high  concentration   from  10µM  (Babenko   et  al.,   1998;  Ashcroft   and  Gribble,   2000;   Fujita   and   Kurachi,   2000;   Reimann   et   al.,   2001;   Gribble   and  Reimann,  2003;  Seino  and  Miki,  2003).    To   determine   more   fully   whether   SUR1   channels   can   be   involved   in  regulating  human  hair  follicle  growth,  the  selective  SUR1  channel  opener,  NNC  55-­‐9216,  was  investigated  in  organ  culture  using  insulin-­‐free  medium.    NNC  55-­‐9216  (100  µM)  effectively  promoted  follicles  to  remain  in  anagen  with  43+3%  at  day  9  compared  to  0%  in  the  control  medium  (p=0.003;  Figure  3.13a).    The  mean  overall  increase   in   hair   follicle   length   also   showed   a   significant   increase   from  0.30+0.05mm   to   0.67+0.03mm   over   the   9   day   culture   period   (p=0.002;   Figure  3.13b).      This   corresponds   with   Davies    ǯ (2005)   findings   where   another  selective   SUR1   channel   opener,   NNC   55-­‐0118,   effectively   stimulated   growth   in  deer   hair   follicles   in   organ   culture,   an   effect   which   was   inhibited   by   1   mM  tolbutamide.    In  the  human  follicles  the  lower  concentration  of  tolbutamide,  1  µM,  successfully  hindered  the  stimulatory  effect  of  NNC  55-­‐9216  on  percentage  anagen  (p=0.008;  Figure  3.13a)  and  reduced  the  overall   increase   in  hair   follicle   length  to  0.21  +  0.03mm  (p<0.001;  Figure  3.13b)  supporting  the  concept  that  NNC  55-­‐9216  is  acting  via  a  SUR1  K+ATP  channel.    Interestingly,  the  combination  of  NNC  55-­‐9216  and  1  µM  tolbutamide  reduced  the  overall  growth  to  less  than  two  thirds  of  that  of  the   control   (p=0.032),   indicating   a   very   strong   inhibition   of   hair   growth   rate   as  anagen  was  insignificantly  prolonged  compared  to  the  control  (p=0.06).      The  response  of  human  hair  follicles  to  the  SUR1  channel  opener  in  culture  fits  well  with  Shorter  ǯ(2008)  detection  of  SUR1  gene  expression   in  human  hair   follicles,   suggesting   a   possible   role   for   SUR1   K+ATP   channels   in   human   hair  
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follicles.    It  also  agrees  with  the  detection  of  SUR1  gene  expression  in  deer  follicles  reported   in   Chapter   2   and   the   pharmacological   effects   on   deer   follicle   growth  reported  previously  by  Davies  et  al  (2005).     Unfortunately,   this  suggests   that   the  development   of   novel   drugs   for   pancreatic   disorders,   which   act   via   selective  stimulation  of  the  SUR1  K+ATP  channels,  is  also   likely  to  facilitate  hair  growth  as  a  side   effect,   like   the   broad   acting   diazoxide.      When   diazoxide   is   used   for  hyperinsulinemia   in   babies   it   generally   causes   such   pronounced   general  hypertrichosis  that  the  parents  often  feel  their  child  is  becoming  like  a  monkey  and  request   a   pancreatectomy   (Stanley,   2002).      It   had   been   hoped   that   as   the   hair  growth   promoting   potassium   channel   openers   in   the   clinic,   minoxidil   and  diazoxide,  were  either  a  SUR2B  channel  opener  (the  former)  or  a  broad  spectrum  SUR1   and   SUR2   opener   (the   latter)   that   a   selective   SUR1   channel   opening   drug  would   improve   pancreatic   symptoms  without  promoting   hair   growth.     However,  the  stimulation  of  hair  follicle  growth  in  organ  culture  does  suggest  a  novel  field  of  pharmaceuticals  that  act  via  SUR1  K+ATP  channels  with  the  objective  of  stimulating  hair   growth.      In   addition,   this   raises   the   possibility   that   if   incorporated  with   the  currently   used  minoxidil   hair   loss   treatment,   which   acts   via   the   SUR2B   channel,  novel   therapies   could   prove   to   be   far   superior   to   current   treatments.      As   SUR1  channels  are  expressed  in  the  matrix  of  the  hair  follicle  bulb  and  SUR2B  channels  in  the  dermal  sheath  and  dermal  papilla  cells  (Shorter  et  al.,  2008),  such  treatment  holds  the  possibility  of  effectively  acting  on  different  parts  of  the  hair  bulb.  With  the  above  suggestion  for  novel  pharmaceuticals  in  mind,  the  effects  of  combined   minoxidil   and   NNC   55-­‐9216   were   examined.      Minoxidil   (1mM)  significantly   stimulated   the   percentage   of   follicles   remaining   in   anagen   to   about  50+0%  compared  to  0%  in  the  control  medium  (p<0.001),  whilst  100  µM  NNC  55-­‐
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9216  prolonged   anagen   to   about   43+3%   (p=0.003)   and   the   combined   treatment  had   the   greatest   effect   on   the   follicles   with   about   60+2%   remaining   in   anagen  (p<0.001;  Figure  3.14a).     This   increase  was   significantly  higher  by  about  17+1%  than  that  achieved  with  NNC  55-­‐9216  alone  (p=0.03),  whilst  it  was  insignificantly  higher  than  minoxidil   (p=0.099)  (Figure  3.14a).     Similarly,   the  overall   increase   in  hair   follicle   growth   over   9   days   in   culture  was   significantly   stimulated   by   1mM  minoxidil   to   0.80+0.043mm   compared   to   the   control   0.30+0.05mm   (p<0.001);  whereas   in  100  µM  NNC  55-­‐9216   the   follicles  grew  0.67+0.03mm  (p=0.002)  and  the  combined  treatment  had  the  most  effect,  promoting  growth  of  1.10  +  0.04  mm  (p<0.001)  (Figure  3.14b).    The  combined  effect  was  significantly  higher  compared  to   that   produced   by   NNC   55-­‐9216   (p=0.001)   and   minoxidil   alone   (p=0.006)  (Figure  3.14b).          This   increase  with   the   two  drugs   combined   appears   to   be   additive   rather  than  synergistic  and  does  suggests  that  they  are  not  necessarily  acting  on  the  same  point,  i.e  that  there  are  two  routes  involving  SUR2B  and  SUR1  K+ATP  channels  that  can  regulate  hair  growth.    The  stimulatory  effect  of  the  combined  treatment  on  the  number  of  follicles  remaining  in  anagen  was  reduced  with  1  µM  tolbutamide  from  about      60+2%   to   about   23+3.4%   after   9   days   culture,   but   in   comparison   to   the  control,   the   percentage   of   follicles   remaining   in   anagen   were   still   significantly  raised  (p=0.01)  (Figure  3.15a).    However,  the  overall  increase  in  hair  follicle  length  was   significantly   inhibited   with   the   addition   of   1   µM   tolbutamide   from  1.10+0.04mm   to   0.42+0.04mm      (p<0.001)   over   9   days   (Figure   3.15b).      This  inhibition  strongly  supports   the   idea  that  SUR1  channel  opener,  NNC  55-­‐9216,   is  stimulating  human  hair  follicles  via  K+ATP  channels.          
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4.1   Introduction  The  effect  of  potassium  channel  modulators  on  human  and  deer  hair  follicle  growth   in   organ   culture   (see   Chapter   3),   and   the   absence   of   the   K+ATP   channel  subunit  gene  expression  in  telogen  follicles,  though  present  in  anagen  follicles,  as  demonstrated   in   the   deer   model   (Chapter   2),   signify   the   importance   of   K+ATP  channels  within   hair   follicles.      They   suggest   that   hair   follicle   K+ATP   channels   are  implicated   in  the  clinical  observation  of   increased  hair  growth  with  treatment  by  potassium   channel   openers   such   as  minoxidil   and   diazoxide   (Olsen   et   al.,   1987;  Olsen   et   al.,   1990).      At   present,   the   specific  mechanisms   by  which  K+ATP   channel  openers   modulate   hair   growth   remain   unclear.      Schwanstecher   et   al   (1998)  reported  minoxidil  to  have  specific  affinity  to  the  SUR2B  subunit,  and  Shorter  et  al  (2008)  indentified  SUR2B  in  the  dermal  papilla  of  human  hair  follicles.    This  raises  the  intriguing  prospect  of  the  dermal  papilla  providing  the  target  through  which  at  least  some  K+ATP  channel  openers  function.      The  dermal  papilla  is  known  to  play  a  major  role  in  mesenchymal-­‐epithelial  interactions  in  the  hair  follicle  and  to  regulate  many  aspects  of  hair  follicle  activity  including   determining   the   type   and   size   of   hair   produced   (Reynolds   and   Jahoda,  1991;  Jahoda  and  Reynolds,  1996;  Richardson  et  al.,  2005;  Waters  et  al.,  2007).    It  is   also   believed   to   be   the   focus   of   androgen   alteration   of   hair   follicle   size   by  changing   the   production   of   paracrine   factors   such   as   soluble   growth   factors   or  extracellular  matrix  proteins  when  androgens  bind  to  receptors  in  dermal  papilla  cells  (Randall  et  al.,  1991;  Randall,  2008).    Therefore,  a  possible  mechanism  is  the  binding   of   minoxidil   to   SUR2B   containing   K+ATP   channels   in   the   dermal   papilla  which  would  be  the  signal  for  the  alteration  of  factors  that  could  act  on  cells  of  the  
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hair  follicle  such  as  the  keratinocytes.     This  makes  the  dermal  papilla  an  essential  subject  for  further  investigation.      In   1981,   Jahoda   &   Oliver   successfully   cultured   cells   from   isolated   rat  vibrissa   dermal   papilla.   The   dermal   papilla   cells   retain   at   least   some   of   their  inductive   characteristics   for   a   short   time   in   culture   and   can   induce   hair   growth  when  implanted  into  follicles  which  otherwise  would  not  grow  hair  (Jahoda  et  al.,  1984).      Retaining   androgen-­‐sensitivity   differences   of   their   parent   follicles   in  culture   (Randall  et  al.,   1991;  Randall,   2008)  also  marks  dermal  papilla   cells   as   a  useful  model  with  which  to  investigate  the  action  of  hair  follicle  regulatory  factors.    Furthermore,   in   cultured   human   dermal   papilla   cells,   minoxidil   stimulated   the  vascular   endothelial   growth   factor   (VEGF)   (Lachgar   et   al.,   1998).     Minoxidil  was  also  found  to  increase  the  production  of  prostaglandin  E2  in  cultured  rat  vibrissae  dermal   papilla   cells   (Lachgar   et   al.,   1996a).      Interestingly,   Sanders   et   al   (1996)  found   that   minoxidil   was   initially   inhibiting   the   NIH   3T3   fibroblast   cell  proliferation,   however   omitting   streptomycin   from   the   medium,   reversed   that  effect.      Proteins   are   essential   in   cell   behaviour   and   determine   their   phenotypes,  therefore   the   study   of   proteins   altered   by   potassium   channel   regulators   using  proteomic  methods  should  grant  us  a  greater  comprehension  of  the  mechanisms  of  minoxidil   action.      The   term   proteomics   refers   to   the   characterisation   of   the  complete  set  of  proteins  encoded  by  the  genome  of  a  given  organism   (Wilkins  et  
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by  Fredrick  Sanger  with  his  success  in  sequencing  the  complete  genomes  of  a  virus  and   mitochondrion   (Fiddes   et   al.,   1977).      His   group   pioneered   techniques   of  sequencing,   genome   mapping,   data   storage,   and   bioinformatics   analyses.      It  received   incredible   media   attention   in   2001,   with   sequencing   of   the   human  genome   (Venter   et   al.,   2001).      Though   research   in   the   field   of   genomics   has  contributed   abundantly   to   medical   research,   the   study   of   genes   alone   is   not  sufficient   to   understand   how   cells,   tissues   and   the   body   functions.      Synthesised  proteins  are  the  main  components  of  the  physiological  and  metabolic  pathways  of  cells   and   their   structure.     Thus,   analysis  of  proteins  affected   by  minoxidil   should  contribute  greatly  to  our  understanding  of  the  processes  and  pathways  involved.  Coined   as   an   analogy   to   genomics   by  Marc  Wilkins   in   1994,   proteomics   has   the  capacity  to  merge  analytical   techniques  with  complex  bioinformatics   to  allow  for  further   biological   investigation.      Earlier   protein   research   used   the   Edman  degradation   sequencing   (Edman,   1949)   and   two-­‐dimensional   polyacrylamide   gel  electrophoresis  (2D-­‐PAGE)  (O'Farrell,  1975).    Breakthrough  development  of  mass  spectrometry  technologies,  which  has  led  to  characterisation  of  proteins,  not  only  propelled  mass   spectrometry  as  a  prominent   force   in   the   field  of  proteomics  but  also   established   proteomics   as   a   leading   research   field.      Mass   spectrometry   is  incredibly  proficient  at   identifying  peptides.     Prevalently   in  proteomics   research,  the   complex   mixture   of   proteins   is   digested   into   peptides   prior   to   mass  spectrometry   analysis   (Rappsilber   and   Mann,   2002).      This   digestion   step   is  undertaken   for   two  primary   reasons:   the   peptides   are   rendered  more   soluble   in  solution   than  as  a  whole  protein,   and   though  mass   spectrometry  measures  mass  with  high  precision,  it  does  not  merit  confident  identification  of  a  protein  de  novo  ascertained   exclusively   on   its   molecular   weight.      Thus,   the   peptide   enables   the  
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identification   of   the   protein   it   originates   from,   by   proxy.      Typically,   peptide  fragments   formed   by   digestion   by   an   enzyme,   such   as   trypsin,   produce   a   mass  spectrum;         ǲ ǳ   ǲ ǳ(Blackstock  and  Weir,  1999).      Identification  of  a  protein  can  then  be  achieved  by  the   comparison  of   the   collected  masses   to   in   silico   (computer   simulated)  peptide  maps,  obtained  from  either  a  protein  or  genomic  database.      Data   mapping   is   most   preferable   for   the   purposes   of   identifying   a   single  protein  within  a  simple  mixture;  furthermore  access  to  data  is  realised  with  ease.    However,   this   process   does   not   offer   conclusive   identification   for   complex  mixtures  (e.g.  cell   lysates),  as   the  peptide  masses  recorded   in  the  mass  spectrum  will   arise   from   scores   of   different   species.      Nevertheless,   the   available  instrumentation   allows   for   a   greater   depth   of   information   to   be   obtained   from  peptide   masses   observed   in   mass   spectrometry.      Rather   than   depend   upon   the  accurate   mass   of   a   specific   peptide,   collision   induced   dissociation   (CID)   can   be  employed   to   isolate   and   fragment   individual   peptide   ions   (Martin   et   al.,   1987).    Following  this,  the  masses  of  the  fragment  ions  are  recorded  and  are  drawn  upon  to   acquire   partial   or   complete   sequence   information.      This   process,   typically  referred   to   as   tandem  mass   spectrometry   (MS/MS),   does   not   completely   reduce  the   peptides   into   their   constituent   amino   acids;   rather,   what   is   achieved   is   a  collection  of  fragments  containing  diverse  lengths  of  the  peptide   (Nesvizhskii  and  Aebersold,   2004)Ǥ   Ǯ ǯ      information  lead  to  the  deduction  of  primary  sequence  information  of  the  peptide.    The   following   step   involves   the   use   of   software   programmes   that   are   capable   of  comparing  the  experimental  data  to   in  silico  MS/MS  mass  spectra  calculated  from  
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the  protein  sequences  in  the  database  to  analyse  the  collected  raw  data  (Chamrad  
et  al.,  2004).  Originally  research  in  proteomics  strived  to  identify  all  the  components  of  a  proteome  and  generate  a   complete  protein  database  or  biological  map.      In  order  for   comparisons   to   be  made   between   different   experimental   states   the   proteins  must   be   studied   quantitatively.      Quantitative   proteomics   has   several   formats  (Bantscheff  et   al.,   2007),  however,   stable   isotope   labelling  by  amino  acids   in   cell  culture  (SILAC)  is  both  a  simple  and  powerful  approach.    SILAC  efficiently  reveals  how  inhibitors  or  perturbations  affect   the  dynamic  properties,  as  well  as  cellular  distribution   of   proteins.      Mass   spectrometry   analysis   then   determines   and  quantitates   the   relative   ratios   of   each   isotopic   form   of   every   peptide;   thereby  measuring  any  increase,  decrease  or  consistency  in  the  level  of  each  protein  in  the  complex  following  use  of  treatment.  
  
4.2   Aims  and  experimental  design  The  overall  aim  of  this  chapter  was  to  clarify  further  the  modes  of  action  of  minoxidil  in  human  hair  follicle  dermal  papilla  cells.    Initially,  the  aim  was  to  see  if  minoxidil   would   affect   dermal   papilla   cell   proliferation,   and,   if   so,   whether   this  could   be   inhibited   by   the   opposing   effects   of   the   potassium   channel   blocker,  tolbutamide.      The   second   aim   was   to   investigate   the   mechanisms   of   action   of  minoxidil   by   determining   which   proteins   had   been   altered   via   a   mass  spectrometry-­‐based,  quantitative  proteomics  approach.  To  investigate  the  effect  of  minoxidil  in  cell  proliferation  in  cultured  dermal  papilla   cells,   cells   were   established   from   non-­‐balding   scalp   hair   follicles   of   five  
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individuals  between  the  ages  of  42-­‐60.      The  cells  were  incubated  in  medium  RPMI  1640   (supplemented   with:   10%   fetal   calf   serum,   100   units/ml   penicillin   G,   100  ng/ml  amphotericin  B  and  2  mM  L-­‐glutamate),  containing  0.001%  of  DMSO.    The  latter  was  added  as  the  tolbutamide  had  to  be  dissolved   in  DMSO,  and  the  media  for  all   conditions  were   similarly   supplemented   in  order   to  maintain   consistency.    Streptomycin  was   reported   to   inhibit   the   stimulatory  effect  of  minoxidil   (50  µM)  on  dermal  fibroblast  cell  proliferation;  therefore  it  was  excluded  from  the  culture  conditions  of  this  investigation  (Sanders  et  al.,  1996).      The  concentration  of  minoxidil  selected  for  this  study  was  100  µM,  which  is  within   the   range   of   concentrations   used   in   previous   investigations   that   had  reported  stimulation  with  minoxidil  in  dermal  papilla  cell  proliferation  e.g.  500  µM  by  Kurata  et  al  (1996)  and  1  µM  by  Han  et  al  (2004).    Tolbutamide  was  used  at  1  mM  to  assess  whether  the  channel  blocker  inhibited  any  effect  of  minoxidil.      To   study   the   effect   on   cell   proliferation   several  methods  were   employed,  initially  the  Trypan-­‐Blue  exclusion  technique  was  employed  to  identify  viable  cells  to  perform  manual  viable  cell  counting,  using  a  haemocytometer.     To  validate  the  results   further,   the   protein   in   cell   extracts  was   quantified   using   a   protein   assay.    Finally  an  MTT  cell  proliferation  assay  was  also  performed  similar   to  a   study  by  Han  et  al  (2004).    However,  they  seeded  cells  at  1.5  x  104  cells  per  well  in  96-­‐well  plates  for  5  days  in  the  presence  of  minoxidil,  while  in  this  investigation  the  cells  were  seeded  at  5  x  103  cells  per  well  in  96-­‐well  plates  and  when  they  reached  80%  confluence  the  treatments  were  added  for  48  hours.    The  48  hours  of  exposure  was  decided  upon  in  light  of  the  study  by  Lachgar  et  al  (1998)  in  which  dermal  papilla  cells  incubated  for  48  hours  with  various  concentrations  of  minoxidil  showed  that  
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minoxidil   stimulated   VEGF   expression   (vascular   endothelial   growth   factor)  (Lachgar  et  al.,  1998).      To   investigate   the   effect   of   minoxidil   on   protein   profiles,   dermal   papilla  cells  from  four  individuals  were  used,  the  cells  were  seeded  at  20%  confluence  in  duplicate   in   SILAC   (Stable   Isotopic   Labelling   of   Amino   acids   in   Cell   culture)  
ǡ    Ǯǯ ȋǤǤ      Ȍ 
Ǯǯ ȋǤǤ 13C   labelled  arginine  and   lysine  amino  acids)   form  of   the  amino  acid  supplemented   with   10%   of   dialysed   fetal   calf   serum.      For   cell   labelling   to   be  completed,  the  cells  were  grown  to  80%  confluence,  which  was  approximately  five  population  doublings,   in   the  appropriate   Ǯǯ  ǮǯǤ     Dialysed   fetal  calf   serum  was   then  o   Ǯǯ  ǮǯǤ   
ǮǯͳͲͲρͶͺǤ 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4.3  Materials  and  Methods  
4.3.1  Investigation  into  the  effects  of  potassium  channel  modulators  on  
human  hair  follicle  derived  dermal  papilla  cells  in  vitro  
4.3.1.1  Hair  follicle  dermal  papilla  isolation  The  skin  specimens  were  obtained  as  described  in  section  3.3.1.1,  with  the  exception  of  the  transport  media.     The  medium  used  for  this  procedure  consisted  of   RPMI   1640   (RPMI   supplemented   with:   10%   fetal   calf   serum,   10   units/ml  penicillin/streptomycin,   100   ng/ml   fungizone   and   2mM   L-­‐glutamate)   (Gibco,  Paisley,   UK).      Anagen   hair   follicles  were   dissected   from   the   skin   as   described   in  section   3.3.1.2   (Figure   3.1),   with   the   exception   that   the   entire   procedure   was  carried  out  inside  the  transport  medium.  Once   the   anagen   follicles  were   isolated   the   hair   fibre   and   the   connective  tissue   sheath   (dermal   sheath)   were   gently   disengaged,   using   sterile   needles  (271/2G   tuberculin   syringe).      This   left   the   dermal   papilla   (DP)   intact  within   the  dermal  sheath  (DS)/connective  tissue  sheath  (CTS)  (Figure  4.1b).    The  connective  tissue  sheath  was  then  cut  above  the  bulb,  with  the  dermal  papilla  remaining  intact  in   the  bulb   (Figure  4.1d).     An   incision  was  made  along   the  bulb  allowing   for   the  dermal   papilla   to   be   exposed   (Figure   4.1e)   and   subsequently   detached   from   the  connective   tissue   sheath   (Figure  4.1f).     The   isolated  dermal  papilla   (Figure  4.1g)  was   then   placed   into   tissue   culture   dishes   (35mm),   which   had   been   pre-­‐coated  with  fetal  calf  serum  (FCS)  creating  a  sticky  surface  that  would  assist  adhesion  of  the   DP   to   the   surface.      This  was   achieved   by   overnight   incubation   of   the   dishes  with  1  ml  of  FCS  at  37oC.     With  the  tip  of     a  271/2G  needle  the  papilla  was   fixed  onto  the  35mm  dish,  containing  2  ml  RPMI  growth  medium  (RPMI  growth  medium  comprising:   FCS   20%,   10   units/ml   penicillin/streptomycin,   2.5   ng/ml   fungizone  
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(amphotericin  B)  and  2mM  L-­‐glutamate)  (Gibco,  Paisley,  UK),  at  an  average  of  four  
ǤǮǯreby  fixing  them   further   as  well   as   breaking   the   capsule,   this   aided   better   cell   explantation  (Figure   4.1h).      The   dishes   were   left   undisturbed   for   a   week.      Once   cell  multiplication  was  evident  (Figure  4.2),  the  medium  was  changed  every  two  days.    Cells  were   incubated   in   a   Heraeus   incubator   in   a   humid   atmosphere   of   5%  CO2,  95%  air  at  37oC.                                              
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Figure  4.1    Isolation  of  hair  follicle  dermal  papilla  by  micro-­dissection  
(a)  The  anagen  hair   follicle  was  micro-­‐dissected   from  scalp   skin,   as  described   in  Figure   2.3,   Scale   Bar   =   190   µm.   (b)   The   connective   tissue   sheath   and   dermal  papilla,   were   isolated   (c)   by   the   separation   of   the   epithelial   components   of   the  follicle,  Scale  Bar  =  200  µm  (d)  The  connective  tissue  sheath  containing  the  intact  dermal  papilla  was  cut  above  the  bulb  level,  with  great  dexterity,  Scale  Bar  =  200  µm.      An   incision   along   the   side   of   the   bulb   was   made   (e)   and   the   remaining  connective   tissue   sheath  was   carefully  peeled  away,   leaving   the  DP  exposed.      (f)  The  connection  between  the  DP  and  remnants  of  the  sheath  were  then  completely  severed  and  any  excess  connective  tissue  sheath  removed,  (g)  leaving  a  completely  isolated   DP,   Scale   Bar   =   22.4   µm.   (h)   The   isolated   dermal   papilla   was   then  transferred   into   a   tissue   culture   dish   and   scored   to   break   the   capsule   and   aid  better   adhesion,   Scale   Bar   =   133   µm.   Photographed   on   dissecting   microscope  (Leica   MZ8,   Leica,   Germany)   using   a   Nikon   Coolpix4500   (Nikon   E4500)   digital  camera.      
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Figure  4.2    Dermal  papilla  primary  cultures    Early  dermal  papilla  fibroblast  explantation  outgrowth  began  to  appear  within  two  weeks  after  the  incubation  of  the  primary  culture,  Scale  Bar  =  50  µm.        
    
4.3.1.2  Maintenance  of  cell  cultures  Rectangular   canted-­‐neck   plastic   cell   culture   flasks   were   used   to   culture  cells;  these  were  sealed  with  vented  caps  (Corning  Life  Sciences,  UK).    Three  sizes  of  flask,  with  surface  areas  25  cm2,  75  cm2  and  225  cm2,  were  used  depending  on  the   number   of   cells.      DP   cell   cultures   had   the   medium   changed   every   2   days.    Medium   consisted   of   RPMI   1640   with   10%   FCS,   10   units/ml  penicillin/streptomycin  (Gibco,  UK),  25  ng/ml  fungizone  (amphotericin  B),  2mM  L-­‐glutamate  (Biowest,  UK)  and  0.001%  dimethyl    sulfoxide  (DMSO)  (Sigma).    
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4.3.1.3  Passaging  of  cell  cultures  When   cell   cultures   reached   around   80%   confluence,   passaging   was  performed.    The  medium  was  removed  from  the  flasks,  and  the  cells  were  washed  thrice  in  a  suitable  volume  of  sterile  PBS,  to  ensure  the  removal  of  any  trace  serum  that   could   possibly   inactivate   the   trypsin/EDTA.      A   suitable   volume   of  trypsin/EDTA   (500   µl   in  25   cm2,   1ml   in   75   cm2   and   3ml   in  225   cm2   flasks)  was  then  added  to  the  cell  culture  flask  and  placed  in  an  incubator  at  37oC  with  5%  CO2  and  95%  O2  until   the  cells  had  detached,   typically  after  a  minute.     Following  this  the  flask  was  positioned  under  an  inverted  microscope  (Olympus,  CKX41,  Olympus  Optical  Co  Ltd,  UK)  and  lightly  tapped  until  all  cells  had  detached  from  the  surface  of   the   flask.     To   inactivate  the  trypsin/EDTA,  growth  medium  (containing  serum)  was   added   to   the   cell   culture   flask.      The   cells  were   transferred   to   a   larger   flask  (1:3)   and   placed   back   in   the   incubator   for   about   24   hours,   allowing   the   cells   to  attach  to  the  surface  of  the  culture  flask.    
4.3.1.4  Freezing  and  thawing  of  cell  cultures  Confluent   cells   that   needed   to   be   frozen   down   for   storage   and   later   use,  were   trypsinised   (as  described   in   section  4.3.1.3)  and  spun  down   in  a   centrifuge  (Sanyo  Harrier  15/80)  at  1200  rpm  (290  g)  for  about  5  minutes.    The  supernatant  was   then   carefully   removed   to   avoid   disruption   of   the   cell   pellets,   which   were  resuspended   in   cell   freezing   solution   consisting   of   90%   FCS   and   10%   dimethyl  sulphoxide  (DMSO,  Sigma,  UK),  which  acts  as  a  cryoprotectant.    Approximately  1  x  106  cells  were  aliquoted   into  1  ml  cryovials  (Nunc,  UK)   from  the  cell  suspension,  and  placed  in  an  isopropanol  bath,  at  -­‐80oC,  overnight  before  being  transferred  to  liquid  nitrogen  for  long-­‐term  storage.      
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Thawing  of   the  cells  required  the  removal  of   the  cryovials   from  the   liquid  nitrogen,  and  their  placement  into  a  water  bath  at  37.5oC.    Near  the  completion  of  the  thawing  the  contents  of  the  cryovial  were  added  to  a  T75  culture  flask,  with  10  ml   growth  medium.     For   cells   to   attach   to   the   surface   of   the   flask,   the   flask  was  placed  in  the  incubator  for  24  hours.    The  medium  was  changed  every  2  days.        
4.3.1.5  Cell  counting  using  the  haemocytometer  method  The   Trypan-­‐Blue   technique   was   employed   to   perform  manual   viable   cell  counting   by   observation   in   triplicate.      Trypan-­‐Blue   technique   is  most   commonly  used  to  distinguish  viable  from  nonviable  cells.    Viable  cells  prevent  uptake  of  the  dye,  whereas  nonviable  cells  absorb  the  dye  and  become  blue.        Cells  were  detached  from  the  culture  flasks  as  described  in  section  4.3.1.3.    The   cell   suspension   was   then   transferred   to   a   25   ml   universal   tube   and  mixed  meticulously  for  equal  cell  distribution.    The  cell  suspension  (100  µl)  was  added  to  a  1.5  ml  eppendorf  tube  containing  100µl  of  0.4%  Trypan-­‐Blue  in  PBS;  this  solution  was  pipetted  repetitively  to  ensure  tǤͳͲɊof   Trypan   Blue   stained   cell   suspension   was   transferred   into   each   of   the   two  chambers  of   a   coverslipped   Improved  Neubauer  Counting  Chamber   (Gallencamp,  UK),  with  care  not  to  overfill  the  chamber  (Figure  4.3a).  The  viable  (unstained)  cells  in  each  of  the  four  large  corner  squares  and  the  centre   square   (Figure   4.3c)   (viewed  under   x20  magnification)   (Olympus,   CKX41,  Olympus   Optical   Co   Ltd,   UK)   were   counted   with   an   average   number   being  calculated.      The   cell   numbers   were   counted   three   times,   and   to   obtain   the   total  yield  of  cells,  the  average  value  calculated  was  multiplied  by  104  (volume  factor  for  chamber)  giving  the  total  number  of  cells  per  ml  of  cell  suspension  and  multiplied  
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by   the   dilution   factor   (x2)   and   total   medium   used   to   resuspend   the   cells   after  trypsinisation.    The  average  cell  count  was  calculated  with  +  standard  error  of  the  mean  (SEM)  based  on  the  triplicate  counts.          
  
Figure  4.3    The  principle  of  haemocytometer    Diagrams   highlighting   the   principle   of   haemocytometry.     Number   of   cells   per  ml  calculated=   Average   cell   count   in   each   of   the   four   large   corner   squares   and   the  centre  square  (c)  x  104  x  dilution  factor  (The  cell  suspension  was  mixed  in  1:1  ratio  with   Trypan   blue,   therefore   dilution   factor   is   2)   (Adapted   and   modified   from  Experimental  Biosciences).      
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4.3.1.6  Cell  seeding  for  growth  curve  construction  Dermal  papilla  cells   from  five   individuals  between  the  ages  of  42-­‐60  were  used   to   assess   the   effect   of   potassium   channel   regulators   on   growth   of   dermal  papilla   cells   in   culture.      The   growth   media   used   consisted   of   RPMI   1640  supplemented  with  10units/ml  penicillin  G  (sigma),  10%  FCS,  25  ng/ml  fungizone  (amphotericin  B),  2mM  L-­‐glutamate,  and  0.001%    DMSO  (Biowest,  UK).     The  cells  were  cultured  in  the  presence  of  either:  vehicle  control  as  above,     minoxidil  (100  µM);  tolbutamide  (1  mM);  or  a  combination  of  both  minoxidil  (100  µM)  and  tolbutamide  (1  mM).           The   cells  were   counted  as  described   in  Section  4.3.1.5,   and   the  volume  of  cell   suspension   containing  1  x  104   cells  was  determined  and  seeded   into  12-­‐well  plates.      The   final   volume   in   each   well   was   brought   up   to   1   ml   using   growth  medium.     Overall,  21  wells  were   seeded   for  each  condition,   from  each   sample   to  perform   7   counts   in   triplicate   over   a   period   of   15   days.      The   cell   counting   was  performed  on  days  3,  5,  7,  9,  11,  13  and  15.    The  medium  was  changed  every  two  days  throughout  the  experiment.    Cells  were  incubated  in  a  Heraeus  incubator  in  a  humid  atmosphere  of  5%  CO2,  95%  air  at  37ºC.    Using  Microsoft  Excel  (Microsoft  Corporation,  Ca.,  USA)  the  growth  curves  
Ǯǯ-­‐Ǯǯ-­‐axis.      The  data  was  analysed  with   the  ANOVA   test  using  SPSS   statistical   analysis  program   (SPSS   Inc.,  Chicago,  Illinois).    All  cells  used  for  proliferation  were  from  the  fourth  passage.              
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4.3.1.7  Protein  extraction  of  dermal  papilla  cells  at  completion  of  cell  
counting  study  Cell  suspensions  in  all  conditions  were  retained  at  the  completion  of  the  cell  counting   study,   at   day   15.      Across   the   five   samples   the   same   conditions   were  pooled   together  and  protein  was  extracted   from   these   cells   to  perform  a  protein  assay.    A  comparison  could  then  be  drawn  between  the  cell  counting  and  resultant  protein  values.      Each  cell  suspension  was  transferred  to  a  1.5  ml  eppendorf  tube.    This  was  centrifuged   at   1,200   rpm   (290   g)   (Sanyo   Harrier   15/80)   for   the   duration   of   7  minutes.    When  this  process  ended  the  supernatant  was  disposed  of  and  the  pellet  was  resuspended   in  100µl  of  sample  buffer  (Glycerol  (BDH  Lab  Supplies)  2.5  ml;  ethylenedaiminetetraacetic  acid  (EDTA)  (Sigma)  0.185  g;  sodium  dodecyl  sulphate  (SDS)   (Sigma)   1.5   g;   Tris   (Sigma)   0.19   g;   25  ml   distilled  water).      This  was   then  transferred   to   a   0.5   ml   eppendorf   tube   with   protease   inhibitor   cocktail   (1:20)  (Sigma).     Using  a  1  ml  syringe,  the  cell  suspension  was  triturated  several  times  to  ensure  the  protease  inhibitor  cocktail  was  thoroughly  dispersed.    The  sample  was  put  on  to  ice  for  three  hours,  at  which  point  the  cell  suspension  was  vortexed  at  30  minute   intervals   for  10  seconds  at  a   time.     After   three  hours  the  cell  extract  was  centrifuged   for   three   minutes,   at   13,000   rpm   (13,000   g)   and   the   resultant  supernatant,  which   contained   the   solubilised  protein,  was   transferred   to   a   clean  eppendorf  and  frozen  at  -­‐800C,  until  further  use.        
4.3.1.8  Quantification  of  protein  in  cell  extracts  (Bradford  Assay)  
ȋͳȌȋͷɊȌto  the  appropriate  well  on  a  96  well-­‐Ǥ ǯȋʹͷɊȌ
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ȋʹͲͲɊȌȋͳȌǤ ʹͲminutes,  using  a  plate  shaker;  it  was  then  placed  into  a  plate  reader  (Dynex  MRX)  that  measured  each  sample  absorbance  at  750  nm.    The  calibration  curve  and  the  noted   absorbance   of   the   protein   samples   were   used   to   ascertain   the   protein  concentration  of  cell  extract  samples.        
  
4.3.1.9  MTT,  (3-­(4,  5-­dimethylthiazol-­2-­yl)-­2,5-­diphenyltetrazolium  
bromide)  cell  proliferation  assay.    The  MTT  assay   is  a  quantitative  colorimetric   technique  used  to  determine  cell   proliferation   or   cell   survival.      When   cells   are   exposed   to   the   dye,   live  mitochondria  cleave  MTT  (tetrazolium  salt)  turning  the  dye  from  pale  yellow  salt  to  a  dark  formazon  product.    Dead  cells  are  unable  to  cleave  the  MTT  therefore  less  of   the   blue   colour   signifies   less   living   cells.      The   absorbance   of   the   solution   is  measured  with  a  plate  reader  at  a  wavelength  of  570  nm.    The  absorbance  value  is  directly  proportional  to  the  number  of  living  cells  (Mossman,  1983).                The   cells  were   counted  as  described   in  Section  4.3.1.5,   and   the  volume  of  cell   suspension   containing   5   x   103   cells  was   determined.      96-­‐well   flat-­‐bottomed  tissue  culture  plates  were  used  to  seed  the  cells  at  the  above  density  and  the  final  volume   in   each   well   was   brought   up   to   0.1   ml   using   growth   medium.      The  experiment  was  performed  three  times  with  12  wells  seeded  from  each  sample  for  every  condition.    The  culture  conditions  and  media  used  were  the  same  as  stated  in  Section  4.3.1.5.    After  15  days  in  culture  the  MTT  assay  was  performed,  and  0.01  ml  of  MTT   (5mg/ml)  was   added   to   all   wells.      The   plates  were   then   incubated   in   a  humidified  atmosphere  of  370C,  for  4  hours.    During  this  time  formazan  crystal  was  able   to   form  at   the  base  of   the  wells.     Following   incubation   the   spent  media  was  
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removed  along  with  the  suspension  of  cultured  cells.    To  ensure  that  minimal  or  no  lighting   disturbed   the   next   processes,   200   µl   of   DMSO   was   added   to   each   well,  thoroughly  mixed   to  dissolve   the  dark  blue   crystals  and   the  plates  were   covered  with  foil  and  left  undistributed  for  15  minutes  at  room  temperature.    This  allowed  for   the   formazon   to  precipitate  and   for  air  bubbles   to  dissolve.     The  plates  were  then   read   using   a   plate   analyser  with   a   test  wavelength   of   570  nm.     The   results  were  charted  and  the  percentage  viability  was  calculated.                                                                  Mean  Absorbance  of  Sample  %  Viability=-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐    x  100                                                                               Mean  Absorbance  of  Control     The  data  was  analysed  using  the  ANOVA  test  using  SPSS  statistical  analysis  program  (SPSS  Inc.,  Chicago,  Illinois).     All  cells  used  for  the  MTT  assay  were  from  the  fourth  passage.      
  
4.3.1.10  Statistical  analysis  and  interpretation  methodology  Statistical   analysis   was   performed   using   the   SPSS   Version   16   software  package.      Statistical   significance   for   these   tests  was   set   to   a   probability   value   of  P<0.05*  (P<  0.01**,  P<0.001***)  statistical  significance.    The  software  runs  tests  to  check   whether   the   data   is   parametric   (normally   distributed)   or   non-­‐parametric  (not   normally   distributed);   i.e.   the   histogram   plot;   probability-­‐probability   (P-­‐P)  plot;  and  the  Kolmogorov-­‐Smirnov  test.    If  two  sets  of  these  tests  are  normal  then  it  can   be   assumed   that   the   data   is   parametric,   at  which  point   Analysis   of   Variance  (ANOVA)   can   be   applied.      However,   if   two   of   these   tests   are   not   normally  distributed  then  the  non-­‐parametric  Kruskal-­‐Wallis  test  is  applied.      The  processes  that  these  tests  run  on  are  clarified  below:  
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Histogram  plot:      The  histogram  plots   the  values  of  observations  on  the  horizontal  axis,  and  the  frequency  with  which  each  value  occurs  in  the  data  set  on  the  vertical  axis.  Its  advantage  is  that  it  not  only  clearly  shows  the  largest  and  smallest  categories  but  gives  an  immediate  impression  of  the  distribution  of  the  data.    In  fact,  a  histogram  is  a  representation  of  a  frequency  distribution  (Field  and  Hole,  2003).  
Probability-­Probability  (P-­P)  plot:  The   P-­‐P   plot   is   used   to   see   whether   a   given   set   of   data   follows   some  specified   distribution.      It   should   be   approximately   linear   if   the   specified  distribution  is  the  correct  model  (Field,  2009).  






4.3.2  Investigating  the  mechanisms  of  action  of  minoxidil  via  a  mass  
spectrometry  (MS)-­based  quantitative  proteomics  approach  Figure   4.4   exhibits   the   mass   spectrometry   quantitative   proteomics  approach,  using  SILAC  (Stable  Isotopic  Labelling  of  Amino  acids  in  Cell  culture),  in  its  entirety.     The  processes   involved  have  been  visually  simplified.     The   following  section  discusses  each  step  in  detail.  
4.3.2.1  Cell  preparation    Dermal   papilla   cells   were   established   from   four   individuals   for   this  experiment   and   were   seeded   at   5   x   104   cells   in   duplicate   in   T25   (surface   area  25cm2)  rectangular  canted-­‐neck  flasks.    One  ǮǯSILAC   media   (DMEM-­‐containing   carbon-­‐13   labelled   arginine   and   lysine   amino  
 ȋ͸͸ȌȌǡ        Ǯǯ   ȋ-­‐containing   unlabelled   arginine   and   lysine   amino   acids   (R0K0))   (Dundee   Cell  Products  Ltd,  Dundee),  both  media  were  supplemented  with  10%  of  dialysed  fetal  calf  serum  so  that  unlabelled  lysine  and  arginine  had  been  excluded.    Cell  cultures  had   their   media   changed   every   3   days.      When   the   cells   had   grown   to   80%  confluence  the  cells  were  washed  five  times  with  PBS,  the  new  media  placed  into  
ǤǮǯ
ͳͲͲρͶͺǤǮǯcontrol.    At  the  completion  of  the  48  hour  period,  the  media  was  carefully  removed  from  the  flasks  and  immediately  replaced  by  1.5  ml  of  PBS.    The  cells  were  gently  scraped  from  the  base  of   the   flasks   into  the  PBS,  using  a  cell  scraper.     The   flasks  were  gently  agitated  to  ensure  that  the  cell  suspension  was  thoroughly  mixed  and  the  cells  were  rapidly  placed  into  a  1.5  ml  eppendorf  tube.    This  was  centrifuged  at    
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Figure  4.4    Quantitative  proteomics  approach,  using  SILAC  Cells   were   cultured   in   SILAC     Ǯǯ  Ǯǯ   
 Ǥ      Ǯǯ      ͳͲͲρ





1,200   rpm   (290   g)   (Sanyo   Harrier   15/80)   for   7  minutes.      The   supernatant  was  disposed  of  and  all  pellets  were  stored  at   -­‐80oC,  until  protein  extraction  could  be  performed.  
  
4.3.2.2  Protein  extraction  and  quantification  The   pellets   were   removed   from   -­‐80oC   and   placed   on   ice   for   protein  extraction   to  be  performed.     The  pellets  were  dissolved   in  50µl  of   sample  buffer  (Glycerol   (BDH   Lab   Supplies)   2.5   ml;   ethylenedaiminetetraacetic   acid   (EDTA)  (Sigma)  0.185  g;  sodium  dodecyl  sulphate  (SDS)  (Sigma)  1.5  g;  Tris  (Sigma)  0.19  g;  25  ml  distilled  water)  added  with  protease   inhibitor   cocktail   (1:20)   (Sigma)  and  protein   extraction   was   carried   out   as   described   in   Section   4.3.1.7.      Protein  quantification  was  carried  out  as  described   in  Section  4.3.1.8,  using  the  Bradford  Assay.    
  
4.3.2.3  Reduction  and  alkylation    Reduction  and  alkylation  was  a  necessary  procedure  to  unfold  the  proteins  for   gel   electrophoresis   and   separate   them   according   to   their   molecular   weight.    
ͶǮǯȋͶͲρȌǮǯ
ȋͶͲρȌ  ȋ 	 ͶǤͶȌ   ȋȌ   ͳͲɊ 50mM   dithiothreitol   (DTT)   for   20  minutes   at   60°C.      Once   reduced,   the   proteins  
ͳͲɊͳͲͲȋȌʹͲ  temperature  in  the  dark.    The  solution  was  then  lyophilised  (dried)  (EZ-­‐2  personal  evaporator,  GENEVAC);  this  procedure  allowed  for  the  protein  sample  (Total:  320  µg)   to   be   stored   in   a   stable   form,   at   -­‐ͺͲǏǡ     from  the  solution.  
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4.3.2.4  Protein  separation  using  one-­dimensional  sodium  dodecyl  sulphate-­
polyacrylamide  gel  electrophoresis  (SDS-­PAGE)  of  proteins  The   lower  separating/running  gel  was  prepared  using  the  materials   listed  in  (see  Appendix  2),  and  was  subsequently  poured  into  a  gel  cassette  (Invitrogen)  1  mm  above  the  first  division  line  (see  Figure  4.5).     Iso-­‐butanol  (1  ml)  was  added  on  top  of  the  acrylamide  running  gel  to  overlay  the  lower  separating  gel  to  prevent  drying  and  oxidation  of  the  gel  surface.    The  lower  separating  gel  polymerised  after  about   60   minutes   at   room   temperature.      The   upper   stacking   gel   was   prepared,  whilst  the    
  
Figure  4.5    An  illustration  of  an  apparatus  used  for  SDS-­PAGE  (Adapted  and  modified  from  the  School  of  Chemistry  and  Biochemistry,  Georgia  Institute  of  Technology,  with  permission  of  author)  
  gel  was  polymerising,  with  the  list  of  materials  in  Appendix  2.    After  60  minutes  the  iso-­‐butanol   was   discarded   and   the   top   of   the   acrylamide   was   then   rinsed   with  water  and  the  upper  stacking  gel  was  added  to  the  cassette.     The  comb  was  then  
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placed  into  the  gel  whilst  the  gel  was  setting;  this  was  done  with  care  to  avoid  air  bubbles  forming  in  the  gel.    This  was  then  left  undisturbed  for  about  30  minutes  to  polymerise.      While   the   upper   stacking   gel   was   polymerising,   the   protein   extract   (see  4.3.2.3)  was  readied  for  electrophoresis.    For  this  process  85  µl  sample  loading  dye  (outlined   in  Appendix   2)  was   added   to   re-­‐dissolve   the   protein   sample   (320   µg),  and   was   subsequently   boiled   for   3   minutes   at   80ºC.      The   sample   was   then  centrifuged  for  1  minute,  at  12,000  rpm  (Sanyo  Harrier  15/80).    Following  this,  the  electrophoresis   chamber  was   assembled   and   filled  midway  with   electrophoresis  buffer   (See   Appendix   2).      Once   the   gel   cassette   was   added   to   the   chamber,   the  protein   samples  were   loaded   into   the   correct  well  on   the  gel,   c.  40  µg  of  protein  was  loaded  per  lane.    Next  the  electrophoresis  chamber  was  sealed  and  run  at  80  V  for  20  minutes,  followed  by  a  further  70  minutes  run  at  150V.    The  gels  were  then  stained  with  Coomassie  Blue  (R-­‐250)  for  2  hours  on  a  shaker,  and  then  destained  with  HPLC  grade  water  overnight.        
4.3.2.5  Peptide  generation  using   in-­gel  digestion  of  Coomassie  Blue  stained  
proteins  using  trypsin    
 ǯ       information   is   at   the   core   of   its   utility   for   protein   and   peptide   analysis.      On   the  whole,  the  sensitivity  for  protein  analysis  is  lower  than  that  for  peptides,  as  protein  size  is  larger.    Proteins  hit  the  detector  with  lower  velocity  than  peptides  resulting  in   less   secondary   electron   emission.      Furthermore,   peptides   are   ionized   more  readily  than  intact  proteins.    Thus,  it  is  preferable  to  digest  proteins  into  peptides  using   specific   proteases   for   mass   spectrometry   to   be   conducted.      The   most  
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Figure  4.6    Illustration  of  excising  bands  procedure  from  SDS  gel  for  in-­gel  
digestion    
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Acetonitrile   (100  µl;  10%)   in  HPLC  water   (Fisher  Scientific)  was  added   to  the  gel  pieces  and  left  for  15  minutes.    This  was  a  dehydration  step  and  during  this  time  the  gel  pieces  shrank,  becoming  opaque.    The  supernatant  was  then  removed,  ammonium  bicarbonate  (20  µl;  25mM)  (Fluka)  was  added  to  the  gel  pieces  and  left  for  a  further  15  minutes  to  ensure  rehydration.     These  steps  were  repeated  twice  and   the   gel   pieces   were   dehydrated   for   15   minutes   whilst   acetonitrile   (100   µl;  10%)  was  added.     The  supernatant  was  removed  and  a   further  50  µl  acetonitrile  was  added,  this  was  then  left  for  15  minutes.    All  liquid  was  decanted,  and  the  gel  pieces  were  allowed   to  dry   in  a   tube  at  room  temperature,   for  approximately  30  minutes.     The  dry  gel  pieces  were  then  resuspended  in  10ng/µl  trypsin  in  25  mM  ammonium  bicarbonate.     Depending  on  the  size  of  the  gel  pieces  either  10  µl  (for  small  gel  pieces)  or  20  µl  (for  larger  gel  pieces)  was  used.     For  the  next  24  hours  the  gel  was  digested  at  28 C.    Upon  completion  of  digestion,  most  of  the  buffer  had  evaporated   and   was   affixed   to   the   lid;   the   samples   were   then   spun   down   in   a  centrifuge  (Sanyo  Harrier  15/80)  at  1200  rpm  (290  g)  for  about  5  minutes.    
4.3.2.5.1  Peptide  extraction  from  gel  slices  For  each  in-­‐gel  digest,  the  incubation  liquid  was  decanted  from  around  the  gel  to  a  new  0.5  ml  eppendorf  tube  and  50  µl  of  100%  acetonitrile  was  added  to  the  gel   slice.      This  was   then   vortexed   and   left   for   15  minutes   at   room   temperature  before   centrifugation  at  1200   rpm   (Sanyo  Harrier  15/80).     The   supernatant  was  transferred   to   the   tube   containing   the   incubation   liquid   and   5   µl   of   25   mM  ammonium   bicarbonate   was   added   to   the   gel   and   left   for   10   minutes   at   room  temperature.    After  this  process  had  been  repeated,  50  µl  of  100%  acetonitrile  was  added  to  the  gel  slice,  vortexed  and  left  for  15  minutes  at  room  temperature.    This  
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was  again  centrifuged  and  transferred  to  the  0.5  ml  eppendorf  tube.    The  extracts  from  all  20  samples  were  lyophilised  separately  and  this  alongside  the  residual  gel  was  stored  at  -­‐80oC.      
  
4.3.2.6   Mass   spectrometry   using   Matrix-­Assisted   Laser   Desorption  
Ionization-­(MALDI)  Matrix  assisted  laser  desorption  ionization  mass  spectrometry  (MALDI  MS)  (Karas  et  al.,  1987)  is  one  of  the  main  techniques  used  in  proteomics.    The  diagram  below  outlines  the  main  components  of  the  MALDI  MS  process.      
   In  this  process  the  analyte  is  mixed  with  an  organic  compound,  acting  as  a  matrix,   which   has   the   same   wavelength   of   absorption   as   that   of   the   MS   laser.    When  mixed  with  analyte,  this  results  in  the  formation  of  a  crystalline  layer  on  the  target  plate  (Gobom  et  alǤǡʹͲͲͳȌǤ Ƚ-­‐cyano-­‐4-­‐hydroxycinnamic   acid   (CHCA).      The   matrix   has   an   important   role   in  protecting  biomolecules  from  being  destroyed  by  the  beam  of  the  direct  laser.    The  
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matrix  also  facilitates  absorption  of  the  laser  energy,  heating  of  the  matrix/analyte  crystals  and  allowing  vaporisation  and  ionisation  to  occur.      A   pulse   of   laser   energy   is   fired   at   the   dried   analyte/matrix   mixture   in   a  vacuum,  creating  a  plume  of  ions  (Figure  4.7).    By  applying  a  voltage  of  25  kV  to  an  extraction   lens   in  the  source,   the   ions  are  accelerated   into  a   field-­‐free   flight   tube,  which   separates   the   ions   on   the   basis   of   mass-­‐to-­‐charge.      An   MS   spectrum   is  generated   by  measuring   the   time   it   takes   for   ions   of   different  mass-­‐to-­‐charge   to  reach  the  detector  at  the  end  of  the  flight  tube.      
Figure  4.7    Analyte  ionization    The  cartoon  of  laser  beam  is  adapted  and  modified  from  the  National  High  Magnetic  Field  Laboratory  (http://www.magnet.fsu.edu/education/tutorials/tools/ionization_maldi.html),  with  permission  of  author.                 
   True  to   its  name  tandem  mass  spectrometry  (MS/MS)   involves  two  stages  of  mass  analysis.    The  first  stage  involves  separation  of  the  parent  ions  in  MS  mode  as  described  above.  An   ion  gate   is   then  employed  to  allow  only  the  parent   ion  of  interest   to   continue   along   the   flight   path   and  all   the   others   are   deflected.   In   the  
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second  stage  the  selected  parent  ion  is  fragmented  by  collision-­‐activated  (CAD)  or  collision-­‐induced   decomposition   (CID)   in   the   second   part   of   the   flight   tube.   The  parent   ions   are   fragmented   along   their   peptide   backbone,   this   results   in   the  production  of  signature  daughter  or  product  ions,  with  masses  that  correspond  to  the  amino  acid  from  which  they  originate  (Roepstorff  and  Fohlman,  1984).            Depending   on   the   type   of   trypsin-­‐digested   sample,   protein   identification  can   be   achieved   using   MS   data   (parent   ions   only)   also   known   as   peptide   mass  fingerprinting   (PMF),   or  MS/MS   data   (parent   and   fragment   ions)   also   known   as  peptide   fragment   fingerprinting  (PFF)  to  search  a  database  of  all  known  proteins  (for   example,   Swissprot)   using   a   search   engine   such   as   Mascot  (http://www.matrixscience.com/).      
4.3.2.6.1  Preparation  of  analyte  and  matrix  on  target  plate  As   the   samples   are   complex   heterogeneous   mixtures   following   trypsin  digestion,   peptide   separation  was   achieved   using   nano-­‐High  Performance   Liquid  Chromatography  (nano-­‐HPLC)  and  fraction  collection  system  on  to  a  MALDI  target  prior  to  analysis  by  mass  spectrometry.        
The  following  materials  were  prepared  for  the  nano-­HPLC  system:  
(a)  Matrix  
Ƚ-­‐Cyano-­‐4-­‐hydroxycinnamic  acid  (CHCA)  was  used  as  the  matrix  of  choice.  A   stock   solution   was   prepared   by   solubilising   CHCA   in   1ml   of   30%   (v/v)  acetonitrile  (CH3CN)  (Fisher)  with  0.1%  (v/v)  TFA  (Trifluoroacetic  acid,  CF3CO2H,  Fluka).     CHCA  is  solubilised  through  vortexing  for  2  minutes  and  sonicated  for  30  minutes  to  generate  a  saturated  solution.      
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(b)  Working  solution  preparation  From   the   stock   solution   a   working   solution   was   prepared.      CHCA   stock  
ȋͳʹͲɊȌͳǤͲͷ6  ml  of  ethanol:acetone  (2:1  ratio),  followed  by  
ͳʹɊͳͲͲȋ4)3PO4  ͳʹɊͳͲΨtrifluoroacetic   acid   (TFA),   with   vortexing   between   each   added   component   and  placed  in  the  ProteineerFC  fraction  collector  (Bruker  Daltonic  GmbH).    
(c)  Preparing  a  sample  The  lyophilised  in-­‐gel  digested  peptides  were  re-­‐dissolved  in  6.5  µl  of  10%  acetonitrile  (CH3CN)  (Fisher),  vortexed  for  30  seconds,  and  then  centrifuged  for  1  minute.    The  sample  was  transferred  with  care  to  a  HPLC  vial  using  a  pipette  with  a  gel-­‐loading  tip  to  avoid  formation  of  any  bubbles;  the  sample  was  then  positioned  into  the  nano-­‐HPLC  system  (Figure  4.8a).        
The  Procedure  for  nano-­HPLC  separated  peptides:  The  prepared  sample  was  placed   into   the  auto   sampler   in   the  nano-­‐HPLC  system  (Figure  4.8b).      The  autosampler  needle   injects   the   sample  onto  a   column  where   peptide   separation   takes   place;   this   is  done   using   an   LC  Packing  UltiMate  3000   capillary   high-­‐performance   liquid   chromatography   system   (Dionex,  Camberley,  Surrey,  UK).      A   sample   loop   injected   the   sample   into   the   LC   system  onto   a   pre-­‐column  (C18ǡ ͳͲͲ&ǡ͵ͲͲɊ inner  diameter  ͷ ǡͷɊparticle   size)   (LC  Packings,   Sunnyvale,   CA).      The   sample   was   then   washed   at   a   flow   rate   of  300nl/min,  for  3.5  minutes  with  carrier  solvent  (carrier  solvent,  0.05%  TFA).    The  sample   was   switched   onto   another   column   (C18ǡ ͳͲͲ & ǡ ͹ͷɊ inner  diameter   x   15cm   ǡ ͵Ɋparticle   size)   (LC  Packings),   equilibrated  with   2%  CHCN  with  0.05%  TFA.        
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Peptides   were   eluted   from   the   column,   passing   through   the   UV   detector,  which  produces  UV  profile  at  215  nm  (detects  peptide  bonds)  and  280  nm  (detects  aromatic  amino  acids)  and  then  on  to  the  fraction  collector.                The   LC-­‐MALDI   fraction   collector   (Proteineer   fc   (fraction   collector),   Bruker  Daltonik   Bremen,   Germany)   (Figure   4.8c)   enables   automatic   liquid   handling   for  MALDI  preparation  of  a  sample.    The  fraction  collector  gathers  samples  separated  on   nano-­‐HPLC   and   deposits   discrete   fractions   of   the   eluted   peptides   on   MALDI  targets  (MTP  800/384  AnchorChipTM)  (Bruker  Daltonics,  Bremen,  Germany).    Each  fraction   comprised   of   75nl   of   sample,   collected   every   15   second,   co-­‐eluted  with  















Figure  4.8    A  guide  to  the  MALDI  target  preparation  process  using  the  nano-­
HPLC  system    









4.3.2.6.2  MALDI  mass  spectrometry   Mass   spectrometric   analysis   was   carried   out   using   a   MALDI-­‐TOF/TOF  UltraFlex  II  instrument  (Bruker  Daltonics,  Bremen,  Germany)  (Figure  4.9);  this  was  done   using   reflector   positive   ion   mode.      Peptides   were   screened   using   fully  automated   analysis,   firing   400   laser   shots   per   fraction   (mass   range   of   700-­‐4000Da).      A   non-­‐redundant   peptide   list   was   compiled   from   spectra   of   the   384  fractions   and   data-­‐dependent  MS/MS  of   each  peptide  was   generated   using   1500  laser  shots  to  acquire  each  spectrum.  
  












Figure  4.9    Significant  components  in  the  matrix-­assisted  laser  desorption  






















4.3.1    Investigation  into  the  effects  of  minoxidil  and  tolbutamide  on  human  
scalp  hair  follicle  derived  dermal  papilla  cells  in  vitro  Cultured   dermal   papilla   cells   from   5   individuals   aged   42-­‐60   were   used   to  investigate  the  effects  of  minoxidil,  tolbutamide,  and  the  combined  effect  of  minoxidil  and   tolbutamide   on   cell   proliferation   by   counting   cells   using   the   haemocytometer  method,   protein   quantification,   and  MTT   assay.      The   dermal   papilla   cells   in   culture  gradually  increased  in  number,  exhibited  a  lean  kite-­‐like  multipolar  shape  and  formed  small  clumps  (Figure  4.10);  when  confluent  they  formed  packed,  parallel  arrays.  To   construct   the   growth   curve,   dermal   papilla   cells   were   used   from   five  individuals,   and   cell   counting   was   performed   in   triplicate   on   these   cells   for   each  condition,  over  a  period  of  15  days.    The  average  cell  count  was  used  for  all  conditions  to   construct   the   growth   curve.      Cells   grown  under   all   conditions   exhibited   a   similar  pattern  of  growth.    They  grew  rapidly  from  day  3  to  7  before  slowing  and  plateauing  from  day   11.      The  maximum   rate   of   cell   doubling   time   for   all   conditions  during   the  experimental  phase  was  48  hours  (Figure  4.11).  When  cell  proliferation  between  conditions  were  statistically  compared  during  the  experimental  phase,   there  was  no  significant   overall  difference   in  comparison   to  the   control   (Figure  4.11)  with   either   100µM  minoxidil   (P=0.495),   1mM   tolbutamide  (P=0.318)  or  when  they  were  combined  (P=0.270).  Treatment  with  100µM  minoxidil  and  1mM  tolbutamide  appeared  to  inhibit  any  further  proliferation  after  day  11;  this  effect   was   greatest   when   minoxidil   and   tolbutamide   were   combined   (Figure   4.11).    Statistical   analysis   comparing   the   total   cell   proliferation   at   the   end   of   the   culture  period   revealed   that   1mM   tolbutamide   significantly   inhibited   cell   proliferation  (P=0.05*),  however  minoxidil  had  no  effect  (P=0.21)  and  did  not  alter  the  tolbutamide  effect  significantly  when  given  in  combination  (Figure  4.12).  
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Figure  4.10  Phase  contrast  images  of  dermal  papilla  cells  in  culture  Dermal   papilla   (DP)   cells   were   cultured   for   15   days   for   the   purposes   of  constructing  a  cell  proliferation  growth  curve.    These  phase  contrast  images  of  the  DP  cells,  taken  at  x100  magnification  on  days  2  (a)  scale  bar  =  25µm,  5  (b)  scale  bar  =  25µm  and  day  15  (c)  scale  bar  =  25µm,  show  the  morphology  of  cells  during  the  period  of  culture.      The  DP  cells   in   culture   increased   in  number  exhibited  a   lean  kite-­‐like  multipolar  shape   and   formed   small   clumps;   when   confluent   they   formed   packed,   parallel  arrays.    (d)  The  magnified  image,  displays  the  lean  kite-­‐like  multipolar  shape  of  the  cells,  scale  bar  =  50µm.        




Figure  4.11  Minoxidil   and   tolbutamide  did  not   alter   the   growth  kinetics   of  
human  dermal  papilla  cells      The   cells   were   cultured   for   15   days   in   the   four   conditions   outlined.      The   cells  grown   in   all   conditions   exhibited   a   similar   pattern   of   growth.      The   cells   grew  rapidly  from  day  3  to  7  before  slowing  and  plateauing  from  day  11.    There  was  no  significant   difference   in   comparison   to   the   control,   with   100µM   minoxidil  (p=0.495),  1mM  tolbutamide  (p=0.318)  or  when  they  were  combined  (p=  0.270).    Values  are  the  mean  +  SEM  of  5  samples;  each  condition  was  calculated  in  triplicate  at  each  time  point.      Statistical   analysis  was  performed  using  a   two-­‐factor  within-­‐subjects  ANOVA  using  SPSS  after  confirming  normal  distribution.              





























Figure  4.12  Proliferation  of  human  dermal  papilla  cells  at  day  15  in  culture  
determined  by  haemocytometer    
(a) The   cell   count   at   day   15   in   culture   expressed   as   a   percentage   of   the   control.      Values  are  the  mean  +  SEM,  n=5  with  triplicate  count  for  each  sample.        
  
(b)  Statistical  differences  in  cell  proliferation  at  day  15,  the  values  represent  the  mean  +  SEM  from  triplicate  assays  of  5  samples.         Condition     Cell  count  on  Day  15  +    SEM     PȂvalue  (ANOVA)    Control       123,180  (+    1,180)    
  -­‐  
  Minoxidil  (100µM)     112,454  (+    4,854)    
  0.21  NS      Tolbutamide  (1mM)     99,167  (+    834)    
  0.05*      Minoxidil  (100µM)  &  Tolbutamide  (1mM)    
  97,582  (+    118)    



















l) * * 
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Figure   4.13      Total   cellular   protein   content   of   dermal   papilla   cells   from   5  
individuals  following  treatment  of  minoxidil  and  tolbutamide  Cells  were  seeded  at  1x104  and  cultured  for  15  days   in  the  stated  conditions.     At  day   15   the   proteins  were   extracted   from   cells   in   all   treatments.      Values   are   the  mean  +  SEM,  n=5.              
    
(b)    Statistical  differences  in  total  cellular  protein  content  from  5  cell  lines  at  day  15;  the  values  represent  the  mean  +  SEM  from  triplicate  assays  (n=5).      
  









Control Minoxidil  (100µM) Tolbutamide  (1mM) Minoxidil  (100µM)    















Condition   Cellular  protein  content  (µg)  +    SEM    
PȂvalue  (ANOVA)  
  Control       101  (+    4)       -­‐    Minoxidil        (100µM)     93.75  (+    2.25)       0.15  NS      Tolbutamide  (1mM)     80.52  (+    3.82)       0.01**        Minoxidil                (100µM)  &Tolbutamide  (1mM)    





Figure.4.14  Proliferation  of  human  dermal  papilla  cells  determined  by  MTT  
(a)  Cell  proliferation  was  determined  by  MTT  assay.     Cells  were   incubated  for  48  hours  with  minoxidil;   tolbutamide;   a   combination   of  minoxidil   and   tolbutamide;  and  a  vehicle  control.     The  results  are  expressed  as  percentages  in  comparison  to  the  control;  values  are  based  on  the  mean  from  five  samples  in  9  replicates  +  SEM.              
  
  
(b)  Statistical  differences   in   percentage  of   the  cell   viability,   in   comparison   to   the  control   at   day   15;   the   values   represent   the   mean   +   SEM   from   triplicate   assays,  (n=5).      
   Condition   Viability  (%)  +    SEM     PȂvalue  (ANOVA)    Minoxidil        (100µM)     98.97  (+    0.374)    
  0.487  NS      Tolbutamide  (1mM)     94.29  (+    1.496)    
  0.037*      Minoxidil                (100µM)  &Tolbutamide  (1mM)    

























4.3.2  Proteomics  Results  The  effect  of  minoxidil  on  protein  profiles   in   cultured  dermal  papilla   cells  were   investigated   by   culturing   cells   in  SILAC   (Stable   Isotopic  Labelling  of  Amino  acids  in  Cell  culture)  medium.    Dermal  papilla  cells  used  for  this  experiment  were  from  four  women  aged  between  42-­‐60  years.    The  cells  from  each  individual  were  cultured   in  duplicate,  one   set  of   the   cells  was     Ǯǯ ȋǤǤarginine  and  lysine  amino  acids)  and  the  other  set  was  cultured  in  ǮǯȋǤǤ13C  labelled   arginine   and   lysine   amino   acids)   form   of   the   amino   acid   (for   more  information  see  section  4.3.2.1).      
	ǡǮǯͳͲͲρ
  Ͷͺ Ǥ      Ǯǯ      control.      The   proteins  were   then   extracted   from   all   the   samples,   quantified   and  combined  together  to  increase  biological  validity  of  the  data  (Figure  4.4;  for  more  information  see  section  4.3.2.3).      These  were   then   separated  by  SDS  PAGE  and  trypsin-­‐digested   for  peptide  generation   (section   4.3.2.5).      The   resulting   peptides   were   separated   by   reverse  phase   chromatography   on   a   nanoHPLC   (Figure   4.8;   section   4.3.2.6.1).      Peptides  were  analysed  by  MALDI  MS/MS  analysis  and  were  identified  through  a  database  search,   using   Mascot   search   engine   (http://www.matrixscience.com/)   (Figure   4.9;  section   4.3.2.6).      The   use   of   SILAC   allowed   for   quantitative   information   to   be  obtained   from   the   mass   spectrometry   spectra.      Peptides   that   occurred   in   the  mixture  were  identified  as  pairs  (SILE  pairs).    The  intensity  ratio  of  the  two  peaks  (light/heavy;   i.e.   control/minoxidil)   of   the   pair   was   a   measure   of   any  differentiation  in  peptide  abundance  within  the  mixture  (Figure  4.4).    This  enabled  the  determination  of  quantitative  differences  due  to  minoxidil  at  the  protein  level  
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(i.e.   if   proteins   had   up-­‐regulated,   down-­‐regulated   or   remained   unaltered   when  treated  with  minoxidil),  if  the  labelled  protein  had  the  same  abundance  in  both  the  control   and   the   minoxidil   treated   cells   the   ratio   was   =1   (Ratio=  control/+minoxidil),  if  the  ratio  was  <1  it  was  indicative  of  a  stimulation  with  the  treatment,  and  if  the  ratio  was  >1  it  indicates  an  inhibition  with  treatment.      The   Mascot   search   engine   (http://www.matrixscience.com/)   identified   941  proteins   in   the   cultured   dermal   papilla   cells.   These   were   then   separated   into  networks   with   regard   to   their   functions   within   the   cell,   using   the   IPA   Software  (www.ingenuity.com).    ProteinȂprotein  interactions  (PPIs)  are  a  regulating  factor  in  many   fundamental   cellular   processes.      Therefore,   it   is   essential   to   identify   all  potential   interacting   partners   in   order   to   establish   an   understanding   of   the  functions   of   a   protein   in   its   cellular   context.      This   will   also   allow   for   a   more  comprehensive  visualisation  of  the  functional  and  dynamic  properties  of  the  cell.    By  nature  the  breadth  of   the   full   functioning  of   the   identified  proteins  are  too  vast   to  be   investigated   in   this   report.     Thus,   this   study  narrowed   its   focus   to  proteins   implicated   in   cellular   assembly,   maintenance   and   protein   trafficking  functions   (CAMPTF),   due   to   their   central   role   in   cell   survival.      The   software  generated   a   visual   representation   of   all   the   proteins   involved   in   the   selected  network   using   the   database   information,   including   associated   proteins   that  may  not  have  been  expressed  by  the  cultured  dermal  papilla  cells  (Figure  4.15).        This  offers   an   advanced   representation   of   the   results;   Image   4.15a   and   4.15b   are   the  same  network,  however  4.15b  is  a  generated  image  of  the  proteins  in  a  subcellular  layout.  
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Figure  4.15  Networks  of  proteins  associated  in  cellular  assembly,  maintenance  and  protein  trafficking  in  cultured  dermal  papilla  
cells      Image  (a)  displays  proteins  associated  in  the  networks  and  the  effect  of  minoxidil  in  the  protein  profile.    Proteins  in  green  are  up-­‐regulated  by  minoxidil,   and   proteins   in   red   are   down-­‐regulated.      The   intensity   of   the   colour   is   an   indicator   of   the   degree   of   up-­‐regulation   or   down-­‐regulation.    Those  in  grey  represent  identified  proteins  that  underwent  no  change  and  those  marked  in  white  are  suggested  as  possible  linking  proteins,  but  not   identified.   Image   (b)   is   the   same  network  but  proteins   in  normal   subcellular   layout  at   the   forefront.  Molecules   for  which  currently  no  information  on  subcellular  localisation  is  present  are  also  displayed  as  an  unknown  category.      
  
Key:    (a)  
*  
*  









To   analyse   statistical   significance   in   the   alteration  of   protein   levels   the  Ingenuity  pathway  analysis (IPA)  Software  (www.ingenuity.com)  was  used;   the  
    ζͲǤͲͷǤ  This   revealed   that   from   the   941  proteins  only  8  of  the  proteins  were  significantly  up-­‐regulated  by  minoxidil  (Table  4.1),  and  only  a  further  9  were  down-­‐regulated  (Table  4.2).  Some   proteins   that   were   up-­‐regulated   were   of   particular   interest:    Cathepsin   K   precursor   (CTSK)   which   has   high   specificity   for   kinins   has   been  associated  with  prostaglandin  production;  DNAj  homolog  subfamily  C  member  3   (DNAJC3)   down-­‐regulates   apoptosis.      Down-­‐regulated   proteins   of   particular  interest   from  Table  4.2   include  Mitochondrial  carrier  homolog  1  (MTCH1)  and  Fibronectin   1   (FN1)   both   of   which   have   been   associated   with   inducing  apoptosis.          Since  this  study  focused  on  the  (CAMPTF)  network,  attention  was  given  to  proteins  altered   in  that  network.     Within  the  network  15  proteins  had   been  down-­‐regulated  with   5   reaching   statistical   significance   (P<0.05);  while   only   3  proteins  were  significantly  up-­‐regulated  (P<0.05)  (Figure  4.15).      The   proteins   involved   in   the   cellular   assembly   network   which   were  significantly   up-­‐regulated   by   minoxidil   were:   Amyloid   beta   (A4)   precursor  (APP)   (p=0.005),   Small   nuclear   ribonucleo   protein   G   (SNRPG)   (p=0.004)   and  Cathepsin  K  precursor  (CTSK)  (p=0.007).     The  APP  protein  is  normally   located  in  the  plasma  membrane,  the  SNRPG  protein  is  located  in  the  nucleus,  and  CTSK  located  in  the  cytoplasm.    The   five  proteins  significantly  down-­‐regulated  by  minoxidil  were:  Actin  related   protein   2/3   complex   subunit   4   (ARPC4)   (p=0.0004),   Collagen,   type   I,  alpha   1   (CO1A1)   (p=0.005),   Mitochondrial   carrier   homolog   1   (MTCH1)  
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(p=0.007)   located   within   the   cytoplasm,   Collagen   alpha-­‐2(I)   chain   (CO1A2)  (p=0.007)   and   Fibronectin   (FN1)   (p=0.01)   located   in   the   plasma   membrane.    Interestingly   this   pathway   implicated   several   proteins   which   have   been  reported   to   be   produced   by   cultured   dermal   papilla   cells,   but   were   not  identified   in   this   experiment   including   vascular   endothelial   growth   factor  (VEGF)   (Lachgar   et   al.,   1996c;   Hibberts,   1996a;   Merrick,   1999)   and  transforming   growth   factor-­‐Ⱦͳ ȋ
























Table  4.1  Up-­regulated  proteins  identified  in  cultured  dermal  papilla  cells  





Role  in  cell  growth    (Source:  Ingenuity  Knowledge  Base  and  The  Human  Gene  Compendium:   
www.genecards.org)      Gamma-­‐glutamyl  hydrolase  precursor  (GGH)     x  5.0  (0.20)  
  Crucial  enzyme  in  the  metabolism  of  folic  acid  
Amyloid  beta  A4  protein  precursor  (APP)   x  3.2  (0.31)  
Limited  information  available  about  its  function,  could  bind  to  other  proteins  on  the  surface  of  cells  or  could  possibly  assist  in  attachment  of  cells  to  one  another    
Cathepsin  K  precursor  (CTSK)   x  2.9  (0.34)  
Protease   that   is   defined   by   high  specificity   for   kinins,   (small  peptides  that   act   on   phospholipase   and  
increase   arachidonic acid   release   and  
thus  prostaglandin  (PGE2)  production)    
Small  nuclear  ribonucleo  protein  G  (SNRPG)   x  2.8  (0.36)  
Has  been  shown  to  interact  with  DDX20  (DEAD);  associated  in  cellular  processes  involving  stimulation  of  RNA  secondary  structure  (translation  initiation,  nuclear  and  mitochondrial  splicing,  and  ribosome  and  spliceosome  assembly)    Thyroid  hormone  receptor-­‐associated    protein  3  (THRAP3)     x  2.6  (0.38)  
Nuclear  receptor  with  association  in  transcriptional  co-­‐activation  of  RNA  polymerase  II,  which  is  an  enzyme  found  in  eukaryotic  cells.  It  catalyses  the  transcription  of  DNA  to  synthesize  precursors  of  mRNA.        DNAJ  homolog  subfamily  C  member  3  (DNAJC3)     x  2.5  (0.40)  
Inhibits  the  apoptosis  influencing  protein  kinase  resource  (PKR),  i.e.  down-­‐regulates  apoptosis          Heme  oxygenase  1  (HMOX1)   x  2.2  (0.46)   Acts  as  a  protective  protein  against  oxidative  stress    Aldose  reductase  (AKR1B1)   x  2.2  (0.46)   Stress  inducible  protein,  that  stimulates  glucose  metabolism  
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Table   4.2   Down-­regulated   proteins   identified   in   cultured   dermal   papilla  
cells  treated  with  100µM  minoxidil  
Protein  
Decreased  
by  minoxidil                    (Ratio)  
  
Role  in  cell  (Source:  Ingenuity  Knowledge  Base  and  The  Human  Gene  Compendium:  
www.genecards.org)  
    Actin  Related  Protein  2/3  Complex  subunit  4  (ARPC4)     x  0.23  (4.38)  
    Stimulates  actin  polymerisation      Heterogeneous  Nuclear  Ribonucleoprotein  U-­‐like  1    (HNRNPUL1)     x  0.36  (2.77)  
    Represses basic  transcription  
Collagen,  type  I,  alpha  1  (CO1A1)   x  0.37  (2.69)     Functions  as  a  mechanical    support    for    structural  organisation    
Wiskott-­‐Aldrich  syndrome-­‐like  (WASL)   x  0.37  (2.40)  
  Stimulates  actin  polymerisation  via  stimulation  of  the  actin-­‐nucleating  activity  of  the  Arp2/3  complex  subunit  4    
Collagen,  type  XII,  alpha  1  (COCA1)   x  0.43  (2.30)  
  An  anchoring  fibril  between  the  external  epithelia  and  the  underlying  stroma    Mitochondrial  carrier  homolog  1  (MTCH1)   x  0.50  (2.00)     Induces  apoptosis  when  over-­‐expressed    
Procollagen-­‐lysine  1,  2-­‐oxoglutarate  5-­‐dioxygenase  1  (PLOD1)   x  0.50  (1.99)  
  Provides  instructions  for  making  an  enzyme  called  lysyl  hydroxylase  1  (this  is  key  to  the  stability  of  the  intermolecular  collagen  cross-­‐links)    Collagen  alpha-­‐2(I)  chain  (CO1A2)   x  0.51  (1.97)     Functions  as  a  mechanical    support    for    structural  organisation    Fibronectin    1  (FN1)     x  0.54  (1.84)     Induces  apoptosis  
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4.5    Discussion  The   dermal   papilla   plays   a   significant   role   in   mesenchymal-­‐epithelial  interactions  within  the  hair  follicle  and  in  the  regulation  of  hair  follicle  activity  (Reynolds   and   Jahoda,   1991;   Jahoda   and   Reynolds,   1996;   Rendl   et   al.,   2005;  Richardson   et   al.,   2005;  Waters   et   al.,   2007).      The   presence   of   SUR2B   in   the  human  follicular  dermal  papilla  ȋʹͲͲͺȌǯcific  affinity  to   SUR2B   (Schwanstecher   et   al.,   1998)   flagged   the   dermal   papilla   cell   as   a  possible   site   through   which   at   least   some   KATP   channel   modulators   function,  thereby  making  dermal  papilla  cells  a  significant  model  to  investigate  the  effects  of   minoxidil.   This   study   investigated   the   effect   of   100µM   minoxidil   on   cell  proliferation.      This   concentration   was   selected   based   on   previous   studies  (Kurata  et  al.,  1996;  Sanders  et  al.,  1996;  Han  et  al.,  2004).    Normal  scalp  dermal  papilla  cells  were  cultured  in  the  presence  of  minoxidil  over  a  period  of  15  days  and  to  construct  a  growth  curve  cell  counting  was  performed  in  triplicate  dishes  at   48-­‐hour   intervals.      Minoxidil   at   100µM   had   a   slight,   but   insignificant,  inhibitory   effect   on   cell   proliferation   over   the   15   days   in   culture   (p=0.495;  Figure  4.11),  though  the  pattern  of  growth  was  unchanged.    This  result  mirrored  that   of   Katsuoka   et   al   (1987)   who   looked   at   the   effect   of   an   increasing  concentration   of   minoxidil   (10   to   160   µM)   on   dermal   papilla   and   connective  tissue  sheath  cells  cultured  from  human  occipital  scalp.    This  group  detected  no  alteration  in  growth  over  a  14  day  culture  period.     The  effect  of   the  potassium  channel  blocker   tolbutamide  (1mM),  and  the  combined  treatment  of  minoxidil  and   tolbutamide   was   also   investigated;   both   inhibited   cell   proliferation  insignificantly  (p=0.318;  p=0.270)  (Figure  4.11).    Statistical  analysis  comparing  cell   proliferation   on   day   15   revealed   that   tolbutamide   inhibited   cell  
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proliferation   significantly   (p=0.05*),  but   that  minoxidil  had  no  effect   (p=0.21).    Combined  minoxidil   and   tolbutamide  cell  numbers  were   similar   to   those  with  tolbutamide  and  significantly  lower  than  control  (Figure  4.12).      Protein   quantification   revealed   that   the   total   cellular   protein   content  from   the   cells  on  day  15   followed   the   same  pattern,  with  minoxidil  having  no  effect   (p=0.15),   but   significant   inhibition   exhibited   by   tolbutamide   (p=0.01**)  and  combined  minoxidil  and  tolbutamide  (p=0.05*)  (Figure  4.13).    However,  in  this  instance  the  difference  between  the  application  of  minoxidil  alone  and  that  of   the   combined   treatment   of   minoxidil   and   tolbutamide   was   significant  (p=0.03*).   Since   Han   et   al   (2004)   reported   that   minoxidil   stimulated   the  proliferation   of   cultured   human   dermal   papilla   cells   using   a   MTT   (3-­‐(4,   5-­‐dimethylthiazol-­‐2-­‐yl)-­‐2,5-­‐diphenyltetrazolium   bromide)   assay,   at   varying  concentrations  (0.01,  0.1,  1  µM)  in  a  dose-­‐responsive  manner,  a  MTT  assay  was  also   carried   out   on   cultured   dermal   papilla   cells,   treated   with   minoxidil,  tolbutamide,  or  the  combined  effect  of  minoxidil  and  tolbutamide,  for  48  hours.    The   results   showed   that   100µM   minoxidil   had   no   effect   on   cell   viability  (p=0.487;   Figure   4.14),   in   contrast   to   the   significant   inhibitory   effect   that  tolbutamide  (p=0.037*)  and  the  combined  treatment  had  (p=0.037*).    Similar  to  the  difference  between  the  total  cellular  protein  content,  the  difference  between  the   application   of   minoxidil   alone   and   that   of   the   combined   treatment   of  minoxidil   and   tolbutamide  was   also   significantly  different   for   the   cell   viability  assay   (p=0.04*).      Han   et   al   (2004)   also   reported   that   minoxidil   exerted   an  inhibitory   affect   on   cell   growth,   but   at   the   highest   concentration   of   2mM.    Interestingly,   Sanders   et   al   (1996)   reported   minoxidil   at   50µM   to   have   a  stimulatory  effect  on  dermal  fibroblast  cell  proliferation.     Additionally,  another  
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investigation  revealed  that  minoxidil  stimulated  3H-­‐thymidine  uptake  in  dermal  papilla   (500   µM)   and   outer   root   sheath   cells   (100   µM)   cultured   from   stump-­‐tailed  macaque  scalp  hair   follicles   (Kurata  et  al.,  1996)  although  minoxidil  had  no   effect   on   cells   that   were   non-­‐follicular.      The   diverse   range   of   culture  conditions  and  concentrations  used  across  this  area  of  research  make  it  difficult  to   ascertain   the   exact   effect   of   minoxidil   on   dermal   papilla   cell   proliferation  (Katsuoka  et  al.,  1987;  Lachgar  et  al.,  1996a;  Kurata  et  al.,  1996;  Sanders  et  al.,  1996;   Lachgar   et   al.,   1998;   Han   et   al.,   2004).      This  may   not   be   a   particularly  biologically  relevant   in  vitro  assay  parameter  since  dermal  papilla  cells  are  not  seen   to   divide   very   often   in   adult   follicles   (Pierard   and   Brassinne,   1975).    Therefore,   it   is   more   appropriate   to   investigate   the   mechanism   of   action   of  minoxidil  with  an  alternative,  more  comprehensive  method  which  assesses  the  actual  proteins  altered  by  minoxidil.  The   study   of   proteins   elucidates   cell   behaviour   and   identifies   the  particular  phenotypes  of  a  cell.    Using  proteomics  to  analyse  dermal  papilla  cell  proteins  has  the  potential  of  revealing  the  mechanisms  of  action  of  minoxidil  on  cells   via   the   alteration   of   protein   levels.      Quantitative   analysis   of   the   proteins  allows  comparisons  to  be  drawn  between  different  experimental  states.     From  the  several  formats  available  (Bantscheff  et  al.,  2007)  stable  isotope  labelling  by  amino  acids  in  cell  culture  (SILAC)  was  chosen  for  its  simplicity  and  strength  in  efficiency.      The   effect   of   external   agents   such   as   minoxidil   on   a   ǯ  concentration   can  be   clearly  demonstrated  with  SILAC.     To   increase  biological  validity   four   individual   scalp   dermal   papilla   cells   were   derived   from   four  women  aged  between  42  and  60  were  used  for  this  experiment.    Each  line  was  cultured  in  duplicate  and  the  first  set  was  placed  in  Ǯǯ  medium,  i.e.  medium  
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containing   unlabelled   arginine   and   lysine   amino   acids,   and   the   second   set   in  
Ǯǯǡi.e.  that  containing  13C-­‐labelled  arginine  and  lysine  amino  acids.    Five  cell  cycles  were  necessary  to  allow  for  complete  labelling  of  the  cells  with  
ǤǮǯͳͲͲρͶͺ
ǮǯǤ	  the  extraction  of  protein  from  the  cells,  quantification  and  peptide  generation,  mass  spectrometry  analysis  was   carried  out  on  cell  protein  extracts   combined   from  all   4   samples   of   dermal   papilla   cells.      This   determined   and   quantitated   the  relative   ratios   of   each   isotopic   form   of   every   peptide,   which  was   analysed   to  measure  any  increase,  decrease  or  consistency  in  the  level  of  each  protein  after  treatment.    The  intensity  ratio  of  the  two  peaks  ǮǯǮǯ(control   vs.   minoxidil)   was   a   measure   of   any   differentiation   in   peptide  abundance  within   the  mixture   (Figure   4.4).      This   highlighted   the   quantitative  differences  introduced  with  the  application  of  minoxidil  at  a  protein  level.     The  Mascot   search   engine   identified-­‐941-­‐proteins-­‐in-­‐the-­‐cultured-­‐dermal-­‐papilla-­‐cells  (http://www.matrixscience.com/).          Using   IPA   Software   (www.ingenuity.com)   all   941   proteins   were  separated   into   networks   depending   on   their   functions.      As   mentioned  previously,   the  extent  of   all   the   functions  of   the  941  proteins   identified   is   too  widespread   to   be   followed   in  one   investigation,   thus   this   report   narrowed   its  concentration   to   cellular   assembly,   maintenance   and   protein   trafficking  functions   (CAMPTF),   as   these   are   essential   for   cell   survival.      The   visual  representation  of   the  proteins  within  that  network  also  revealed  proteins  that  may   not   have   been   identified   in   the   cultured   dermal   papilla   cells,   but   have  possible   associations   with   that   network   (Figure   4.14),   including   vascular  
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endothelial  growth  factor  (VEGF)  which  has  been  shown  to  have  been  secreted  and   expressed   in   cultured   human   dermal   papilla   cells   (Lachgar   et   al.,   1996c;  Hibberts,  1996a;  Merrick,  1999).  Interestingly   minoxidil   stimulated   VEGF   mRNA   expression   in   cultured  dermal   papilla   cells   (Lachgar   et   al.,   1998).      The   visual   representation   of   the  proteins  in  Figure  4.14  also  revealed  transforming  growth  factor-­‐Ⱦͳȋ
	-­‐ȾͳȌ  as  a  possible  associated  protein  (Figure  4.15).    Minoxidil  has  been  reported  to  have  an   inhibitory  effect  on  TGF-­‐Ⱦͳ   induced  apoptosis  (Otomo,  2002).     This  growth  factor  also   inhibits  human  hair   follicle  growth   in  vitro  (Philpot,  2000)  and  has  been  suggested  as  a  factor  associated  with  androgenetic  alopecia.    Hamada  and  Randall   (2006)   reported   that   cultured   balding   dermal   papilla   cells   produced  inhibitory   autocrine   factors   and   TGF-­‐Ⱦͳ   has   been   found   to   be   stimulated   by  androgens   in  balding  dermal  papilla   cells   (Heine   et  al.,   1987;   Inui   et  al.,   2002;  2003;  Hamada  and  Randall,  2006).  To  our  knowledge,   the  only  other  research  conducted  using  proteomics  in   human   dermal   papilla   cells   was   by   Rushan   and   colleagues   (2007),   who  looked   at   the   aggregative   behaviour   of   dermal   papilla   cells   by   comparing  proteins  in  the  cells  before  and  after  aggregation.    They  identified  the  following  5   proteins:   Annexin   A2   isoform   1,   Heat   shock   70kDa   protein,   Mitochondrial  ribosomal  protein,  Transgelin  and  Transgelin  2  which  were  all  over  expressed  in  the  dermal  papilla  cells   following  aggregation.     All  5  proteins  were  amongst  the  identified  proteins  in  this  investigation  but  their  levels  were  unchanged  by  minoxidil.      The   Ingenuity   pathway   analysis (IPA)   Software   (www.ingenuity.com)  analysis  of  the  statistical  significance  in  alteration  of  protein  levels,  with  the  set  
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threshold  of  ζͲǤͲͷǡ  revealed  that  from  the  941  proteins  only  8  of  the  proteins  were  significantly  up-­‐regulated  by  minoxidil  (Table  4.1),  and  a  only  a  further  9  were  down-­‐regulated  (Table  4.2).     Such  a  finding  is  not  entirely  unpredictable,  as   there  was   no   change   in   cell   proliferation  with  minoxidil   (Figure   4.11),   the  cells  were   confluent  and   as   there  are   so  many  processes   that   all   cells  need   to  perform  simply  for  their  existence.  In   the   CAMPTF  network   15   proteins   had   been   down-­‐regulated,   though  only   5  were   significantly   inhibited   by  minoxidil   under   the   statistical   analysis,  and   3   proteins   had   been   up-­‐regulated,   all   significantly,   by  minoxidil   ȋζͲǤͲͷȌ.    The  proteins   that  were   significantly  up-­‐regulated  by  minoxidil   in   the  CAMPTF  network   were   Amyloid   beta   (A4)   precursor   (APP)   (p=0.005),   Small   nuclear  ribonucleo   protein   G   (SNRPG)   (p=0.004)   and   Cathepsin   K   precursor   (CTSK)  (p=0.007)  (Figure  4.15a).    The  APP  protein  is  located  in  the  plasma  membrane:  its   functions   have   not   been   fully   ascertained,   however   it   may   bind   to   other  proteins  on  the  surface  of  the  cell  or  be  a  facilitator  in  the  attachment  of  cells  to  one  another  (Soba  et  al.,  2005;  Zheng  and  Koo,  2006).    Recent  investigations  on  rat   brains   have   shown   evidence   that   a   soluble   APP   has   growth-­‐promoting  properties  and  may  have  a  crucial  role  in  the  formation  of  nerve  cells  (Sayer  et  
al.,   2008).   SNRPG   protein   is   located   in   the   nucleus   of   the   cell,   and   has   been  shown  to  interact  with  DDX20  (DEAD),  which  is  associated  with  several  cellular  processes  involving  stimulation  of  RNA  secondary  translation  initiation,  nuclear  and  mitochondrial  splicing,  and  ribosome  and  spliceosome  assembly  (Godbout  and  Squire,  1993;  Charroux  et  al.,   1999;  Solem  et  al.,   2006).     DEAD  protein   is  implicated   in   cellular   growth   and   division   (The   Human   Gene   Compendium:  www.genecards.org).      Thus   both   these   minoxidil-­‐stimulated   proteins   are  
 -229- 
 
believed  to  increase  cell  activity/growth,  although  their  roles  in  dermal  papilla  cells   are   currently   unknown;   this   type   of   effect  would   be   consistent  with   the  generally   increased   growth   of   hair   follicles   with   minoxidil   treatment   in   vivo.    Although   minoxidil   had   no   effect   on   dermal   papilla   cell   proliferation   in   the  experimentation  of   this   thesis,   further   investigations  are   required   to  ascertain  the  role  of  other  factors  in  culture  conditions,  as  the  conditions  in  the  medium  for   the   cell   proliferation   and   proteomic   study   differed.      Hence,   future  investigations  must  look  at  the  effect  and  interaction  of  such  other  factors,  e.g.  serum,   insulin,  antibiotics  and  the  time   lapse  during  which  cells  were  exposed  to  minoxidil.    CTSK  is  located  in  the  cytoplasm  and  is  a  protease,  which  is  defined  by  its  high  specificity  for  kinins.     Kinins  are  small  peptides  that  act  on  phospholipase  and   increase   arachidonic   acid   release   and   thereby   the   production   of  prostaglandins.     CTSK  was  up-­‐regulated  by  minoxidil,  this   is  worthy  of  note  as  the   prostaglandin   analogue   (Latanoprost)   used   in   the   treatment   of   glaucoma  has  been  reported  to  induce  hair  growth  (Johnstone  and  Albert,  2002)  and  it  has  been   suggested   from   studies   of   the   activation   of   cytoprotective   prostaglandin  synthase-­‐1   in   dermal   papilla   cells   that   minoxidil   can   increase   prostaglandin  synthesis  (Michelet  et  al.,  1997).     Recently,  prostaglandin  F2  analogues  used  to  treat   glaucoma   (Arranz-­‐Marquez   and   Teus,   2008),   have   been   shown   to  stimulate  eyelash  growth  (Wester  et  al.,  2010)  and  isolated  hair  follicle  growth  in  organ  culture  (Khidhir  and  Randall  Ȃ  personal  communication).  Outside   the   CAMPTF   network,   the   following   proteins   also   exhibited  significant   up-­‐regulation   out   of   the   941   (Table   4.1)   with   P<0.05:   Gamma-­‐glutamyl   hydrolase   precursor   (GGH),   Thyroid   hormone   receptor-­‐associated  
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protein   3   (THRAP3),   DNAj   homolog   subfamily   C   member   3   (DNAJC3),   Heme  oxygenase  1  (HMOX1)  and  Aldose  reductase  (AKR1B1).  GGH  is  a  key  enzyme  of  the   metabolism   of   folic   acid   (Eisele   et   al.,   2006),   which   is   essential   for   the  production  and  maintenance  of  new  cells  for  DNA  and  RNA  synthesis  as  well  as  the  prevention  of  changes  to  DNA  (Kamen,  1997).    THRAP3  is  a  nuclear  receptor  that  plays  a  role  in  transcriptional  coactivation  (Ko  et  al.,  2000).    ͵ǯ  and  


ǯ   up-­‐regulation   by  minoxidil   suggests   that   RNA   synthesis  was   increased;  this  would  be  expected   if  minoxidil  was  stimulating  the   increased  secretion  of  paracrine  regulators  which  stimulate  keratinocyte  growth.    The  protein  DNAJC3  functions   as   an   inhibitor   of   the   protein   kinase   resource   (PKR)   (Austbø   et   al.,  2008).      Kinases   participate   in   signalling   cascades   that   influence   apoptosis  (Franklin  and  McCubrey,  2000).    DNAJC3  may  have  been  up-­‐regulated  to  defend  against  apoptosis.      HMOX1,  which  was  also  up-­‐regulated  by  minoxidil,   is  a  stress   inducible  protein,   providing   protection   against   oxidative   stress   (Slebos   et   al.,   2003).      Oxidative  stress  creates  a  disturbance  in  the  normal  redox  state  of  a  cell  and  can  cause  toxic  effects   that  damage  all  components  of  a  cell,   including   its  proteins,  lipids  and  DNA  (Otterbein  et  al.,  2000).    AKR1B1  stimulates  glucose  metabolism  and,  similarly  to  HMOX1,  functions  as  a  stress  inducible  protein  and  is  believed  to  have  a  protective  role  against   steroidgenesis   that,  when  accumulated,  could  affect  cell  growth  or  differentiation  (Lefrancois-­‐Martinez  et  al.,  2004),  indicating  that   AKR1B1   has   a   benefit   against   the   effects   of   the   steroids   produced   by  steroidgenesis.      Steroidgenesis   is   the   process   during   which   desired   forms   of  steroids   are   generated   by   transformation   of   other   steroids.      The   androgens  testosterone   and   5alpha   dihydrotestosterone   (DHT)   are   products   of  
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steroidgenesis   and   are   of   particular   interest   since   male   pattern   baldness,  androgenetic  alopecia,  is  associated  with  a  genetic  sensitivity  of  the  hair  follicle  to   androgen   (Randall.,   2008).      Other   products   of   steroidgenesis   include  oestrogens   and   progesterone,   corticoids   and   aldosterone.      Steroidgenesis  pathways   are   deeply   complex.      This   could   mean   that   the   up-­‐regulation   of  AKR1B1  potentially  protects   cells   against   the   products  of   steroidgenesis,   such  as  testosterone,  which  has  been  shown  to  inhibit  hair  growth  in  the  presence  of  dermal   papilla   cells   from   the   frontal   bald   scalp   of   the   stumptailed   macaque  (Obana  et  al.,  1997).    This  seems  less  likely  in  vivo  because  most  steroidogenesis  takes  place  in  endocrine  organs,  although  the  metabolisnm  of  testosterone  to  its  more  active  metabolite  can  take  place  in  dermal  papilla  cells  (reviewed  Randall  2008).    Alternatively,  male  pattern  hair  loss  is  associated  with  ageing  as  well  as  androgens.    Aging  has  also  been  associated  with  oxidative  stress  (Dröge,  2005),  and  thereforeDNAJC3  and  AKR1B1  may  be  reducing  this  effect.          The   five   proteins   that   were   significantly   down-­‐regulated   included  Fibronectin   (FN1)   (p=0.01)   located   in   the   plasma   membrane,   Mitochondrial  carrier   homolog   1   (MTCH1)   (p=0.007),   Actin   related   protein   2/3   complex  subunit  4  (ARPC4)  (p=0.0004),  Collagen,  type  I,  alpha  1  (CO1A1)  (p=0.005),  and  Collagen   alpha-­‐2(I)   chain   (CO1A2)   (p=0.007).      FN1   protein   induces   apoptosis  within   the   cell,   whilst   MTCH1   induces   apoptosis   only   when   over   expressed  (Sugahara   et   al.,   1994;   Lamarca   et   al.,   2007).      Down-­‐regulation   of   these  apoptotic-­‐inducing  proteins   by  minoxidil,   in   combination  with   the   stimulation  of   increased   production   of   DNAJc3   could   suggest   that   minoxidil   would  inhibit/delay  apoptosis  in  vivo.    Indeed,  one  of  the  clinical  effects  of  minoxidil  is  to  prolong  anagen,  resulting  in  a  larger  hair  (Messenger  and  Rundegren,  2004).    
 -232- 
 
This   involves   delaying   catagen   which   involves   significant   apoptosis  (Botchkareva  et  al.,  2006).  The   ARPC4   protein   stimulates   actin   polymerisation   in   the   cell,   an  essential  function  for  maintaining  cell  shape  (Otsubo  et  al.,  2004),  although  the  mechanism   by   which   it   promotes   this   action   remains   unclear   (Welch   et   al.,  1997).    ARPC4  is  stimulated  by  another  protein:  Wiskott  Aldrich  Syndrome-­‐like  (WASL)  protein,  which  was  significantly  down-­‐regulated  in  this  study,  although  outside   of   the   CAMPTF   network.      This   could   offer   an   explanation   as   to   why  ARPC4   was   down-­‐regulated   by   minoxidil.      WASL   is   implicated   in   the  transduction   of   signals   from   receptors   on   the   cell   surface   to   the   actin  cytoskeleton,   and   while   this   protein   interacts   with   multiple   proteins  (Lyubimova  et  al.,  2010),  no  studies  have  examined  its  full  functioning.    Further  investigations   are   required   to   establish   in   detail   the   functions   and   regulatory  factors   that  modulate  WASL  and   the  possible   inhibitory  effect  of  minoxidil  on  WASL.      The   role   of   reduction   in   actin   polymerisation   is   unclear,   but   could  suggest  that  minoxidil  is  enabling  the  cells  to  move  and  be  more  dynamic.        Collagen   CO1A1   and   CO1A2   generally   function   as   extracellular  mechanical   support   for   the   structural   organisation   of   cells.      This   could   be  important   in   vivo   since   the   dermal   papilla   contains   extensive   extracellular  matrix   (Messenger   et   al.,   1991).      Cultured   dermal   papilla   cells   do   produce  extracellular  matrix  proteins   including   collagen   I   and   type   III   (Katsuoka   et  al.,  1988)   and   collagen   type   IV   (Messenger   et   al.,  1991).      CO1A1   and   CO1A2   are  both   members   of   the   group   1   collagens,   which   are   fibrillar   forming   collagen.    Fibrillar  type  1  collagen  has  been  reported  to  inhibit  cell  growth  (Henriet  et  al.,  
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2000)ǡǯͳͳƬ  A2  again  has  the  potential  to  assist  maintaining  anagen  in  vivo.      Incorporating  the  study  of  proteomics  in  the  treatment  of  dermal  papilla  cells  with  minoxidil  and  identifying  the  specific  intracellular  proteins  that  have  been  influenced  as  a  result,  brings  us  closer  to  forming  a  more  comprehensive  understanding   of   the   intricate   mechanisms   that   stimulate   hair   growth.      The  findings   indicate   that   minoxidil   has   both   inhibitory   and   stimulatory   effects  within  the  protein  profiles  of  dermal  papilla  cells,  which  appear  to  be  relevant  to  its  clinical  effects  on  hair  growth.    However,  there  is  no  really  clear  evidence  suggesting   exactly   how   it   initially   works,   i.e.   an   obvious   specific   mechanism  resulting  from  opening  K+ATP  channels.     Previous  suggestions  by  Li  et  al  (2001)  implicated   an   adenosine-­‐related   mechanism.      Using   DNA  microarray   analysis  Iino   et   al   (2007)   showed   that   adenosine   stimulated   a   2-­‐fold   increase   in  VEGF  gene  expression  and  up-­‐regulated  the  expression  of   fibroblast  growth  factor-­‐7  (FGF-­‐7)   in   the   dermal   papilla   cells.      They   suggested   that  minoxidil   stimulates  adenosine   secretion  by  potassium  channel  opening,  which   in   turn  enables  up-­‐regulation  of  VEGF  and  FGF-­‐7  gene  expression,  resulting   in  stimulation  of  hair  follicle  growth.     This  study  did  not  detect  VEGF  or  FGF-­‐7   in  the  dermal  papilla  cells.     Although  VEGF  and  FGF-­‐7  could  potentially  have  been   secreted   into  the  medium  during  culture,  but  unfortunately  time  did  not  permit  the  examination  of  proteins  secreted  into  the  medium  here.    However,  the  results  in  Chapter  2  of  this   thesis  are  not   in  support  of   the  proposals  made  by  Iino  and  colleagues,  as  minoxidil  stimulated  hair  growth   in  organ  culture   in  the  absence  of   a   vascular  supply.      
 -234- 
 

























Overall  discussion                                    
 -236- 
 
5.  Overall  Discussion  Minoxidil   is   the  main   topical   treatment   for   alopecia   although   it   can   be  rather   limited   in   its  effectiveness  (Messenger  and  Rundegren,  2004).      It  opens  certain   ATP   sensitive   potassium   (KATP)   channels   which   have   been   found   in  human  hair  follicles  (Shorter  et  al.,  2008).     KATP  channels  are  composed  of  two  subunit  classes:  sulfonylurea  receptors  (SUR),   the  site  of  drug   interaction,  and  pore-­‐forming   subunits   (Kir  6.x).  The  expression  of  both   types  of   sub-­‐units  are  necessary  to  form  a  functional  KATP  channel  (Gribble  et  al.,  1997;  Inagaki  et  al.,  1995a;  Yamada  et  al.,  1997).      Previous  investigations  using  human  anagen  hair  follicles  demonstrated  the   presence   of   several   KATP   channels   (Shorter   et   al.,   2008).      To   form   a  comprehensive  outline  of  the  role  of  the  potassium  channels  in  the  hair  follicle,  it   was   important   to   investigate   the   presence   of   these   channels   in   both   their  anagen   and   telogen   phases.      Investigating   the   presence   of   KATP   channels   in   a  human  telogen  hair  follicle  is  extremely  challenging  as  generally  only  scalp  hair  follicles  are  available  and  these  are  in  the  anagen  phase  for  the  majority  of  the  time   (Randall   and  Ebling,   1991).      The   use   of  methods   that   induce   the   telogen  phase  in  humans  is  not  ethical.        The   red   deer   hair   follicle   is   a   well-­‐established   model   (Thomas   et   al.,  1994;   Thornton   et   al.,   1996;   Randall   et   al.,   2003)   and   is   an   ideal   animal   to  investigate   KATP   channels   in   the   telogen   phase.      The   seasonal   growth   cycles  mean   that   follicles   in   any   given   area   are   at   the   same   stage   of   the   hair   cycle  (Lincoln  and  Kay,  1971),   the  pelage   follicles  are   large,  unlike  most  of   those   in  laboratory   animals,   and   are   readily   available   without   ethical   constraints.    Pharmacological  studies  examining  the  responses  of  red  deer  follicles  in  organ  
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culture   revealed   that   minoxidil   and   other   KATP   channel   openers   stimulated  follicle  growth;   an  effect   inhibited  by  potassium  channel   closers   (Davies   et  al.,  2005).      Thereby,   suggesting   the   presence   of   KATP   channels   in   red   deer   hair  follicles  and  associating  them  with  an  ability  to  regulate  hair  growth,  at  least   in  
vitro.       A  histological  comparison  of  human  and  red  deer  hair  follicles  confirmed  that  deer  hair  follicles  are  larger  in  structure  than  that  of  the  human  scalp  hair  follicle,   rendering   the  medulla  visible   in   the  deer  hair   follicle   (Figures  2.7  and  2.8).     However,  the  structure  was  on  the  whole  similar,  thereby  reinforcing  the  deer   hair   follicle   as   a   good   model   system   for   the   research.      Furthermore,  molecular  biological  investigations  in  red  deer  anagen  hair  follicles  revealed  the  expression   of   KATP   channel   subunit   genes   SUR1,   SUR2B,   Kir6.1   and   Kir6.2,  although  SUR2A  was  not  expressed  (Figures  2.13,  2.15,  2.17  and  2.19).     These  results  are  similar  to  a  study  on  human  hair  follicles  (Shorter  et  al.,  2008)  and  also  fit  with  the  pharmacological  stimulation  of  deer  hair  growth  (Davies  et  al.,  2005).      Also   paralleling   human   hair   follicles   (Shorter   et   al.,   2008)   was   the  presence   of   SUR2B   and   Kir6.1   proteins,   in   the   dermal   papilla   and   connective  tissue  sheath  (Figure  2.21).     Therefore,  it  is  most  probable  that  SUR2B  forms  a  KATP   channel  with  Kir6.1   in  deer   follicle  dermal  papilla  while   SUR1  can   form  a  KATP   channel   with   Kir6.2,   as   SUR1/Kir6.1   channels   are   not   physiologically  relevant   (Babenko   et   al.,   1998a).      This   suggests   the   possible   existence   of   two  KATP   channels   in   deer   anagen   hair   follicles.      The   strong   correlation   in   the  expression  of  KATP  channel  sub-­‐units  in  deer  anagen  follicles  with  those  found  in  human   follicles   reinforces   the   practicality   of   the   deer   hair   follicle  model   as   a  
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system   for   understanding  hair   follicle   biology  and   its   use   for   the   screening   of  new  hair  growth  treatments.      When  red  deer  telogen   follicles  (Figure  2.9)  were   isolated   and  the  gene  expression   of   the  KATP   channel   subunits   investigated,   no  KATP   channel   subunit  expression  was  detected  (Figures  2.23-­‐2.26).    The  absence  of  gene  expression  in  telogen   follicles   highlights   the   significance   of   KATP   channels   in   the   normal  anagen  processes.     Several  reports  of  clinical  observations  have  suggested  that  minoxidil   advances   anagen   (Price   and   Menefee,   1996;   Messenger   and  Rundegren,   2004   ),   indicating   towards   an   active   K+ATP   channel   sub-­‐unit   in  telogen.  The  absence  of  K+ATP   channels   in   the  red  deer   telogen  hair   follicles   in  this   thesis   suggests   that   they   are  possibly  expressed   at   the  end  of   the   telogen  phase,  when  exogen  takes  place  (Higgins  et  al.,  2009).  Minoxidil   has   been   reported   to   have   a   specific   affinity   for   SUR2B  (Schwanstecher  et  al.,  1998)  and  has  been  shown  to  have  a  stimulatory  effect  on  growth  in  cultured  red  deer  (Davies  et  al.,  2005)  and  human  scalp  hair  follicles  (Han  et  al.,  2004;  Shorter  et  al.,  ʹͲͲͺȌǤǯfollicles  has  garnered  conflicting  results  of  stimulation,  inhibition  and  no  effect  (Table  3.1).     Comparisons  drawn  between  these  studies  are   limited  due  to  the  varying   culture   conditions,   particularly   because   of   the   use   of   insulin   in   the  culture  medium,  which  aims  to  prolong  anagen.  Therefore,   prior   to   further   investigations   on   KATP   channel   openers   on  human   anagen   follicles   the   role   of   insulin  was   examined.      In   the   comparison  carried   out   in   this   thesis,   in   the   presence   of   insulin   minoxidil   had   no   effect,  whereas,  in  the  absence  of  insulin  it  had  a  significant  stimulatory  effect  (Figure  3.4).    The  potassium  channel  blocker  tolbutamide,  shortened  anagen  in  cultured  
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human  hair   follicles   in   the  presence  of   insulin,  while   in   the  absence  of   insulin  tolbutamide   had   no   effect   (Figure   3.7).      Overall,   it   is   clear   that   insulin   in   the  medium   affects   follicular   responses.      Insulin   advances   the   movement   of   ions  across   the   plasma   membrane   (Irwin   and   Rippe,   2008),   and   the   resultant  alterations  may   lead   to   the   opening   of   KATP   channels,  mirroring   the   probable  main  action  of  minoxidil.    Alternatively,  as  insulin  acts  as  a  stimulant  of  glucose  uptake  into  cells  and  storage  (Cushman  and  Wardzala,  1980;  Suzuki  and  Kono,  1980;  Leney  and  Tavare,  2009),   follicles  may  have  achieved  maximum  growth  already  in  insulin  supplemented  medium.      
ǯthe  closing  of  the  channels;  whilst  in  the  insulin-­‐free  medium,  tolbutamide  had  no  real  effect,  presumably  as  the  channels  were  closed.    The  effects  of  insulin  on  hair   follicles   grown   in   organ   culture   are   not   yet   fully   understood   and   further  
      Ǥ  ǡ ǯ effect   on   anagen   follicles   could   be   harnessed   to   formulate   clinical   topical  treatments  that  reduce  hair  growth,  caused  by  disorders  such  as  hirsutism  and  this  merits  further  investigation.    Minoxidil   only   opens   SUR2B   channels;   however,   both   the   human  (Shorter  et  al.,  2008)  and  deer  hair  follicles  (Chapter  2)  express  both  SUR1  and  SUR2B  KATP  channel  types.    In  red  deer  hair  follicles  NNC  55-­‐0118,  a  drug  which  would  only  open  SUR1  containing  channels,  also  had  a  stimulatory  effect  on  hair  follicle   growth   (Davies   et   al.,   2005).      The   results   presented   in   chapter   3   on  human   hair   follicles,   showed   that   another   SUR1   opener   drug,   NNC55-­‐9216  significantly   prolonged   anagen   and   increased   hair   follicle   length   in   organ  culture   in   the   absence   of   insulin   (Figure   3.13).      This   effect   was   inhibited   by  
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tolbutamide  in  the  absence  of  insulin  (Figure  3.13).    The  combined  treatment  of  minoxidil   and   NNC55-­‐9216   produced   a   significantly   greater   stimulation   of  anagen   and   hair   length   than   either   drug   alone   (Figure   3.14).         Therefore,  opening   SUR1   KATP   channels   in   human   hair   follicles   stimulates   hair   growth.    These   results   suggest   novel   approaches   for  more   effective   pharmaceuticals   to  treat   alopecia   via   SUR1   KATP   channels,   or   perhaps   in   combination   with  minoxidil.  
ǯATP  channels  remains  unclear.     The  presence  SUR2B/Kir6.1  KATP   channels   in  human  dermal  papillae  (Shorter  et  al.,   2008)  offers  a   target   for  minoxidil.     This  holds   the  potential  of  binding  to  the  receptors  and  modifying  the  gene  expression  of  factors  acting  on  other   cell   types   involved   in   hair   follicle   growth.      Thereby,   lending   to   the  prospect   that   the   dermal   papilla   is   a   target   through  which   at   least   some  KATP  channel  openers  function.      The  dermal  papilla  plays  a  crucial  role  in  hair  follicle  activity  (Reynolds  and  Jahoda  1991;  Jahoda  and  Reynolds  1996;  Rendl  et  al.,  2005;  Richardson  et  
al.,   2005;  Waters   et   al.,   2007).      The   effect   of  minoxidil  was   not   significant   on  dermal   papilla   cell   proliferation,   following   15   days   in   culture,   paralleling  findings  by  Katsuoka  et  al  (1987).    The  potassium  channel  blocker,  tolbutamide,  had   an   inhibitory   effect   on   total   cell   proliferation   though   not   the   pattern   of  growth   (Figures   4.11   and   4.12).      The   same   effect   was   noted   in   total   cellular  content  using  protein  quantification  and  the  viability  assay  MTT  (Figures  4.13  and  4.14).  The  study  of  proteomics  lends  to  greater  understanding  of  cell  behaviour  and  identifies  particular  cell  phenotypes.      The  effect  of  minoxidil  on  the  protein  
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profile  was  investigated  using  the  quantitative  proteomic  approach  by  labelling  the   cells   with   SILAC   allowing  measurement   of   quantitative   differences   in   the  levels  of   individual  proteins  after   treatment  with  minoxidil.     This  was  the   first  time  that  the  SILAC  method  had  been  used  at  the  University  of  Bradford  and  is  one   of   the   first   attempts   to   use   the   proteomics   approach   for   investigations   in  human   cultured   dermal   papilla   cells.     The   author   carried  out   all   the   complete  and   time   consuming   processes   in   this   investigation.      The   mass   spectrometry  analysis   identified   941  proteins   in   cultured   dermal   papilla   cells   (Figure   4.14),  from  which  8  proteins  were  significantly  up-­‐regulated  (Table  4.1)  and  another  9  were  down-­‐regulated  (Table  4.2).    The  proteins  were  sorted  into  networks  that  related  to  their   functions.     This   thesis   focused  on  the  proteins  associated  with  cellular  assembly,  maintenance  and  protein  trafficking  functions  (CAMPTF),  due  the  essential  role   they  play   in  cell  survival  (Figure  4.15).     Within  this  network  APP,  CTSK  and  SNRPG  proteins  were  up-­‐regulated  (Table  4.1;  Figure  4.15).    APP  has  a  growth  promoting  factor,  whilst  CTSK  was  associated  with  prostaglandin  synthesis,  which  has  been  known   for   inducing  hair   follicle  growth  and  SNRPG  was  implicated  in  cellular  growth  and  division  (Sayer  et  al.,  2008;  Johnstone  and  Albert,   2002).      FN1,   MTCH1,   CO1A1,   CO1A2   and   ARPC4   proteins   were   down  regulated   in   the   CAMPTF  network   (Table   4.2;   Figure   4.15).      FN1   and  MTCH1  were  both   found  to  be  apoptotic  proteins  (Sugahar  et  al.,  1994;  Lamarca  et  al.,  2007).      CO1A1   and   CO1A2   are   both   associated   with   cell   growth   inhibition  (Henriet   et   al.,   2000).      Thus,   minoxidil   altered   proteins   in   cultured   dermal  papilla  cells  to  increase  cell  synthesis  activity  and  inhibit  apoptosis,  fitting  with  its  effects  in  vivo.  
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Appendix  1.    Reagents  for  Bradford  Protein  Assay      The  following  were  required  for  the  quantification  of  protein  in  cell  extracts:  
(1)  Bovine  Serum  Albumin  (BSA)  stock  solution  
 Sample  Buffer  10  ml  Glycerol  (BDH  Lab  Supplies)  2.5  ml;  ethylenedaiminetetraacetic  acid  (EDTA)  (Sigma)  0.185  g;  sodium  dodecyl  sulphate  (SDS)  (Sigma)  1.5  g;  Tris  (Sigma)  0.19  g;  25  ml  distilled  water)  
 Bovine  serum  albumin  (Sigma)  0.1  g  (final  concentration  of  10  mg/ml)    








 ʹͲͲͲɊȀǣͺͲͲɊΪʹͲͲɊ    
(3)  ǯ  
 Reagent  A  (Dc  protein  assay,  Bio-­‐Rad  Labs)  2  ml  
 Reagent  S  (Dc  protein  assay,  Bio-­‐ȌͶͲɊ    
(4)  ǯ  
 Reagent  B  (Dc  protein  assay,  Bio-­‐ǡȌʹͲͲɊ          
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Appendix  2.    Reagents  for  SDS  gel  separation  of  proteins        
 The  following  are  required  for  SDS  Gel  preparation  and  protein  separation  to  be  carried  out:  
(1)  Lower  Separating  Gel    
   High  performance  liquid  chromatography  grade  water  (HPLC  )  (Fisher  Scientific)  3.3ml  
 30%  Acrylamide  (Sigma)  4ml  
 1.5  M  Tris-­‐Cl    pH  8.8  (Sigma)  2.5  ml  
 10%  Sodium  dodecyl  sulphȋȌȋȌͳͲͲɊ  
 10%  Ammonium  persulphate  (APS)  (100mg/ml)  ȋȌͳͲͲɊ  
 ȋȌȋȌͶɊ    
(2)  Upper  Stacking  Gel  
 High  performance  liquid  chromatography  grade  water  (HPLC  )  (fisher  scientific)  3.4ml  
 30%  Acrylamide  (Sigma)0.83ml  
 0.5  M  Tris-­‐Cl    pH  6.8  (Sigma)0.63ml      
 ͳͲΨȋȌȋȌͷͲɊ  
 10%  Ammonium  persulphate  (APS)  (100mg/ml)  ȋȌͷͲɊ  
 ȋȌȋȌͷɊ    
(3)  Sample  loading  dye  composition:  For  10ml    
 Tris-­‐base  (Sigma)-­‐  1.25  ml  of  0.5M  Tris  HCl  pH  6.8  
 Glycerol  (Sigma)-­‐  2.5  ml  
 Beta-­‐  mercaptoethanol  ȋȌͷͲɊ  
 Sodium  dodecyl  sulphate  (SDS)    (Sigma)  2ml  of  10%  SDS  
 Bromo-­‐Phenol-­‐Blue  (BPB)  (Sigma)  Traces    
(4)  Electrophoresis  Buffer    
 Distilled  water  450ml  
 10x  electrode  buffer  50ml  
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(5)  10x  Electrode  buffer    pH  8.3  
 Tris  (Sigma)  15.15g  
 Glycine  (Sigma)  72g  
 Sodium  dodecyl  sulphate  (SDS)    (Sigma)5g  
 Distilled  water  500ml    
(6)  Marker    (Invitrogen),  Novex®  Sharp  Pre-­‐stained  Protein  Standard  catalogue  number  :  LC5800    The  protein  standard  consists  of  12  pre-­‐stained  protein  bands  that  cover  the  range  of  3.5-­‐260  kDa  when  used  in  electrophoresis.  The  bands  are  spaced  at  convenient  kDa  weights:  260,  160,  110,  80,  60,  50,  40,  30,  20,  15,  10,  and  3.5.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
